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Supervisor:  Michael J. Krische 
 
In Michael J. Krische research group we are developing new transition metal 
catalyzed Carbon-Carbon (C-C) forming reactions focusing on atom economy and 
byproduct free, environmental friendly approaches. We have developed a broad family of 
C-C bond forming hydrogenations with relative and absolute stereocontrol which provide 
an alternative to stoichiometric organometallic reagents in certain carbonyl and imine 
additions. Inspiring from the group work my goal was to develop new reactions, extend 
the scope of our group chemistry and their application towards synthesis of biologically 
active natural products. I have been part of enantioselective Rh catalyzed Aldol reaction 
of vinyl ketones to different aldehydes. Also, we have found that iridium catalyzed 
transfer hydrogenation of allylic acetates in the presence of aldehydes or alcohols results 
in highly enantioselective carbonyl allylation under the conditions of transfer 
hydrogenative. Based on this reactivity a concise enantio- and diastereoselective 
synthesis of 1,3-polyols was achieved via iterative chain elongation and bidirectional 
iterative asymmetric allylation was performed, which enables the rapid assembly of 1,3-
polyol substructures with exceptional levels of stereocontrol. The utility of this approach 
stems from the ability to avoid the use of chirally modified allylmetal reagents, which 
require multistep preparation, and the ability to perform chain elongation directly from 
the alcohol oxidation level. This approach was utilized for the total synthesis of (+)-
 vii 
Roxaticin from 1,3-propanediol in 20 longest linear steps and a total number of 29 
manipulations. Further, advancements were made in iridium catalyzed C-C bond 
formation under transfer hydrogenation. While methallyl acetate does not serve as an 
efficient allyl donor, the use of more reactive leaving group in methallyl chloride 
compensate for the shorter lifetime of the more highly substituted olefin π-complex. 
Based on this insight into the requirements of the catalytic process, highly 
enantioselective Grignard-Nozaki-Hiyama methallylation is achieved from the alcohol or 
aldehyde oxidation levels. Also, a catalytic method for enantioselective vinylogous 
Reformatsky- type aldol addition was developed in which asymmetric carbonyl addition 
occurs with equal facility from the alcohol or aldehyde oxidation level. Good to excellent 
levels of regioselectivity and uniformly high levels of enantioselectivity were observed 
across a range of alcohols and aldehydes.  
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Chapter 1 Hydrogenation and Transfer Hydrogenation C-C Bond Formation for 
Polyketide Natural Product Synthesis  
1.1 Introduction 
 Polyketide natural products are one of the most complex groups of secondary metabolite 
originates from plants, animals, fungi and bacteria. The common feature of this class is they are 
biosynthesis product of enzymes polyketide syntheses (PKS), by recurring linear addition of two 
or three carbons building blocks named as polyacetates or polypropionates.
1
 This apparently 
simple two or three carbon chain elongation can give rise to complex families of compounds 
such as polyenes, polyphenols, polyethers and macrolides. Nearly 10,000 members of this class 
have been characterized exhibiting complex structural features.
1e
 Like other secondary 
metabolites their exact role in biological systems is not known, it is believed that they can 
function as pigments, virulence factors, infochemicals, or for defense. However, from a human 
pharmacological point of view, polyketides displays extensive practice in human medicine.
 
Polyketide natural products possess antibiotic, anticancer, antiparasitic, antifungal and 
immunosuppressive properties.
2
 Approximately 20% of the top-selling small molecule drugs are 
polyketides, and it is estimated that polyketides are five times more likely to possess drug 
activity compared to other natural product families (Figure 1.1). 
 
Figure 1.1 Example of polyketide natural products. 
2 
 
The polyketide biosynthesis is extensively reviewed, particularly a comprehensive survey 
in 2001 by Stasunton.
1f
 Here we will refresh our memory how different oxidation level in 
complex polyketide natural product are achieved. Later we will discuss efforts from our 
laboratory for the synthesis of polyketide natural products. 
1.2 Polyketide Biosynthesis  
 As investigations into polyketide biosynthesis
1
 and chemical biology continue to uncover 





 methods for polyketide construction remains at the forefront of research. It is very 
important from synthetic chemist point of view to understand the polyketide biosynthesis parting 
into different redox state and complex template, so that can be mimicked or replaced in 
laboratory. In recent years, lots of efforts have been put forth in chemical synthesis mimicking 
polyketide biosynthesis.  
 Polyketide biosynthesis is principally similar to fatty acid biosynthesis, as both follow 
similar mechanism of iterative chain elongation employing common building blocks such as, 
acetyl coenzyme A (CoA) and malonyl-CoA (MCoA) units. The multifunctional enzyme 
complexes, polyketide synthesas (PKSs) are responsible for such iterative addition sequence. 
The polyketide synthesis initiate by a decarboxylative Claisen condensation of an acyl transfer 
unit attached to an acyl carrier protein (ACP) with malonyl-CoA, mediated by ketosynthase 
(KS). The ACP is a phosphopantetheine acyl carrier protein, attached to extending chain by a 
thiol residue, function as a long flexible arm transports the growing chain to various enzymes 
required for chain extension. The condensation product is a β-keto ester, which can repeat the 
same process as required adding two or more carbon unit to the growing chain giving rise to 
polyketide, having a carbonyl group at alternate position along the chain. These polyketides 
generally cyclizes to aromatic intermediates, which in turn evolves in polyphenolic among other 
natural products. 
However, the PKSs can differentiate the β-keto ester in a highly selective and control 
manner to generate polyketides in reduced oxidation states. Such as, the β-keto ester is reduced 
by a ketroreductase (KR) to generate β-hydroxy ester. Further dehydration by dehydratase (DH) 
3 
 
will introduce unsaturation and finally again reduction by enoyl reductase (ER) will produce 
saturated polyketide subunits. These differentiation processes can be intercepted at any stage to 
an acyl transfer process to generate a different ketosynthase (KS), enable it to re-enter the 
biosynthesis (Figure 1.2). 
 
Figure 1.2 Schematic representation of Polyketide synthesis. 
4 
 
PKSs assemble the polyketide intermediates in a highly selective and controlled manner 
in different oxidation level, such as these differentiations can give rise to ketone, hydroxyl, olefin 
and deoxygenative polyacetates and polypropionates as evidently observe in many complex 
natural products. In divergence to polyketide, fatty acid biosynthesis follows the full cycle of 
reduction to give rise to fatty acids. The initial polyketide chain formed may survive in some 
cases, but mostly it is further elaborated by addition biosynthetic modification to give 
structurally more complex products. Examples of these elaboration processes are oxidative 
changes, for instance hydroxylation, epoxidation, oxidative cleavage, alkylation, esterification 
and glycosylation. These permutations of chain assembly and elaboration result in great diversity 
in polyketide structures. Indeed the biosynthesis is programmed in genetic codes, until recently 
considerable understandings have been made. Discodermolide an anticancer polyketide for 
example is made up of four acetate and 8 propionate units. It also has a 6-membered lactone at 
C-1 and O-amide at C-19 (Figure 1.3). 
 
Figure 1.3 Discodermolide, showing the acetate (blue) and propionate (red) units. 
1.3 Polyketide Chemical Synthesis 
 In general, the low natural abundance of polyketide natural products and tedious isolation 
protocols coupled with biomimetic approaches are in infancy, required efficient chemical 
synthesis.
3
 However, these devoted and meticulous efforts are still very compelling, challenging, 
unviable, strenuous and above all low yielding. A convincing case is the Novartis synthesis of 
discodermolide, enabling availability for clinical trial in anticancer study.  As the biosynthesis 
of polyketide started with recurring addition of small structural unit to make complex natural 
product, it would be highly desirable if we can learn from nature and can apply the same 
approach to chemical synthesis of polyketide. This strategy however, is challenging to imitate in 
5 
 
chemical synthesis, since the length of the resulting synthetic scheme quickly becomes 
intractable. The problem on hand is by far that simple, chemical reactivity, regioselectivity and 
stereoselectivity coupled with the backbone modifications are difficult as well. There are many 
methods for complex molecule exists, yet the majority of this technology required the use of 
multi-stage preactivation, premetallated nucleophiles, chiral auxiliaries, chiral reagents and 
excessive byproduct generation. 
1.4 Hydrogenation and Transfer Hydrogenation C-C Bond Formation 
Many methods for complex molecule synthesis exist, yet the majority of this technology 
is not easily brought to scale. Hence, there is an authentic need to discover and develop catalytic 
processes that embody the principal characteristics of “process-relevance,” in particular, the 
ability to transform abundant, renewable feedstocks to value-added products in the absence of 
stoichiometric byproducts. This quality is embodied by catalytic hydrogenation, which has found 
broad application across all segments of the chemical industry, including the manufacture of 
chiral pharmaceutical ingredients, and alkene hydroformylation
5
, the prototypical C-C bond 
forming hydrogenation and largest volume application of homogenous catalysis.
6, 7
 Inspired by 
the impact of hydrogenation and hydroformylation, we have developed a broad, new family of 
eanantioselective C-C bond forming hydrogenation and transfer hydrogenations. The atom-
economy exhibited by these transformations, particularly the exclusion of stoichiometric metallic 
byproducts, suggests these methods would be viable candidates for use at the process level upon 
minimization of catalyst loading.  
We have found that diverse π-unsaturated reactants are reductively coupled to polarized 
C=X (X = O, NR) bonds under hydrogenation conditions, offering an alternative to 
stoichiometric organometallic reagents in a broad range of carbonyl and imine addition 
processes. This concept is extended further by related transfer hydrogenative processes, for 
which hydrogen exchange between alcohols and π-unsaturated reactants triggers generation of 
electrophile-nucleophile pairs that combine to form products of carbonyl addition directly from 







Scheme 1.1 Hydrogen-mediated C=X (X = O, NR) addition bypasses stoichiometric byproduct 
generation. 
1.4.1 C-C Bond Forming Hydrogenation 
Despite its routine use for well over a century, alkene hydroformylation and the parent 
Fischer-Tropsch process were the only examples of hydrogen-mediated reductive coupling at the 
onset of our studies.4-6 Hence, it became necessary to identify a mechanistic pathway that would 
unlock hydrogenation for C-C bond formation. Whereas neutral rhodium complexes engage in 
rapid hydrogen oxidative addition,
9
 hydrogen oxidative addition is turnover limiting for cationic 
rhodium catalysts.
10,11
 Accordingly, for cationic complexes of rhodium, it was found that the 
diminished rate of hydrogen oxidative addition, along with the availability of an additional 
coordination site, conspire to promote oxidative coupling to form metallacyclic intermediates, 
which participate in hydrogenolysis to form products of reductive C-C bond formation in the 






Scheme 1.2 Cationic rhodium complexes promote hydrogen-mediated reductive coupling via oxidative 
coupling pathways. 
 Through the implementation of oxidative coupling pathways, numerous C-C bond 
forming hydrogenations were developed. For example, hydrogenation of enones in the presence 
of aldehydes employing a cationic rhodium catalyst modified by a TADDOL-like phosphonite 
ligand delivers products of reductive aldol addition with high levels of relative and absolute 
stereocontrol.
12
 The aldol reaction is one of the most important transformations for the synthesis 
of polyketide as it follows the same technique for C-C bond as utilized in biosynthesis as Claisen 
condensation. There has been tremendous amount of work done in this field. The important 
feature is the synthesis of branch selective aldol addition as lacking in unsymmetrical ketone, 
aldehyde organocatalysis. 
Similarly, high levels of substrate directed asymmetric induction are achieved in 
hydrogen-mediated reductive aldol additions to N-Boc-α-amino aldehydes.
13
 Notably, due to 
their configurational instability of N-Boc-α-amino aldehydes, corresponding additions of alkali 
enolates are unknown. This reactivity pattern is applicable to related activated olefins, as 
demonstrated by hydrogen-mediated coupling of 2-vinylpyridines and N-arylsulfonyl imines to 
furnish branched products of imine addition.
14
 In each case, syn-diastereoselectivity is observed, 






Scheme 1.3 Hydrogenation of activated olefins to form products of C-C bond formation.  
Next important reaction in polyketide synthesis is vinylation of carbonyls availing the 
same connectivity in variety of polyketide. Hydrogenation of alkynes in the presence of carbonyl 
and imine partners provides allylic alcohols and allylic amines, respectively, in the absence of 
stoichiometric byproducts. For example, hydrogenation of acetylenic aldehydes employing a 
cationic rhodium catalyst induces reductive cyclization to form enantiomerically enriched 
heterocycles.
15
 Using cationic iridium catalysts, hydrogenation of 1,2-dialkyl substituted alkynes 
9 
 
in the presence of N-arylsulfonyl imines provides trisubstituted allylic amines.
16
 For both 
processes, complete levels of E:Z selectivity (≥95:5) is observed. Such alkyne-C=X (X = O, NR) 
reductive couplings bypass use of preformed vinylmetal reagents (Scheme 1.4).  
 
Scheme 1.4 Intra- and intermolecular hydrogen-mediated C-C coupling of unactivated alkynes.  
 Underscoring functional group compatibility, diverse heterocyclic aromatic aldehydes 
and ketones are subject to hydrogen-mediated reductive coupling to conjugated enynes to 
provide heteroaryl substituted secondary and tertiary carbinols, respectively. Using rhodium 
catalysts modified by (R)-tol-BINAP or (R)-xylyl-WALPHOS, uniformly high levels of 
enantioselectivity are observed. Manipulation of the diene moiety of the coupling products 







Scheme 1.5 Hydrogen-mediated couplings of 1,3-enynes with heterocyclic aromatic aldehydes or ketones.  
 Using cationic rhodium catalysts, hydrogenation of conjugated alkynes in the presence of 
glyoxalates and pyruvates provides the corresponding α-hydroxy esters with high levels of 
enantiomeric enrichment.
18
 Conjugated enynes and diynes also participate in reductive couplings 
to (N-sulfinyl)iminoacetates under the conditions of rhodium catalyzed hydrogenation.
19
 Using 
appropriately substituted N-sulfinyl substituent,
20
 the corresponding β,-unsaturated α-amino 
acid esters are generated as single diastereomers. Exhaustive hydrogenation of the diene or enyne 
side chain of the C-C coupling product provides access to β-substituted α-amino acids (Scheme 
1.6).  
 
Scheme 1.6 Formation of α-hydroxy esters and α-amino esters via C-C bond forming hydrogenation.  
11 
 
The hydrogen-mediated reductive coupling of acetylene in the presence of carbonyl and 
imine partners provides products of (Z)-butadienylation.
21
 As corroborated by isotopic labeling, 
ESI-MS and computational studies,
22
 the reaction occurs through an unusual mechanism 
involving formation of a rhodacyclopentadiene
23
 followed by C=X (X = O, NR) insertion and 
hydrogenolysis of the seven-membered metallacycle. Using chirally modified cationic rhodium 
catalysts, allylic alcohols and allylic amines are formed in highly optically enriched form. 
Hydrogenative coupling of acetylene to α-chiral aldehydes using enantiomeric rhodium catalysts 
ligated by (S)-MeO-BIPHEP and (R)-MeO-BIPHEP provides adducts with good levels of 










1.4.2 C-C Bond Forming Transfer Hydrogenation 
Under transfer hydrogenation conditions using ortho-cyclometallated iridium catalysts 
generated in situ from allyl acetate, 3-nitrobenzoic acid and a chiral bis-phosphine ligand, 
enantioselective carbonyl allylation is achieved from the alcohol or aldehyde oxidation level 
using allyl acetate as the allyl donor.
24
 Aliphatic, allylic and benzylic alcohols are transformed to 
the corresponding homoallylic alcohols with uniformly high levels of enantioselectivity. In the 
presence of isopropanol, but under otherwise identical conditions, aldehydes are converted to an 
equivalent set of adducts. This protocol circumvents cryogenic conditions and the stoichiometric 
use of metallic reagents or reductants (Scheme 1.8). 
 
Scheme 1.8 Enantioselective iridium catalyzed carbonyl allylation from the alcohol or aldehyde 
oxidation level 
 The cyclometallated iridium π-allyl C,O-benzoate complexes, which have been 
characterized by single crystal x-ray diffraction, are sufficiently robust that they may be purified 
chromatographically. A catalytic mechanism consistent with the collective data begins with 
protonolysis of the iridium π-allyl complex by the reactant alcohol to furnish a pentacoordinate 
iridium alkoxide. β-Hydride elimination produces aldehyde and an iridium hydride, which 
deprotonates to generate an anionic iridium(I) intermediate. Oxidative addition of allyl acetate 
provides the π-allyl complex. Because the π-allyl complex is the catalyst resting state, it can be 
13 
 
chromatographically recovered from the reaction mixture. Turnover-limiting aldehyde addition 
provides an iridium alkoxide. This hexacoordinate 18-electron complex is resistant to β-hydride 
elimination due to coordination of the homoallylic olefin. Exchange of the homoallylic iridium 
alkoxide with reactant alcohol releases the product and regenerates the pentacoordinate iridium 
alkoxide to close the catalytic cycle (Scheme 1.9). 
 
 
Scheme 1.9 Catalytic mechanism for iridium catalyzed carbonyl allylation under transfer hydrogenation 
conditions.  
Corresponding carbonyl crotylations employing α-methyl allyl acetate can be conducted 
using the iridium C,O-benzoate complex that is assembled in situ from [Ir(cod)Cl]2, allyl acetate, 
4-cyano-3-nitrobenzoic acid and the chiral phosphine ligand (S)-SEGPHOS.
25a
 However, 
although in situ assembly of the catalyst is convenient and excellent enantioselectivities typically 
were observed (>95% ee), only modest levels of anti-diastereoselectivity were evident (5:1 – 
11:1 dr). Use of the chromatographically purified catalyst allows the reaction to be performed at 
lower temperature (60 
o









Scheme 1.10 Enantioselective iridium catalyzed carbonyl crotylation from the alcohol or aldehyde 
oxidation level.  
Enantioselective carbonyl allylation and crotylation from the alcohol oxidation level 
enables carbonyl allylation processes that are not possible using conventional allylmetal and 
crotylmetal reagents. For example, although 1,3-dialdehydes are intractable and cannot be used 
in enantioselective double allylation,
26
 1,3-propanediols are stable and engage in efficient two-
directional allylation to provide C2-symmetric adducts.
27
 In these processes, the minor 




Beyond carbonyl allylation and crotylation, other types of enantioselective allylations are 








each case, enantioselective carbonyl addition is achieved in the absence of stoichiometric 
metallic reagents (Scheme 1.11).  
 
Scheme 1.11 Enantioselective double and polypropionate building blocks.  
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The appearance of iridium hydrides in the catalytic mechanism, suggests the feasibility of 
recruiting allenes and dienes as allyl donors via hydrometallation. Indeed, cyclometallated 
iridium C,O-benzoates modified by (S)-SEGPHOS promote enantioselective carbonyl tert-





 For reactions conducted from the alcohol oxidation level, stoichiometric 
byproducts are completely absent. Interestingly, the absolute stereochemistry of tert-prenylation 
is opposite to that observed in the aforementioned allylations (Scheme 1.12). 
 
Scheme 1.12 Enantioselective carbonyl tert-prenylation from the alcohol or aldehyde oxidation level.  
 Finally, transfer hydrogenation catalysts based on ruthenium also promote carbonyl 
addition from the alcohol or aldehyde oxidation level. For example, using chiral ruthenium 
catalysts modified by (R)-SEGPHOS or (R)-DM-SEGPHOS, the indicated silyl-substituted 
butadiene, which is prepared in a single manipulation from chloroprene, engages in syn-
diastereo- and enantioselective carbonyl crotylation from the alcohol or aldehyde oxidation 
level.
31 
Here, to address the issue of relative stereocontrol, the silyl-substituent directs formation 
17 
 
of geometrically defined σ-allylruthenium intermediates, which react stereospecifically through 
closed, chair-like transition structures (Scheme 1.13).  
 
Scheme 1.13 Enantioselective syn-diastereo- and enantioselective carbonyl crotylation from the alcohol or 
aldehyde oxidation level via ruthenium catalyzed transfer hydrogenation.  
1.5 Application in Polyketide Synthesis 
 Through iterative two-directional chain elongation of 1,3-propanediol, a total synthesis of 
the oxo-polyene macrolide (+)-roxaticin was achieved in 20 steps.
32
 Corresponding double 
crotylations of 2-methyl-1,3-propanediol result in the generation of pseudo-C2-symmetric 
polypropionate stereoquintets the fragment C14−C28 which appear as substructures in diverse 
polyketide natural products. In this approach, nine of ten C-C bonds formed in the longest linear 
sequence was made via metal catalysis, including 7 C-C bonds formed via iridium catalyzed 
alcohol C-C coupling. The important feature of this approach bypasses the redox manipulations 
and use of any chiral auxiliary. Notably, this total synthesis represents the most concise 
preparation of any oxo-polyene macrolide reported to date, and is achieved in the absence of 






Scheme 1.14 Retrosynthesis of Roxaticin and application of double allylation in synthesis. 
 The synthesis of bryostatin 7 is accomplished in 20 linear and 36 total steps.
33
 The 
concise nature of this approach can be attributed to the rapid assembly of key fragments A and B, 
as availed through application of C-C bond forming hydrogenations. The same double allylation 
of 1,3-propanediol to form C2-symmetric diol. Interestingly, ozonolysis of diol 11 delivers an 
unstable lactol, which is protected in situ as the bis-TBS ether to provide aldehyde 12 as a single 
isomer. Transfer hydrogenation in the presence of 1,1-dimethylallene promotes tert-
prenylation
17b
. Elaboratin of this product by ozonolysis provides β-acetoxy aldehyde 14. 
Reductive coupling of aldehyde 14 and allyl acetate under transfer hydrogenation conditions 
results in the formation of homoallylic alcohol 15, which was elaborated to fragment B of 









Using the chromatographically isolated iridium catalyst modified by (R)-SEGPHOS, 1 of 
16 possible stereoisomers is formed predominantly.
34 
This methodology was used to form the 
C19-C27 ansa chain of rifamycin S in 8 steps (originally prepared in 26 steps), constituting a 
formal synthesis of the natural product (Scheme 1.16).
35
 
Scheme 1.16 Enantioselective double allylation and double crotylation of 1,3-propanediols to form 
polyacetate and polypropionate building blocks.  
1.6 CONCLUSION 
Polyketides are usually biosynthesized through recurring addition of small two to three 
carbon unit addition through a decarboxylative condensation of malonyl-CoA derived extender 
units in a similar process to fatty acid synthesis. The polyketide chains produced by a polyketide 
synthases (PKSs) are often further derivitized and modified into bioactive natural products. 
Inspired by the process-relevance of hydrogenation and hydroformylation, we have developed a 
broad, new family of enantioselective C-C bond forming hydrogenation and transfer 
hydrogenations.The atom-economy associated with these transformations, particularly the 
exclusion of stoichiometric metallic byproducts, the control of relative and absolute stereocontrol 
make them a viable candidate in the synthesis of complex molecules, especially in synthesis of 




Chapter 2: Diastereo- and Enantioselective Rhodium Catalyzed Aldol Coupling Reaction of 
Enone to Aldehydes via Catalytic Hydrogenation 
2.1 Introduction 
In today’s proficient, innovation driven and environmentally conscious chemical society, 
the focus of chemical research resides to develop a sustainable means of preparing the chemical 
commodities. Therefore, the focus of many effective researches is to improve upon the present 
set of principle in chemical transformation to atom economy
36
, step economy, green chemical 
processes and ideal synthesis which avoid the generation of stoichiometric byproducts. An 
example of such transformation is hydrogenation.
37
 In modern chemical transformations catalytic 
hydrogenation has found broad application across all parts of the chemical industry, especially in 
the manufacture of chiral pharmaceutical ingredients. In fact, industrial syntheses of more than 
half of the chiral compounds excluding physical and enzymatic resolution are made via 
asymmetric hydrogenation.
38
 This is the reason why this process is an ideal chemical 
transformation and avoids the generation of stoichiometric byproducts moreover, hydrogen gas is 
the cheapest possible reductant. Even though its routine use for well over a century, alkene 
hydroformylation
39
 and the parent Fischer-Tropsch process
40
 were the only examples of 
hydrogen-mediated reductive coupling. The alkene hydroformylation, the prototypical C-C bond 
forming hydrogenation is the largest volume application of homogenous catalysis.
41
 Hence, it 
became necessary to identify a mechanistic pathway that would unlock hydrogenation for C-C 
bond formation. Whereas neutral rhodium complexes engage in rapid hydrogen oxidative 
addition,
42 
hydrogen oxidative addition is turnover limiting for cationic rhodium catalysts.
43,44
 
Consequently, for cationic complexes of rhodium, it was found that the diminished rate of 
hydrogen oxidative addition, along with the availability of an additional coordination site, 
promote oxidative coupling to form metallacyclic intermediates, which participate in 
hydrogenolysis to form products of reductive C-C bond formation in the absence of byproducts 




Scheme 2.1 Cationic rhodium complexes promote hydrogen-mediated reductive coupling via oxidative 
coupling pathways. 
Inspired by the impact of hydrogenation and hydroformylation on industrial chemistry,
45
 
our research group carried out systematic investigations into reductive C-C bond formation via 
catalytic hydrogenation.
46
 Through the implementation of oxidative coupling pathways, our 
research group has established numerous C-C bond forming hydrogenations. We have found that 
diverse π-unsaturated reactants can couple to polarized C=X (X = O, NR) bonds under 
hydrogenation conditions, offering an alternative to stoichiometric organometallic reagents in a 
broad range of carbonyl and imine addition processes (Scheme 2.2). 
 
 








 is among the versatile chemical transformation available to synthetic 
community particularly for the synthesis of polyketide natural products. In recent past many 
advances were made in aldol reaction due to our mechanistic understanding of chemical 
transformation. This meticulous cross aldol reaction resulted due to development of well-defined 
enolization protocols, regioselective coupling of enolates, relative and absolute stereocontrol by 
highly effective chiral auxiliary and ideally metal or organo- catalyzed direct aldol 
transformation. However, with the evolution of these modern techniques still the aldol reaction 
lacks a general ideal reactivity. For instance, the site specific enolization in direct aldol addition 
of non-symmetric ketones remains a significant challenge. Regioselective enolate formation in 
direct enantioselective aldol additions of nonsymmetric ketones generally favors the sterically 
less demanding position. For instance, L-proline or the heterobimetallic catalyst LaLi3-
tris(binaphthoxide) (LLB) catalyze couling of 2-butanone couple and aldehyde to furnish the 
linear product
48
 (Scheme 2.3). 
 
Scheme 2.3 Linear regiocontrol in direct aldol addition of nonsymmetric ketone 
 Gilbert Stork reported a solution to this problem by regiospecific enolate formation from 
an enone.
49
 The dissolving metal reduction using Li/NH3 was found to promote the regiospecific 




Scheme 2.4 Regiospecific enolate generation using dissolving metal reduction. 
2.3 Catalytic Hydrogenative Aldol Coupling Reaction 
In 1987, Revis,
15a
 benefiting from Stork work, first reported the metal catalyzed reductive 
coupling of α,β-unsaturated esters to carbonyl compounds to form aldol products, termed as the 
“reductive aldol reaction”.
50
 In this transformation, RhCl3•3H2O serves as the precatalyst and 
trimethylsilane serves as terminal reductant. At ambient temperature, α,β-unsaturated esters and 
lactones were found to couple to both aldehydes and ketones. Notably, as demonstrated by the 
coupling of methyl methacrylate to acetone, two contiguous tetra-substituted centers may be 
created in this transformation (Scheme 2.5). 
 
Scheme 2.5 Seminal reductive aldol reaction of methyl acrylate. 
2.3.1 Intramolecular Catalytic Hydrogenative Aldol Coupling Reaction of Enones 
In order to evaluate the viability, our group investigated the intramolecular enone to 
aldehyde reductive aldol addition under hydrogenation conditions. Interestingly, employing 2.18 
with a neutral complex, Wilkinson catalyst, the reaction mostly delivers the product of 
conventional hydrogenation 2.20. However, rhodium salts that embodied increased cationic 
character, such as Rh(cod)2OTf provided nearly equal proportions of syn-aldol 2.19 and 
25 
 
conventional reduction products 2.20. Furthermore, when Rh(cod)2OTf is used in conjunction 
with basic additive, potassium acetate, the aldol addition product was formed as major reaction 
product. Using electron deficient ligand, 4-trifluorophenylphosphine the competing reduction 
pathway was completely suppressed. We found out these reaction condition were applicable to 
other similar systems
51
 (Table 2.1). 
Table 2.1 First example of intramolecular catalytic reductive aldol keto-aldehyde cyclization. 
 
Additionally, our group has found reductive aldol cyclization of keto-enones, under 
slightly modified conditions. Using keto-enone 2.21 under slightly different condition, we 
obtained the syn-aldol product 2.22 as single diastereomers, with small quantities of conjugate 
reduction product (8%) (Table 2.2). The competitive 1,4-redution products resulted since the 









Table 2.2 Reductive aldol cyclizatio of keto-enones via catalytic hydrogenation, yield of 
conjugate reduction product is indicated in parentheses. 
 
However, 1,3-diones 2.30 and 2.31 are more electrophilic due to inductive effect and 
dipole-dipole interactions, they can reductively cyclized under very similar condition in addition 
to at ambient temperature provided mainly the desired reductive product with minimal to no 
conjugate reduction  product 2.32 (R = Ph). However, in generation of decaline system 2.37 
which are more seterically demanding we observed some extent of conjugate reduction (Table 
2.3).
17
 Our research group was able to perform similar intramolecular coupling reaction,
53
 among 
them the much challenging addition of aldehyde enolate to ketones to deliver the corresponding 










Table 2.3 Reductive aldol cyclization of dione-enones via catalytic hydrogenation. 
 
2.3.2 Intermolecular Catalytic Hydrogenative Aldol Reaction of Enones 
 Based on the intermolecular hydrogenative aldol reaction, our group have developed 
more desirable intermolecular variant which is much needed tool for the construction of 
polypropionate natural products. For the reaction of methyl vinyl ketone 2.40 and aldehyde 2.2 
the previously employed catalyst Rh(cod)2OTf and triphenylphosphine provided good yield of 
aldol product 2.4 as mixture of diastereomers. However, with ligand screening it was found that 
 -acidic ligands such as tri(2-furyl)phosphine promote exceptionally high level of syn 
diasteroselectivity. It was reasoned that the  -acidic ligand may increase the diastereoselectivity 
by increasing the Lewis acidity at the rhodium center, which should result in compact chair like 
transition state resulting in destabilization of the competitive pathways. Based on these finding 
the our group was able to couple methyl vinyl ketone 2.40 (MVK) and ethyl vinyl ketone 2.40a 
(EVK) to a wide variety of aldehydes (Table 2.4).
18c
 In subsequent work, the scope of high 
diastereoslective reaction was extended to coupling of MVK and EVK to α-chiral amino 
aldehydes
18d
 and coupling of crotyl vinyl ketone
18e





Table 2.4 Intermolecular syn-diastereoselective reductive aldol reaction. Tri(2-furyl)phosphine 
effect on diastereoselectivity. 
 
2.4 Diastereo- and Enantioselective Rhodium Catalyzed Aldol Reaction of Enone 
 Enantioselective reductive aldol couplings of vinyl would enable access to branched aldol 
adducts, providing regiochemical complement to direct organocatalyzed and metal catalyzed 
aldol couplings of nonsymmetric ketones. However, due to our understanding of hydrogenative 
aldol reaction the enantioselective variant is specially challenging. The problem poses the 
following problems, 
a) Chelating phosphine ligands provides only trace quantities of product. 
b) Diastereoselectivity can be enforced by using π-acidic ligands, such as tri(2-
furyl)phosphine. 
c) Monodentate chiral phosphine ligands having π-acidic character are commercially 
limited. 
Therefore, the task of design, synthesis and evaluation of novel chiral monodentate 





2.4.1 Identification of Lead Chiral Monodentate Phosphine Ligand 
 The enantioselective hydrogenative aldol reaction evaluation starts with screening with 
different π-acidic chiral ligand. Methyl vinyl ketone 2.40 and 2-benzyloxyacetaldehyde 2.41 was 
couple under previously optimized hydrogenation condition varying the chiral ligand. Some of 
these ligands were effective, displaying low to moderate selectivity. As proposed, bidentate 
ligands 2.46 and 2.47 were not effective resulting in low conversion (Table 2.5, entries 4 and 5). 
However, monodentate ligands resulted in good yields though, the enantioselectivity was low. 
The best ligand in terms of enantiocontrol was furyl substituted BINAP based phosphonite 
structure 2.48 (Table 2.5, entry 6). However, over the years numerous ligands were modified and 
screened without any promising improvement.  
Table 2.5 Initial screening of ligands for enantioselective aldol reaction. 
 
 Further considering the best ligand 2.48 in table 2.5 (entry 6) left us considering if it can 
be refined into a system that can easily modified with different structural variation, which will 
enable us to investigate well defined structure selectivity relationships. A comparable structure 
30 
 
unit is TADDOL like phosphonites
54
 2.49, offer a versatile template amenable to systematic 
structural variation that may be independently optimized; a) the P-aryl unit (Aryl), b) the groups 
appended to the tertiary carbinol center (R1) and c) the ketal substructure (R2), scheme 2.6. 
Additionally, it might be possible to combine the independently optimized units to in a ligand 
augmenting the effect of individual subunits. 
 
Scheme 2.6 TADDOL like phosphonite ligand. 
2.4.2 Ligand Optimization: Structure Selectivity Relationship 
 The chiral phosphonite ligands were synthesized from chiral pool, starting from L-
Tartaric acid 2.50. The synthesis involved conventional transformations to the desire ligands 
2.54. It is important to note that the synthesis is very divergent and the different structural unit 
can be installed with slight modification. The synthesis outline is given in scheme 2.7. 
 
Scheme 2.7 General synthesis scheme for TADDOL like phosphonite ligand. 
 The structural modification started with P-aryl moiety while R1 and R2 were fixed as 
methyl groups. We know beforehand that 2-furyl is vital for reactivity and enantioselectivity. 
Therefore, the very first ligand, 2-furyl substituted phosphonite ligand 2.57 was synthesized and 
31 
 
to our delight it gave excellent reactivity with moderate selectivity (90%, 59% ee) (Table 2.6, 
entry 1). Encouraged by this finding we prepared and screened different P-aryl substituted 
ligands. 2-methyl furyl gave poor selectivity 2.58 (50% ee) (Table 2.6, entry 2), while changing 
the furyl group to benzofuryl 2.59, resulted in good selectivity (66% ee) (Table 2.6, entry 3). The 
phenyl group 2.60 at this position gave very high selectivity (80% ee) however poor reactivity 
(20% yield) (Table 2.6, entry 4). Also, electron withdrawing substituted phenyl group 2.61 were 
also ineffective (Table 2.6, entry 5).  





 The benzofuryl substituted ligand 2.57 was not only superior at chirality transfer but from 
experimental point of view, this ligand was also more stable than for example the 2-furyl 
substituted ligand. Having established the benzofuryl group next the R1 and R2 groups were 
investigated. By changing R1 group from methyl to ethyl 2.62 which in turn increase the steric 
bulk at the phosphine center resulted in poor reactivity with 32%, though with slight increase in 
selectivity (76% ee, table 2.7, and entry 2). However, with introduction of even bulkier subunit 
like phenyl group 2.63 both the selectivity and reactivity decreases (15%, 30% ee, table 2.7, 
entry 3). Therefore, the methyl subunit was considered to be optimal at R1 position. 
Table 2.7 Effect of R1 subunit on structure selectivity relationship in TADDOL like phosphonite 
ligands. 
 
Finally, the ketal substructure (R2) groups were established. When the size of the group 
was increased from methyl to ethyl 2.64, the selectivity and reactivity (75% ee, 75% yield) saw a 
considerable jump (Table 2.8, entry 2). However, further increasing the size to i-propyl group in 
33 
 
ligand 2.65 did not help to increase neither the reactivity nor selectivity (Table 2.8, entry 3). It 
was also found that cyclic ketals such as cyclohexyl group 2.66 resulted in moderate selectivity 
(56% ee, table 2.8, entry 4). The very sterically demanding adamantyl group 2.67 also displayed 
only moderate reactivity and selectivity (Table 2.8, entry 5). Based on these findings, ethyl group 
was established as the optimal R2 group. 
Table 2.8 Effect of R2 subunit on structure selectivity relationship in TADDOL like phosphonite ligands. 
 
Interestingly, the ligand which combines the optimal 2- benzofuryl, diethyl ketal, and 
dimethyl carbinol substructures 2.64, gave the best results, still the selectivity was not practical. 
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Further screening of the aryl group revealed that the benzothiophene P-aryl substituent ligand 
gave better selectivity than benzofuran (Table 2.9, entry 2). This ligand was named as 
Abbasphos I (AP-I). Finally at this point, we anticipated optimization of reaction condition will 
result in higher selectivity. Satisfyingly, at 0 
o
C we were able to obtained very high selectivity 
(94%, 94% ee) (Table 2.9, entry 3). Further, the optimal efficiency and selectivity were observed 
using the preformed Rh complex derived from Rh(cod)2OTf and benzothiophene substituted 
ligand AP-I as a precatalyst. Under these reaction conditions, the parent aldehyde is transformed 
to the syn-aldol adduct with exceptional levels of relative and absolute stereocontrol (Table 2.9, 
entry 4). 





2.4.3 Substrate Scope 
 The optimal chiral TADDOL like phosphonite (AP-I) ligated Rh complex was examined 
in reductive aldol couplings of MVK to diverse aldehydes. The reaction resulted in uniformly 
high relative and absolute selectivities across a wide range of aldehydes. Beyond the parent 
aldehyde 2.56 and 2-benzyloxy acetaldehyde 2.42 (Table 2.10, entry 1 and 2), β-heteroatom 
substituted aldehyde 2.69 (Table 2.10, entry 3) and α-(hetero)aryl aldehydes 2.70-2.72 (Table 
2.10, entry 4, 5 and 6) all were found to engage in highly diastereo- and enantioselective 
hydrogenative aldol additions. 




A similar set of reactions were performed with ethyl vinyl ketone 2.40a under the 
optimized reaction conditions. Uniform levels of relative and absolute stereocontrol were 
observed in the hydrogenative aldol additions (Table 2.11). 




2.4.4 Second generation of TADDOL like Phosphonite Ligands 
 The Single crystal X-ray diffraction analysis of [Rh(cod)(L)2]OTf (L = the acetonide of 
AP-I) reveals a C2-symmetric arrangement around Rh (Figure 2.1). Based upon the hypothesis 
that a similar metal-ligand arrangement is evident in the stereo-determining event, ligands AP-II 
and AP-IV were also designed. For ligands AP-II and AP-IV the (benzo)thiophene moiety is 
substituted such that the purported chiral pocket is deepened, thus potentially conferring 
heightened levels of enantioselection.  
 





The figure graphics are depictions of crystallographic data imported 
into ChemDraw Ultra 9.0. For clarity, the following substructures were omitted. Top: The methyl groups 
and triflate ion. Front: The methyl groups, triflate ion and COD. Side: The methyl groups, triflate ion, 
dioxolane rings and phosphonite oxygen atoms.) 
The reliability of this analysis is supported by the fact that AP-II and AP-IV are both 
found to induce higher levels of optical enrichment in aldehyde 2.73, whereas AP-III, which 
projects the methyl residue into an inactive volume of space, displays selectivities comparable to 







Table 2.12 Second generation of TADDOL like phosphonite ligands with improve selectivity. 
 
2.5 Summary 
 In summary, we report the first distereo- and enantioselective reductive aldol couplings 
of commercially available methyl vinyl ketones (MVK) and ethyl vinyl ketone (EVK), This was 
achieved through the design of a novel monodentate TADDOL-like phosphonite ligand. In the 
presence of aldehydes and vinyl ketone using cationic rhodium catalysts modified by chiral 
TADDOL-like phosphonite ligands produces aldol adducts with excellent control of relative and 
absolute stereochemistry. In the course of designing the novel monodentade TADDOL-like 
phosphonite ligand (abbasphos) a structure reactivity relationship of the ligand with respect to 
absolute stereocontrol was displayed. These ligands enabled us to couple aliphatic, aromatic and 
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heteroaromaatic aldehyde in very high enantiocontrol and high yields. Further, developments of 




2.6 Experimental Scetion 
2.6.1 General Procedure for Asymmetric Aldol Coupling of Enones and Aldehydes 
To a 13 mm × 100 mm test-tube were added Li2CO3 (10 mol%), [Rh(cod)(AP-I)2]OTf (5 mol%), 
aldehyde (100 mol%) and DCM (1.0 M). The test-tube was sealed, cooled to 0 
o
C and the 
reaction system was sparged with Ar(g) followed by H2(g) for 20 seconds each. The reaction 
system was placed under one atmosphere of hydrogen using a balloon and enone (300 mol%) 
was added to the reaction mixture. The reaction mixture was allowed to stir for 24 h at 0 
o
C. The 
reaction mixture was evaporated and the aldol products were separated by flash chromatography 
(SiO2: EtOAc/Hexane).  
2.6.2 General Procedure for the determination of Enantiomeric Excess for Compounds 
 Enantioselectivities were determined by chiral stationary phase HPLC analyses made in 
comparison to racemic diastereomeric mixtures prepared by (i) hydrogenation of the 
corresponding Morita-Baylis-Hillman adducts, or in the case of the ethyl vinyl ketone adducts 
1c-7c (ii) the aldol reaction between the lithium enolate of 3-pentanone and the corresponding 
aldehyde, followed by treatment with magnesium bromide etherate.  The enantiomeric excess 
reported for all products is based on the average of two reactions, with a minimum of two HPLC 








2.6.3 Experimental Procedures for Catalyst Formation 
General Procedure for the Formation of [Rh(cod)(AP-I)2]OTf complex 
(3aR,8aR)-6-(Benzo[b]thiophen-2-yl)-2,2-diethyl-tetrahydro-4,4,8,8-tetramethyl-
[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine (AP-I) (700 mg, 1.7 mmol, 210 mol%) and 
Rh(cod)2OTf (375 mg, 0.8 mmol, 100 mol%) were dissolved in DCM (0.1 M) and stirred for 6 h 
at 25 
o
C.  The solvent was removed under reduced pressure and the residue was triturated with 
dry degassed hexanes for 10 h with vigorous stirring.  The resulting mixture was filtered, and the 




H NMR (400 MHz, CDCl3): δ 7.85 (d, J = 7.9 Hz, 2H), 7.65 (d, J = 7.9 Hz, 2H), 7.46-7.36 (m, 
6H), 5.55 (bs, 2H), 5.47 (bs, 2H), 3.86 (d, J = 9.2 Hz, 2H), 3.74 (d, J = 9.2 Hz, 2H), 2.70-2.50 
(m, 8H), 1.51 (m, 14H), 1.25 (m, 12H), 1.06 (s, 6H), 0.79 (q, J = 8.2 Hz, 12H). 
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P NMR (121.5 






H NMR (400 MHz, CDCl3): δ 7.61-7.59 (m, 4H), 7.44-7.36 (m, 10H), 5.55 (bs, 2H), 5.42 (bs, 
2H), 3.89 (d, J = 9.4Hz, 2H), 3.78 (d, J = 9.4Hz, 2H), 2.69-2.52 (m, 8H), 1.62 (m, 8H), 1.52 (s, 
6H), 1.39 (s, 6H), 1.31 (s, 6H), 1.14 (s, 6H), 0.85 (t, J = 7.4Hz, 6H), 0.84 (t, J = 7.0 Hz, 6H). 
31
P 








2.6.4 Spectroscopic Data and Experimental Procedures for Selected Chiral Ligands  
a) Representative procedure for the synthesis of Chiral Ligands:   
 
To a solution of (4R,5R)-diethyl- 2,2-dimethyl-1,3-dioxolane-4,5-dipropan-2-ol (4.0 g, 16.2 
mmol, 100 mol%) and triethylamine (6.8 mL, 48.6 mmol, 300 mol%) in THF (0.1 M) at -78 
o
C, 
PCl3 (2.2 mL, 20.0 mmol, 120 mol%) was added quickly with stirring, and the reaction was 
allowed to come to 25 
o
C over 1 hour, and then was stirred for 10 hours at 25 
o
C.  The reaction 
was then filtered through a plug of celite under an argon atmosphere with the exclusion of 
moisture, and the solvent was removed via distillation at reduced pressure.  The crude solid was 
then dissolved in 50 mL of ether, and the solids were removed by filtration through a plug of 
celite under an argon atmosphere with the exclusion of moisture.  The solvent was again 
removed under reduced pressure.  The resulting oil (3aR,8aR)-6-chloro-2,2-diethyl-tetrahydro-
4,4,8,8-tetramethyl-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine (4.9 g, 15.8 mmol) was of 
sufficient purity to be used directly in the next step.  
To benzothiophene (1.65 g, 12.3 mmol, 100 mol%) dissolved in THF (0.1 M)  and cooled to -78 
o
C, tert-butyllithium (1.2 M, 10.2 mL, 12.2 mmol, 100 mol%) was added dropwise and the 
mixture was stirred for 1 hour at -78 
o
C.  This solution was then transferred via cannula quickly 
to a solution of (3aR,8aR)-6-chloro-2,2-diethyl-tetrahydro-4,4,8,8-tetramethyl-[1,3]dioxolo[4,5-
e][1,3,2]dioxaphosphepine (4.9 g, ~15.8 mmol, 100 mol%) in THF (0.1 M) at  -78 
o
C.  The 
reaction was allowed to warm to 25 
o
C over 1 hour, and then stirred for 10 hours at 25 
o
C.  The 
solvent was then removed under reduced pressure and the crude product was purified by flash 
chromatography (SiO2: Ether/Hexane) to give the title compound in 59% yield over 2 steps (3.88 

















H NMR (400 MHz, CDCl3): δ 7.63 (d, J = 1.4 Hz, 1H), 6.84-6.81 (m, 1H), 6.42–6.40 (m, 1H), 
4.46 (dd, J = 9.2, 3.7 Hz, 1H), 3.99 (d, J = 9.2 Hz, 1H), 1.53 (s, 6H), 1.44 (s, 3H), 1.41 (s, 6H), 
1.35 (S, 3H). 
13
C NMR (100 MHz, CDCl3): δ 155.6 (d, J = 11.2 Hz), 146.7 (d, J = 4.5 Hz), 
118.2 (d, J = 26.9 Hz), 110.1 (d, J = 5.2 Hz), 109.7, 82.5 (d, J = 3.7 HZ), 81.8 (d, J = 22.4 Hz), 
76.5 (d, J = 4.5 Hz), 76.4 (d, J = 6.7 Hz), 29.9 (d, J = 3.0 Hz), 29.0 (d, J = 3.0 Hz), 27.3, 27.1, 
23.2, 19.8 (d, J = 9.7 Hz). 
31
P NMR (162 MHz, CDCl3): δ 134.6. HRMS calcd for C15H24O5P 
(M+1): 315.1361, Found: 315.1366. FTIR (neat): 2980, 2936, 2884, 1456, 1370, 1243, 1560, 
1071, 1041, 1010, 972, 926, 906, 883, 829, 750, 743 cm
-1






















H NMR (400 MHz, CDCl3): δ 6.71-6.75 (m, 1H), 6.01-6.00 (m, 1H), 4.45 (d, J = 9.2, 3.7 Hz, 
1H), 3.98 (d, J = 9.2 Hz, 1H), 2.35 (s, 3H), 1.55 (s, 3H), 1.53 (s, 3H), 1.45 (s, 3H), 1.41 (s, 6H), 
1.35 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ 157.2 (d, J = 4.5 Hz), 153.7 (d, J = 10.5 Hz), 120.1 
(d, J = 29.9 Hz), 109.6, 106.6 (6.7 HZ), 82.4 (d, J = 4.5 Hz), 81.8 (d, J = 22.4), 76.4 (d, J = 4.5 
Hz), 76.2 (d, J = 6.0 Hz), 29.9 (d, J = 3.0 Hz), 29.0 (d, J = 3.0 Hz), 27.3, 27.1, 23.2, 19.8 (d, J = 
10.5 Hz), 13.9. 
31
P NMR (121.5 MHz, CDCl3): δ 132.1. HRMS calcd for C16H26O5P (M+1): 
329.1518, Found: 329.1520. FTIR (neat): 2986, 2935, 1508, 1374, 1242, 1169, 1145, 1078, 
























H NMR (400 MHz, CDCl3): δ 7.59 (dm, J = 7.8, 1H), 7.55 (dm, J = 8.2 Hz, 1H), 7.32 (ddd, J = 
8.4, 7.2, 1.4 Hz, 1H),  7.24-7.18 (m, 2H), 4.49 (dd, J = 9.4, 3.7 Hz, 1H), 4.02 (d, J = 9.2 Hz, 1H), 
1.58 (s, 6H), 1.48 (s, 3H), 1.43 (s, 3H), 1.42 (s, 3H), 1.38 (s, 3H). 
13
C NMR (100 MHz, CDCl3): 
δ 158.2 (d, J = 13.5 Hz), 157.3 (d, J = 3.7 Hz), 127.2 (d, J = 6.0 Hz), 125.6, 122.9, 121.8, 114.2 
(d, J = 23.9 Hz), 112.0, 109.9, 82.5 (d, J = 4.5 Hz), 82.0 (J = 22.4 Hz), 30.0 (J = 3.0 Hz), 29.1 (d, 
J = 3.0 Hz), 27.4, 27.2, 23.2 (2C), 19.9, 19.8. 
31
P NMR (121.5 MHz, CDCl3): δ 136.8. HRMS 
calcd for C19H26O5P (M+1): 365.1518, Found: 365.1519. FTIR (neat): 2984, 2974, 1540, 1374, 
1236, 1171, 1089, 979, 794, 753, 641 cm
-1




















H NMR (400 MHz, CDCl3): δ 7.65-7.60 (m, 2H), 7.40-7.37 (m, 3H), 4.54 (dd, J = 9.4, 3.9 Hz, 
1H), 3.95 (d, J = 9.2 Hz, 1H), 1.56 (s, 6H), 1.45 (s, 3H), 1.42 (s, 3H), 1.41 (s, 3H), 1.34 (s, 3H).  
13
C NMR (100 MHz, CDCl3): δ 140.9 (d, J = 6.0 Hz), 130.4, 129.7 (d, J = 23.9 Hz), 128.2 (d, J 
= 7.5 Hz), 109.6, 82.6 (d, J = 3.7 Hz), 82.0 (d, J = 22.4 Hz), 76.4 (d, J = 4.7 Hz), 76.2 (d, J = 5.2 
Hz), 30.2 (d, J = 3.0 Hz), 29.1 (d, J = 3.0 Hz), 27.3, 27.2, 23.3 (2C), 20.1, 20.0. 
1
P NMR (121.5 
MHz, CDCl3): δ 131.6. HRMS calcd for C17H26O4P (M+1): 325.1569, Found: 325.1568. FTIR 
(neat): 2982, 2974, 1520, 11282, 1231, 1171, 1042, 997, 792, 638 cm
-1
























H NMR (400 MHz, CDCl3): δ 8.03 (m, 2H), 7.89 (s, 1H), 4.52 (dd, J = 9.2 Hz, 1H), 3.96 (d, J = 
9.2 Hz, 1H), 1.59 (s, 6H), 1.48 (s, 3H), 1.43 (s, 3H), 1.42 (s, 3H), 1.37 (s, 3H). 
13
C NMR (100 
MHz, CDCl3): δ 144.4 (d, J = 14.2 Hz), 131.4 (qd, J = 33.7, 6.0 Hz, 2C), 130.0 (dm, J = 23.2 Hz, 
2C), 124.0 (m), 123.3 (q, J = 273.0 Hz, 2C), 110.0, 82.6, 82.0 (d, J = 21.6 Hz), 77.3 (d, J = 3.7 
Hz), 77.2 (d, J = 5.2 Hz), 30.0 (d, J = 3.0 Hz), 29.2 (d, J = 3.0 Hz), 27.3, 27.1, 23.2, 20.0 (d, J = 
9.7 Hz). 
31
P NMR (161 MHz, CDCl3): δ 147.0. HRMS calcd for C19H24O4F6P (M+1): 461.1316, 
Found: 461.1287. FTIR (neat): 2988, 2940, 2896, 1456, 1372, 1280, 1136, 1078, 1016, 973, 























H NMR (400 MHz, CDCl3): δ 7.86-7.83 (m, 1H), 7.81-7.77 (m, 1H), 7.67 (d, J = 7.6 Hz, 1H), 
7.36-7.30 (m, 2H), 4.49 (dd, J = 9.3, 3.5 Hz, 1H), 3.99 (d, J = 9.3 Hz, 1H), 1.57 (s, 6H), 1.46 (s, 
3H), 1.43 (s, 6H), 1.36 (s, 3H). 
 13
C NMR (100 MHz, CDCl3): δ 144.3 (d, J = 26.9 Hz), 142.7, 
139.5 (d, J = 10.5 Hz), 130.4 (d, J = 36.7 Hz), 125.3, 124.4, 124.1, 122.5, 109.8, 82.5 (d, J = 4.5 
Hz), 82.1, 81.9, 76.8 (d, J = 12.7 Hz), 30.1 (d, J = 3.0 Hz), 29.2 (d, J = 3.0 Hz), 27.4, 27.2, 23.2, 
20.0 (d, J = 9.7 Hz). 
31
P NMR (161 MHz, CDCl3): δ 143.4. HRMS calcd for C19H26O4PS 
(M+1): 381.1289, Found: 381.1286. FTIR (neat): 2982, 2976, 1506, 1456, 1370, 1240, 1158, 
1074, 970, 837, 745, 726 cm
-1























H NMR (400 MHz, CDCl3): δ 7.60 (d, J = 7.2 Hz, 1H), 7.54 (dd, J = 8.0 Hz, 0.8 Hz, 1H), 7.31 
(td, J = 8.0 Hz, 1.2 Hz, 1H), 7.22 (td, J = 8.0 Hz, 0.8 Hz, 1H), 7.14 (s, 1H), 4.61 (dd, J = 9.2 Hz, 
2.8 Hz, 1H), 4.29 (d, J = 9.2 Hz, 1H), 2.32-2.24 (m, 1H), 2.03-1.82 (m, 5H), 1.75-1.55 (m, 2H), 
1.39 (s,6H), 1.03-0.94 (m, 12H). 
13
C NMR (75.5 MHz, CDCl3): δ J = 15.4 Hz), 157.3 
(d, J = 4.4 Hz), 127.3 (d, J = 4.4 Hz), 125.2, 122.7, 121.7, 112.9 (d, J = 19.8 Hz), 111.9, 109.2, 
81.1 (d, J = 17.7 Hz), 80.1 (d, J = 2.7 Hz), 79.8 (d, J = 2.7 Hz), 79.5(d, J = 4.4 Hz), 31.6 (d, J = 
5.0 Hz), 30.0 (d, J = 3.9 Hz), 27.3, 27.0, 25.6, 23.5 (d, J = 9.9 Hz), 8.0 (d, J = 1.7 Hz), 7.6, 7.2, 
7.1 (d, J = 2.2 Hz). 
31
P NMR (121.5 MHz, CDCl3): δ 136.8. HRMS calcd for C23H34O5P(M+1): 
421.2144, Found: 421.2144. FTIR (neat): 2971, 2938, 2881, 1461, 1378, 1355, 1275, 1175, 
1134, 1081, 1020, 974, 935, 840, 745, 724 cm
-1




 +34.4, c = 1.13 in DCM 















To (1R,2R)-2,3-bis-trimethylsilanyloxy-succinic acid dimethyl ester (12.2 g, 38 mmol, 100 
mol%) and 2,4-dimethylpentan-3-one (5.4 mL, 38 mmol, 100 mol%) was added freshly distilled 
TMSOTf (6.8 mL, 38 mmol, 100 mol%) and TfOH (0.4 mL, 4.5 mmol, 12 mol%) and the 
reaction was stirred at 60 
o
C for 48 hours.  Et3N (5.3 mL, 38 mmol, 100 mol%) was added, 
followed by saturated aqueous NaHCO3 solution (20 mL), and the mixture was extracted with 
ether (3 X 20 mL), washed with brine and dried (MgSO4) and filtered.  The solvent was removed 
under reduced pressure and the crude (1R,2R)-dimethyl 4,4-diisopropylcyclopentane-1,2-
dicarboxylate (10.4 g, 38 mmol, 100 mol%), which was sufficiently pure to be used directly in 
the next step, was dissolved in ether (0.4 M), MeMgBr (1.4 M, 200 mL, 280 mmol, 740 mol%) 
47 
 
was added over 1hour, and the mixture was stirred for 10 h at 25 
o
C, at which time saturated 
aqueous KH2PO4 solution was added and the mixture was extracted wtih EtOAc (3 X 40 mL), 
washed with brine, dried (MgSO4) and filtered, and the solvent was removed under reduced 
pressure.  The resulting crude material was filtered through a short plug of silica gel to give the 
title compound in 94% yield over 2 steps (9.8 g, 35.7 mmol). 
1
H NMR (400 MHz, CDCl3): δ 4.33 (s, 2H), 3.60 (s, 2H), 2.04 (sep, J = 6.8 Hz, 2H), 1.36 (s, 
6H), 1.28 (s, 6H), 0.94 (d, J = 6.8 Hz, 12H). 
13
C NMR (100 MHz, CDCl3): δ 111.9, 82.6, 70.7, 
34.5, 29.4, 23.5, 18.1, 17.6. HRMS calcd for C15H31O4 (M+1): 275.2222, Found: 275.2225. 
FTIR (neat): 3257, 2971, 1471, 1384, 1366, 1182, 1069, 954, 948 cm
-1

















H NMR (300 MHz, CDCl3): δ 7.60 (bd, J = 7.5 Hz, 1H),  7.57 (dd, J = 8.2, 1.0 Hz, 1H), 7.33 
(td, J = 7.2, 1.4 Hz, 1H), 7.26 – 7.20 (m, 2H), 4.40 (dd, J = 9.6, 3.1 Hz, 1H), 3.98 (d, J = 9.6 Hz, 
1H), 2.18 – 2.05 (m, 2H), 1.65 (s, 3H), 1.62 (s, 3H), 1.55 (s, 3H), 1.46 (s, 3H), 1.04 – 0.99 (m, 
12H).   
 13
C NMR (100 MHz, CDCl3): δ 158.3 (d, J = 13.8 Hz), 157.3 (d, J = 3.9 Hz), 127.2 (d, J 
= 5.4 Hz), 125.5, 122.8, 121.8, 114.8, 114.2 (d, J = 25.4 Hz), 112.0, 82.6 (d, J = 4.6 Hz), 82.1 (d, 
J = 21.5 Hz), 77.4 (d, J = 6.2 Hz), 77.2 (d, J = 6.2 Hz), 34.6 (d, J = 3.8 Hz), 31.6, 30.2 (d, J = 1.9 
Hz), 29.5 (d, J = 2.3 Hz), 25.2, 24.0, 22.6, 20.8 (d, J = 11.5 Hz), 18.1 (d, J = 5.4 Hz), 17.6 (d, J = 
6.2 Hz). 
31
P NMR (121.5 MHz, CDCl3): δ 135.7.  HRMS calcd for C23H34O5P (M+1): 
421.2144, Found: 421.2147. FTIR (neat): 2974, 2939, 2895, 1471, 1445, 1380, 1235, 1179, 
1147, 1113, 1080, 1019, 797, 753, 649 cm
-1






















H NMR (400 MHz, CDCl3): δ 7.59 (ddd, J = 7.8, 1.3, 0.7 Hz, 1H), 7.55, (ddd, J = 8.4, 1.8, 0.9 
Hz, 1H), 7.32 (ddd, J = 8.4, 7.2, 1.3 Hz,1H), 7.22 (ddd, J = 7.9, 7.9, 1.0 Hz, 1H), 7.18 (dd, J = 
1.3, 1.3 Hz, 1H), 4.44 (dd, J = 9.4, 3.4 Hz, 1H), 3.98 (d, J = 9.4 Hz, 1H), 1.67 (q, J = 7.5 Hz, 
2H), 1.66 (q, J = 7.5 Hz, 2H) 1.60 (s, 6H), 1.49 (s, 3H), 1.40 (s, 3H), 0.93 (t, J = 7.5 Hz, 3H), 
0.92 (t, J = 7.5 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ 158.3 (d, J = 13.4 Hz), 157.3 (d, J = 3.7 
Hz), 127.2 (d, J = 5.2 Hz), 125.5, 122.9, 121.8, 114.2 (d, J = 24.7 Hz), 113.2, 112.0, 82.6 (d, J = 
4.5 Hz), 82.1 (d, J = 22.4 Hz), 77.2 (d, J = 6.7 Hz, 2C), 30.2 (d, J = 10.4 Hz, 2C), 30.1 (d, J = 2.9 
Hz), 29.3 (d, J = 2.9 Hz), 23.5, 20.2 (d, J = 10.5 Hz), 8.1 (d, J = 2.2 Hz, 2C). 
31
P NMR (121 
MHz, CDCl3): δ 136.6. HRMS calcd for C21H30O5P (M+1): 393.1830, Found: 393.1831. FTIR 












Me Me  
1
H NMR (400 MHz, CDCl3): δ 3.74 (s, 2H), 3.59 (s, 2H), 1.59–1.57 (m, 8H), 1.40–1.35 (m, 
2H), 1.33 (s, 6H), 1.26 (s, 6H). 
13
C NMR (100.5 MHz, CDCl3) δ 108.0, 82.2, 70.6, 36.8, 29.1, 
25.1, 23.9. HRMS calcd for C14H27O4 (M+1): 259.1909, Found: 259.1915. 
FTIR (neat): 3224(br), 2973, 2932, 2897, 1439, 1381, 1365, 1276, 1192, 1161, 1125, 1144, 
1091, 1057, 949, 906 cm
-1





















H NMR (400 MHz, CDCl3): δ 7.60 (d, J = 7.2 Hz, 1H), 7.54 (dd, J = 8.0 Hz, 0.8 Hz, 1H), 7.31 
(td, J = 8.0 Hz, 1.2 Hz, 1H), 7.22 (td, J = 8.0 Hz, 0.8 Hz, 1H), 7.14 (s, 1H), 4.48 (dd, J = 11.5 
Hz, 5 Hz, 1H), 4.00 (d, J = 11.5 Hz, 1H), 1.62 – 1.55 (m, 16H), 1.37 (s, 6H). 
13
C NMR (100.5 
MHz, CDCl3): δ J = 13.8 Hz), 157.3 (d, J = 3.8 Hz), 127.2 (d, J = 5.3 Hz), 125.5, 
122.8, 121.7, 114.1 (d, J = 23.8 Hz), 111.9, 110.2, 82.0 (d, J = 3.8 Hz), 80.6, 81.4, 77.0 (d, J = 
6.1 Hz), 76.9 (d, J = 6.1 Hz), 36.7 (d, J = 9.2 Hz), 30.0 (d, J = 3.1 Hz), 29.7, 29.1 (d, J = 2.3 Hz), 
25.0, 23.8, 23.2, 19.9 (d, J = 9.9 Hz). 
31
P NMR (121.5 MHz, CDCl3): δ 135.6. HRMS calcd for 
C22H30O5P(M+1): 405.1831, Found: 405.1833. FTIR (neat): 2933, 2856, 1445, 1384, 1368, 
1278, 1253, 1159, 1144, 1122, 1090, 1059, 1009, 970, 945, 927, 826, 793, 743 cm
-1


















H NMR (400 MHz, CDCl3): δ 7.86-7.84 (m, 1H), 7.81-7.79 (m, 1H), 7.67 (dd, J = 7.6, 0.7 Hz, 
1H), 7.35-7.32 (m, 2H), 4.44 (dd, J = 9.4, 3.4 Hz, 1H), 3.95 (d, J = 9.4 Hz, 1H), 1.68-1.64 (m, 
4H), 1.58 (s, 6H), 1.48 (s, 3H), 1.38, (s, 3H), 0.95-0.90 (m, 6H). 
13
C NMR (100 MHz, CDCl3): δ 
144.4 (d, J = 26.2 Hz), 142.8, 139.6 (d, J = 10.47 Hz), 130.4 (d, J = 35.9), 125.3, 124.4, 124.3 (d, 
J = 23.2 Hz), 122.5, 113.1, 82.6 (d, J = 3.7 Hz), 82.0, 77.2, 77.1, 30.2 (d, J = 4.4 Hz, 2C) 29.3 (d, 
J = 2.2 Hz), 23.5, 20.4, 20.3, 8.1 (2C). 
31
P NMR (162 MHz, CDCl3): δ 143.2. HRMS calcd for 
C21H30O4PS (M+1): 409.1602, Found: 409.1602. FTIR (neat) 3400, 2973, 2939, 1503, 1461, 
50 
 
1373, 1227, 1177, 1157, 1075, 1035, 1006, 969 cm
-1
. MP: 66-69 °C. [α]D
25
















H NMR (400 MHz, CDCl3): δ 7.69 (d, J = 8.0 Hz, 1H), 7.64 (d, J = 8.0 Hz, 1H), 7.27 (d, J = 
7.2 Hz, 1H), 7.15-7.12 (m, 1H), 4.45 (dd, J = 9.6, 3.2 Hz, 1H), 3.96 (d, J = 9.6 Hz, 1H), 2.56 (s, 
3H), 1.70-1.63 (m, 4H), 1.58 (s, 6H), 1.49 (s, 3H), 1.39, (s, 3H), 0.95-0.90 (m, 6H). 
13
C NMR 
(100 MHz, CDCl3): δ 143.6 (d, J = 26.0 Hz), 143.0, 139.4 (d, J = 10.4 Hz), 132.1, 131.2 (d, J = 
36.5 Hz), 125.4, 124.6, 122.0, 113.0, 82.6 (d, J = 3.7 Hz), 82.2, 82.0, 77.0 (d, J = 6.0 Hz), 30.3 
(d, J = 3.0 Hz), 30.2 (d, J = 2.9 Hz), 29.3 (d, J = 2.9 Hz), 23.5, 22.6, 20.3 (d, J = 10.4 Hz), 20.3, 
8.1 (2C). 
31
P NMR (121.5 MHz, CDCl3): δ 142.0. HRMS calcd for C22H31O4PS (M+1): 



















H NMR (400 MHz, CDCl3): δ 7.72 (d, J = 8.4 Hz, 1H), 7.60-7.58 (m, 2H), 7.17 (dd, J = 8.4 Hz, 
1.6 Hz, 1H), 4.44 (dd, J = 9.2, 3.2 Hz, 1H), 3.96 (d, J = 9.6 Hz, 1H), 2.45 (s, 3H), 1.70-1.64 (m, 
4H), 1.57 (s, 6H), 1.47 (s, 3H), 1.37, (s, 3H), 0.95-0.90 (m, 6H). 
13
C NMR (100 MHz, CDCl3): δ 
144.3 (d, J = 26.0 Hz), 140.0 (d, J = 16.3 Hz), 130.0 (d, J = 5.2 Hz), 133.8, 130.1 (d, J = 36.5 
Hz), 127.2, 124.1, 122.1, 113.0, 82.6 (d, J = 3.8 Hz), 82.2, 82.0, 77.0 (d, J = 5.2 Hz), 30.2, 30.1, 
29.3 (d, J = 3.0 Hz), 23.5, 21.3, 20.4, 20.3, 8.1 (2C). 
31
P NMR (121.5 MHz, CDCl3): δ 142.1. 
51 
 
HRMS calcd for C22H32O4PS (M+1): 423.1759, Found: 423.1764. FTIR (neat) 2975, 2937, 
1463, 1383, 1368, 1157, 1079, 993, 970, 940 cm
-1
. MP: 92-94 °C. [α]D
25














H NMR (400 MHz, CDCl3): δ 7.61 (ddd, J = 7.6, 2.0, 0.8 Hz, 2H), 7.41-7.34 (m, 3H), 7.30 
(ddd, J = 7.2, 1.2, 1.2 Hz, 1H), 7.27 (dd, J = 3.5, 1.6 Hz, 1H), 4.43 (dd, J = 9.4, 3.3Hz, 1H), 3.94 
(d, J = 9.4Hz, 1H), 1.66 (q, J = 2.9Hz, 2H), 1.66 (q, J = 3.5Hz, 2H), 1.56 (s, 6H), 1.47 (s, 3H), 
1.37 (s, 3H), 0.93 (t, J = 7.4Hz, 3H), 0.92 (t, J = 7.4Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ 
150.8 (d, J = 2.2Hz), 142.8, 142.6, 134.7, 134.4, 134.3, 129.1, 128.2, 126.5, 123.6 (d, J = 9.7Hz), 
113.2, 82.9 (d, J = 3.7Hz), 82.3 (d, J = 21.7Hz), 77.1 (d, 2.2Hz), 77.1, 30.5 (2C), 30.5 (d, J = 
5.2Hz), 29.6 (d, J = 3.0Hz), 23.8, 20.6 (d, J = 10.5Hz), 8.4 (2C). 
31
P NMR (121.5) MHz, 
CDCl3): δ 140.8. HRMS calcd for C23H32O4PS (M+1): 435.1756, Found: 435.1759. FTIR 
(neat): 3062, 2976, 2940, 2881, 1772, 1715, 1601, 1528, 1490, 1463, 1437, 1383, 1368, 1205, 
1174, 1157 cm
-1
. MP: 93-96 °C. [α]D
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H NMR (400 MHz, CDCl3): δ 7.26-7.36 (m, 5H), 4.51 (s, 2H), 4.09-4.10 (m, 1H), 3.41-3.53 
(m, 2H), 2.90 (d, J = 2.7 Hz, 1H), 2.61-2.77 (dq, J = 7.2, 5.1 Hz, 1H), 2.16 (s, 3H), 1.14 (d, J = 
7.2 Hz, 3H).
13
C NMR (100 MHz, CDCl3): δ 212.2, 137.7, 128.3, 127.7, 127.6, 73.3, 71.6, 70.2, 
48.6, 29.2, 11.0.HRMS Calcd for C13H18O3 (M+1): 223.1334, Found: 223.1330.FTIR (neat): 
3439, 3031, 2920, 2867, 1704, 1455, 1360, 1252, 1207, 1181, 1094, 1028, 957, 916, 739, 699 
cm
-1
. HPLC: (Chiralpak AS-H column, 10% i-PrOH/ hexanes, 0.8 mL/ min, 254 nm), tmajor = 9.7 












H NMR (400 MHz, CDCl3): δ 7.26-7.36 (m, 5H), 4.50 (s, 2H), 4.05 (q, J = 5.4, 1H), 3.40-3.47 
(m, 2H), 2.93 (s, 1H), 2.73-2.80 (dq, J = 5.1, 7.2 Hz, 1H), 2.40-2.57 (m, 2H), 1.12 (d, J = 7.2 Hz, 
3H), 1.00 (t, J = 7.4, 3H). 
13
C NMR (100 MHz, CDCl3): δ 214.9, 137.7, 128.3, 127.7, 73.3, 71.6, 
70.5, 47.6, 35.2, 11.5, 7.4. HRMS Calcd for C14H20O3 (M+1): 237.1491, Found: 237.1488. 
FTIR (neat): 3502, 3064, 3031, 2977, 2938, 1705, 1497, 1455, 1410, 1376, 1250, 1208, 1099, 
1028, 976, 915, 738, 699 cm
-1
. HPLC: (Chiralpak OD-H column, 5% i-PrOH/ hexanes, 0.5 mL/ 















H NMR (400 MHz, CDCl3):  7.88-7.84 (m, 2H), 7.74-7.72 (m, 2H), 4.30-4.25 (m, 1H), 3.85 
(dd, J = 14.2, 7.4 Hz, 1H), 3.75 (dd, J = 14.4, 4.4 Hz, 1H), 2.95-2.93 (m, 1H), 2.68 (dq, J = 4.2, 
7.2 Hz, 1H), 2.23 (s, 3H), 1.29 (d, J = 7.5 Hz, 3H). 
13
C NMR (100 MHz, CDCl3):  212.4, 169.0, 
134.4, 132.1, 123.7, 69.9, 49.4, 41.7, 29.2, 10.9. HRMS Calcd for C14H15NO4 (M+1): 261.1001, 
Found: 261.1004. FTIR (neat): 3435, 3053, 2978, 2935, 2872, 2306, 1640, 1446, 1383, 1351, 
1266, 1114, 1076, 896, 743 cm
-1
. Mp: 140-141 
o
C.  HPLC: (Chiralpak AD-H column, 10% i-
PrOH/ hexanes, 1 mL/ min, 254 nm), tmajor = 30.5 min, tminor = 34.7 min); ee = 96%. [α]D
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 +0.6, 










H NMR (400 MHz, CDCl3):  7.88-7.83 (m, 2H), 7.76-7.71 (m, 2H), 4.28-4.23 (m, 1H), 3.85 
(dd, J = 14.0, 7.5 Hz, 1H), 3.73 (dd, J = 14.2, 4.6 Hz, 1H), 3.10 (d, J = 3.8 Hz, 1H), 2.69 (dq, J = 
4.3, 7.2 Hz, 1H), 2.60 (dq, J = 18.1, 7.2 Hz, 1H), 2.51 (dq, J = 18.1, 7.2 Hz, 1H), 1.27 (d, J = 7.2 
Hz, 3H), 1.05 (t, J = 7.2 Hz, 3H). 
13
C NMR (100 MHz, CDCl3):  214.8, 168.6, 134.0, 131.8, 
123.3, 69.6, 48.2, 41.3, 34.7, 10.9, 7.4. HRMS Calcd for C15H17NO4 (M+1): 275.1158, Found: 
275.1158. FTIR (neat): 3454, 3054, 2986, 2305, 2254, 1773, 1714, 1642, 1422, 1397, 1265, 909, 
748 cm
-1
. HPLC: (Chiralpak AD-H column, 4% i-PrOH/ hexanes, 1.0 mL/ min, 254 nm), tminor = 
91.4 min, tmajor = 97.1 min); ee = 96%. [α]D
25














H NMR (400 MHz, CDCl3):  7.87-7.83 (m, 2H), 7.75-7.71 (m, 2H), 3.93-3.77 (m, 3H), 3.20 
(d, J = 3.8 Hz, 1H), 2.61 (dq, J = 3.8, 7.2 Hz, 1H), 2.19 (s, 3H), 1.85-1.67 (m, 2H), 1.17 (d, J = 
7.2 Hz, 3H). 
13
C NMR (100 MHz, CDCl3):  212.8, 168.6, 134.0, 131.9, 123.2, 68.4, 51.1, 34.8, 
33.0, 29.3, 10.5. HRMS: Calcd [M] for C15H17NO4: 275.1158; Found: 275.1156. FTIR (film): 
3469, 3054, 2986, 2305, 2254, 1771, 1710, 1468, 1397, 1372, 1265, 1177, 951, 910, 741 cm
-1
. 
HPLC: (Chiralpak AD-H column, 5% i-PrOH/ hexanes, 1.0 mL/ min, 220 nm), tminor = 57.2 min, 












To a solution of 2-((3S,4R)-3-hydroxy-4-methyl-5-oxohexyl)isoindoline-1,3-dione (100 mg, 
0.36 mmol, 100 mol%) and 2-bromo-4-nitrobenzoyl chloride (133 mg, 0.50 mmol, 140 mol%) in 
1 mL of DCM at ambient temperature, triethylamine (0.15 mL, 1.1 mmol, 300 mol%) was added 
and the solution was allowed to stir for 10 hours at ambient temperature.  The mixture was 
diluted with 10 mL DCM, and the organic layer was washed 2 X 10 mL water, and then dried 
(MgSO4) and filtered.  Removal of the solvent under reduced pressure, followed by purification 




H NMR (400 MHz, CDCl3):  8.64 (d, J = 2.7 Hz, 1H), 8.15 (dd, J = 8.8, 2.7 Hz, 1H), 7.85 (d, 
J = 8.8 Hz, 1H), 7.81 (dd, J = 5.5, 3.1 Hz, 2H), 7.70 (dd, J = 5.5, 3.1 Hz, 2H), 5.54 (q, J = 6.4 
Hz, 1H), 3.93–3.77 (m, 2H), 3.07–3.04 (m, 1H), 2.27 (s, 3H), 2.18 (q, J = 6.7 Hz, 2H), 1.23 (d, J 
= 7.0 Hz, 3H). 
13
C NMR (100 MHz, CDCl3):  208.5, 168.1, 163.7, 146.7, 135.6, 134.1, 133.3, 
131.9, 128.9, 126.6, 126.3, 123.3, 73.8, 49.6, 34.5, 30.6, 29.5, 11.4. HRMS: Calcd [M+1] for 
C22H20BrN2O7: 503.0454; Found: 503.0455. FTIR (film): 2947, 2356, 1713, 1606, 1530, 1347, 
1269, 1125, 1032, 720 cm
-1
. HPLC: (Chiralpak AS-H column, 10% i-PrOH/ hexanes, 1.0 mL/ 











H NMR (400 MHz, CDCl3):  7.87-7.81 (m, 2H), 7.75-7.71 (m, 2H), 3.91-3.71 (m, 3H), 3.34 
(d, J = 4.1 Hz, 1H), 2.64 (dq, J = 4.4, 7.2 Hz, 1H), 2.57 (dq, J = 18.1, 7.3 Hz, 1H), 2.49 (dq, J = 
18.1, 7.2 Hz, 1H), 1.84-1.67 (m, 2H), 1.15 (d, J = 7.2 Hz, 3H), 1.03 (t, J = 7.2 Hz, 3H). 
13
C 
NMR (100 MHz, CDCl3):  215.5, 138.6, 133.9, 131.9, 123.2, 68.6, 50.1, 35.3, 34.8, 33.0, 11.0, 
7.4. HRMS: Calcd [M] for C16H19NO4: 289.1314; Found: 289.1316. FTIR (film): 3466, 3054, 
2985, 2305, 2254, 1771, 1710, 1468, 1397, 1265, 952, 911, 741 cm
-1
. HPLC: (Chiralpak AS-H 




















H NMR (400 MHz, CDCl3):  1.23 (d, J = 7.2 Hz, 3H), 2.16 (s, 3H), 2.56 (dq, J = 3.4, 7.2 Hz, 
1H), 2.67-2.68 (br, 1H), 2.69 (dd, J = 13.7, 5.8 Hz, 1H), 2.79 (dd, J = 13.7, 7.9 Hz, 1H), 4.18-
4.22 (m, 1H), 7.20-7.26 (m, 3H), 7.28-7.33 (m, 2H). 
13
C NMR (100 MHz, CDCl3):  213.4, 
138.1, 129.2, 128.5, 126.5, 72.0, 49.9, 40.3, 29.1, 9.9. HRMS Calcd for C12H16O2 (M+1): 
193.1229, Found: 193.1227. FTIR (neat): 3501, 3054, 2985, 2685, 2306, 1701, 1603, 1496, 
1455, 1358, 1266, 1171, 1031, 909, 896, 734 cm
-1
. HPLC: (Chiralpak OJ-H column, 7% i-








H NMR (400 MH, CDCl3):  7.33-7.20 (m, 5H), 4.19-4.14 (m, 1H),  2.79 (dd, J = 13.7, 8.2 Hz, 
1H), 2.72-2.72 (m, 1H), 2.68 (dd, J = 13.5, 6.0 Hz, 1H), 2.59 (dq, J = 3.4, 7.2 Hz, 1H), 2.52 (dq, 
J = 18.1, 7.3 Hz, 1H), 2.43 (dq, J = 18.1, 7.3 Hz, 1H), 1.22 (d, J = 7.2 Hz, 3H), 1.03 (t, J = 7.4 
Hz, 3H). 
13
C NMR (100 MHz, CDCl3):  216.1, 138.2, 129.1, 128.4, 126.4, 72.2, 48.8, 40.3, 
35.0, 10.3, 7.5. HRMS Calcd for C13H18O2 (M+1): 207.1385, Found: 207.1385. FTIR (neat): 
3943, 3512, 3054, 2984, 2941, 2685, 2305, 1698, 1604, 1496, 1455, 1421, 1379, 1265, 1110, 
1030, 976, 896, 737 cm
-1
. HPLC: (Chiralpak OD-H column, 2% i-PrOH/ hexanes, 1.0 mL/ min, 












H NMR (400 MHz, CDCl3): δ 7.59 (ddd, J = 7.9, 1.9, 1.2 Hz, 1H), 7.28 (ddd, J = 8.2, 1.8, 1.0 
Hz, 1H), 7.22 (ddd, J = 7.9, 6.8, 1.0 Hz, 1H), 7.10 (ddd, J = 7.9, 6.9, 1.2 Hz, 1H), 6.90 (s, 1H), 
4.26 (m, 1H), 3.72 (s, 3H), 2.88 (s, 1H), 2.86 (dd, J = 1.6, 0.6, 1H), 2.62 (qd, J = 7.3, 4.0, 1H), 
2.57 (m, 1H), 2.14 (s, 3H), 1.23 (d, J = 7.2, 3H). 
13
C NMR (100 MHz, CDCl3): δ 213.5, 137.4, 
128.1, 127.7, 122.0, 119.2(2C), 110.6, 109.6, 71.4, 50.6, 32.9, 30.4, 29.5, 10.5. HRMS calcd for 
C15H20NO2 (M+1): 246.1494, Found: 246.1491. FTIR (neat): 3446, 3053, 2935, 1704, 1615, 
1472, 1425, 1375, 1357, 1328, 1250, 1173, 1155, 1126, 1091, 1070, 1032, 1012, 981 cm
-1
. 
HPLC: (Chiralpak OD-H column, 5% i-PrOH/ hexanes, 0.5 mL/ min, 254 nm), tminor = 67.2 min, 








H NMR (400 MHz, CDCl3): δ 7.60 (d, J = 7.9 Hz, 1H), 7.28 (m, 1H), 7.22 (m, 1H), 7.10 (m, 
1H), 6.90 (s, 1H), 4.24 (ddd, J = 10.4, 6.3, 4.2 Hz, 1H), 3.72 (s, 3H), 2.88 (s, 1H), 2.86 (d, J = 
3.2 Hz, 1H), 2.65 (m, 2H), 2.47 (m, 2H), 1.22 (d, J = 7.2 Hz, 3H), 1.01 (t, J = 7.2 Hz, 3H). 
13
C 
NMR (100 MHz, CDCl3): δ 216.3, 137.4, 128.2, 127.7, 122.0, 119.3, 119.2, 110.7, 109.6, 71.7, 
49.6, 35.4, 32.9, 30.4, 11.0, 7.8. HRMS calcd for C16H22NO2 (M+1): 260.1651, Found: 
260.1649. FTIR (neat): 3474, 3054, 2975, 2036, 1704, 1615, 1552, 1473, 1425, 1376, 1328, 
1250, 1155, 1132, 1061, 1012, 974, 741 cm
-1
. HPLC: (Chiralpak OJ-H column, 10% i-PrOH/ 
hexanes, 1 mL/ min, 254 nm), tminor = 17.5 min, tmajor = 20.6 min); ee = 90%. 
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H NMR (400 MHz, CDCl3): δ 7.39 (s, 1H), 7.31 (s, 1H), 6.32 (s, 1H), 4.15-4.11 (m, 1H), 2.65-
2.50 (m, 4H), 2.19 (s, 3H), 1.61 (dd, J = 7.6 Hz, 0.8 Hz, 3H). 
13
C NMR (75 MHz, CDCl3): δ 
213.4, 143.1, 140.0, 120.9, 111.1, 70.9, 49.9, 29.5, 29.1, 9.8. HRMS calcd for C10H15O3 (M+1): 
183.1021, Found: 183.1025. FTIR (neat): 3445, 2922, 1699, 1457, 1360, 1157, 1067, 1024, 874, 
787, 734, 601 cm
-1
. HPLC: (Chiralpak AD-H column, 2% i-PrOH/ hexanes, 1 mL/ min, 230 










H NMR (400 MHz, CDCl3): δ 7.39–73.7 (m, 1H), 7.31–7.29 (m, 1H), 6.32–6.30 (m, 1H), 4.11–
4.06 (m, 1H), 2.88–2.73 (bs, 1H), 2.66–2.42 (m, 5H), 1.18 (d, J = 7.2 Hz, 3H), 1.05 (t, J = 7.2 
Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ 216.2, 143.1, 140.1, 121.0, 111.1, 71.1, 48.8, 35.2, 
29.5, 10.3, 7.6. HRMS calcd for C11H17O3 (M+1): 197.1178, Found: 197.1180. FTIR (neat): 
3441, 2977, 2938, 1709, 1502, 1461, 1378, 1157, 1109, 1502, 1461, 1378, 1157, 1109, 1024, 
976, 874, 786 cm
-1
. HPLC: (Chiralpak AD-H column, 5% i-PrOH/ hexanes, 1 mL/ min, 230 












H NMR (400 MHz, CDCl3): δ 7.36-7.26 (m, 5H), 4.51 (s, 2H), 4.13-4.10 (m, 1H), 3.71-3.60 
(m, 2H), 3.28 (d, J = 2.1, 1 H), 2.66-2.57 (m, 1H), 2.18 (s, 3H), 1.82-1.73 (m, 1H), 1.68-1.61 (m, 
1H), 1.14 (d, J = 7.2 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ 22.8, 137.8, 128.3, 127.6, 127.5, 
73.2, 70.5, 68.5, 51.5, 33.6, 29.3, 10.6. HRMS Calcd [M+1] for C14H20O3: 237.1491, Found: 
237.1496. FTIR (film): 3433, 3031, 2924, 2868, 1701, 1455, 1362, 1207, 1181, 1098, 1028, 737, 
699 cm
-1
. HPLC: (Chiralpak AS-H column, 10% i-PrOH/ hexanes, 0.8 mL/ min, 254 nm), tmajor 










H NMR (400 MHz, CDCl3): δ 7.25-7.36 (m, 5H), 4.5 (s, 2H), 4.06-4.09 (m, 1H), 3.60-3.70 (m, 
2H), 3.35 (s, 1H), 2.58-2.65 (dq, J = 4.4, 8.2 Hz, 1H), 2.45-2.56 (dq, J = 2.7, 7.2 Hz, 2H), 1.80-
1.71 (m, 1H), 1.60-1.67 (m, 1H), 1.13 (d, J = 7.2 Hz, 3H), 1.03 (t, J = 7.4 Hz, 3H). 
13
C NMR 
(100 MHz, CDCl3): δ 215.5, 137.8, 128.3, 127.6, 127.5, 73.2, 70.6, 68.5, 50.4, 35.3, 33.6, 11.0, 
7.5. HRMS Calcd [M+1] for C15H22O3: 251.1647; Found: 251.1648. FTIR (film): 3501, 2975, 
2938, 2876, 1707, 1455, 1411, 1364, 1099, 1028, 975, 739, 699 cm
-1
. HPLC: (Chiralpak AS-H 




















H NMR (400 MHz, CDCl3): δ 7.99–7.81 (m, 1H), 7.87 (dd, J = 7.8, 1.6 Hz, 1H), 7.72 (d, J = 
7.8 Hz, 1H), 4.30 – 4.23 (m, 1H), 3.85 (dd, J = 14.1, 7.6 Hz, 1H), 3.70 (dd, J = 14.1, 4.3 Hz, 
1H), 2.92 (d, J = 4.3 Hz, 1H), 2.67 (qd, J = 7.3, 4.3 Hz, 1H), 2.23 (s, 3H), 1.28 (d, J = 7.3 Hz, 
3H). 
13
C NMR (100 MHz, CDCl3): δ 212.2, 167.8, 167.3, 137.1, 133.5, 130.4, 129.1, 126.8, 
124.6, 69.3, 49.2, 41.5, 28.9, 10.6. HRMS calcd for C14H15NO4Br (M+1): 340.0184, Found: 











Chapter 3: Application of Iridium-Catalyzed Asymmetric Allylation Reaction under 
Transfer Hydrogenation Condition: Mono- and Bi-directional Polyol Synthesis from 
Alcohol Oxidation Level 
3.1 Introduction 
In Nature’s vast collection of polyketide natural products, there exist thousands of 
compounds incorporating polyacetate derived 1,3-diol or higher 1,3-polyol substructures. While 
numerous protocols for the synthesis of these ubiquitous structural motifs have been advanced,
55
 
the allylmetallation of aldehydes has found exceptionally broad use. Carbonyl allylation is one of 
the most important and widely used carbon-carbon bond forming reactions.
56
 The resulting 
homoallylic alcohol products are amongst the most useful synthetic building blocks in organic 
chemistry. Additionally the homoallylic alcohols can be transformed to a range of products by 
functionalization, reduction or oxidation of the double bond. Therefore, tremendous amount of 
effort has been devoted in the development of asymmetric allylation reactions. For example, 











 have been employed in synthetic approaches to 1,3-diols and 
higher homologues. However, most of these transformations involve stoichiometric use of 
chirally modified organometallic allylating reagents, which usually require multi-step synthesis. 
Additionally, the chiral moieties are difficult or impossible to be recovered, so stoichiometric 
amounts of organometallic byproducts are produced. For instance, Brown’s allyl borane 
[Ipc2B(n-C3H5), Ipc = isopinocampheyl]
62
 has found the most extensive use in iterative 
asymmetric carbonyl allylation, likely due to the low cost of both enantiomers of α-pinene and 
the fact that excellent levels of reagent-directed diastereoselectivity are observed in the allylation 
of diverse chiral aldehydes. Despite the effectiveness of Ipc2B(n-C3H5) in carbonyl allylation, 
several factors detract from its use, for instance alkaline peroxide is required to release the 
homoallyl alcohol, which results in the generation of superstoichiometric quantities of 
isopinocampheol, which frequently complicates product isolation.
63
 Additionally, high levels of 
asymmetric induction often require exceptionally low temperatures (-100 °C), yet Ipc2B(n-C3H5) 
is typically generated through the treatment of Ipc2BOMe with allylmagnesium bromide. In 
addition only the magnesium salt-free reagent can be used at –100 °C, as the allylborane would 
otherwise be rendered inactive through the addition of CH3OMgBr. Although some highly 
62 
 
efficient chiral Lewis acid or base catalyzed asymmetric allylation reactions have been 
developed, they still rely on the use of stoichiometric amounts of organometallic allyl transfer 
reagents.  
In the course of our studies on hydrogen-mediated reductive carbon-carbon bond 
formations,
64
 we succeeded in developing a byproduct-free carbonyl allylation via an iridium 
catalyzed reductive coupling of 1,1-disubstituted allenes to various aldehydes under the 
hydrogenation conditions. Later on, we were also successful to discover a very powerful 
catalytic protocol for enantioselective carbonyl allylation employing allyl acetate as the allyl 
donor under the conditions of iridium catalyzed transfer hydrogenation.
65
 Using isopropanol as a 
source of hydrogen, allyl acetate is reductively coupled to diverse aldehydes to furnish highly 
optically enriched homoallylic alcohols. Of greater significance, an alcohol may serve dually as 
hydrogen donor and carbonyl precursor, enabling carbonyl allylation directly from the alcohol 
oxidation level. Whereas reductive coupling of allylic alcohols, ethers or carboxylates to 
carbonyl partners is typically achieved using metallic reductants such as SmI2, SnCl2, Et2Zn or 
Et3B,
66
 transfer hydrogenative carbonyl allylation precludes the use of any stoichiometric 
metallic reagents (Scheme 3.1).  
 
Scheme 3.1 Iridium catalyzed carbonyl allylation from aldehyde and alcohol oxidation level. 
In addition to the step economy associated with bypassing discrete alcohol oxidation and 
the pre-activation attending stoichiometric use of chiral allylmetal reagents, the ability to 
perform carbonyl allylation directly from the alcohol oxidation level enables allylation not easily 
achieved using aldehyde electrophiles. Based on this unique capability, an iterative chain 
elongation of 1,3-diols to furnish 1,3-polyols were devised. This protocol, which involves 
63 
 
iterative allylation from the alcohol oxidation level, avoids β-alkoxy aldehyde intermediates, 
which are often unstable with respect to elimination. 
3.2 Part One: Elongation of 1,3-Polyol via Iterative Catalyst Directed Allylation Reaction 
3.2 .1 Reaction Optimization 
Our initial studies focused on the asymmetric allylation of O-benzyl propylene glycol 3.4. 
Under our previously reported conditions employing the cyclometallated catalyst generated in 





acetate 3.1 (1000 mol%) to 3.4 at 120 
o
C delivers the homoallyl alcohol 3.5 in 82% isolated yield 
and 94% enantiomeric excess (Table 3.1, entry 1). Lowering the reaction temperature to 100 
o
C 
slightly enhanced the degree of optical enrichment, but decreased the isolated yield of 3.5 (Table 
3.1, entry 2). Interestingly at 120 
o
C, a decrease in the loading of allyl acetate from 10 to 5 
equivalents diminished the isolated yield of 3.5 by only 8% (Table 3.1, entries 1 and 3). 
However, upon a further decrease in the loading of allyl acetate from 5 to 2 equivalents, the 
isolated yield was unchanged (Table 3.1, entries 3 and 4).  
Our discovery that the active catalyst is an ortho-cyclometallated iridium C,O-
benzoate
11b 
offered the opportunity to enhance catalyst performance through modification of the 
benzoate moiety. Consequently, using the iridium C,O-benzoate generated in situ from 
[Ir(cod)Cl]2, (S)-Cl,MeO-BIPHEP and 4-chloro-3-nitrobenzoic acid, the homoallyl alcohol 3.5  
is obtained 88% isolated yield and 95% enantiomeric excess (Table 3.1, entry 5). As a decrease 
in reaction temperature (100 
o
C) did not improve this result (Table 3.1, entries 6 and 7), the latter 
conditions employing the catalyst modified by 4-chloro-3-nitrobenzoic acid at 120 
o
C were 







Table 3.1 Reaction optimization of Ir-catalyzed allylation of O-benzyl propylene glycol. 
 
It is assumed that 4-chloro-3-nitrobenzoic acid derived ortho-cyclometallated iridium 
C,O-benzoate catalyst is more reactive due to the electron withdrawing effect of chloro 
substituent which favor the C,O-benzoate by virtue of increase acidity of the iridium hydride 
intermediate. Also the resulting electron deficient iridium center has increase Lewis acidic 
character toward starting material alcohol or aldehyde. 
3.2.2 Monodirectional Elongation of 1,3-Polyol 
An enantiospecific synthesis of 1,3-polyols
67
 via iterative carbonyl allylation requires 
high levels of catalyst-directed diastereoselectivity.
68
 Accordingly, homoallyl alcohol 3.5 was 
converted to the corresponding tert-butyldimethylsilyl ether 3.6 in 90% isolated yield, which was 
subjected to ozonolysis in methanol solvent employing a small quantity of Sudan III as indicator 
(3-5 drops of a 1.5 mM solution in methanol).
69
 Upon complete consumption of 3.6, which is 
revealed through the transformation from a pink to a colorless solution, the reaction mixture was 
treated with sodium borohydride to deliver the alcohol 3.7 in 92% isolated yield. The Sudan III 




Scheme 3.2 Elaboration of homoallylic alcohol product to homologous 1,3-diol. 
Using previously optimized conditions, the alcohol 3.7 was directly employed to give the 
product of carbonyl allylation. By using the catalyst modified by (S)-Cl,MeO-BIPHEP and 1000 
mol% allyl acetate, the product of carbonyl allylation (R,S)- 3.8 was obtained in 74% isolated 
yield as 16:1 ratio of diastereomers. By lowering the allyl acetate loading  and extending the 
reaction time to 40 hours under otherwise identical conditions, (R,S)-3.8 was obtained in 79% 
isolated yield as a 17:1 ratio of diastereomers. Under these same conditions, but using the 
catalyst modified by (R)-Cl,MeO-BIPHEP, the diastereomeric adduct (R,R)-3.8 was obtained in 
79% isolated yield as a 15:1 ratio of diastereomers. It is important to note that upon use of the 
achiral iridium catalyst ligated BIPHEP, (R,S)-3.8 and (R,R)-3.8 were produced in an equimolar 
ratio (Table 3.2).  
Table 3.2 Catalyst directed diastereoselectivity in the transfer hydrogenative carbonyl allylation and 




With compounds (R,S)-3.8 and (R,R)-3.8 in hand, the stereoselective synthesis of higher 
homologues was undertaken. Exposure of (R,S)-3.8 to methanol in the presence of p-
toluenesulfonic acid (10 mol%) with subsequent introduction of 2,2-dimethoxypropane delivers 
the diastereomeric acetonide (R,S)-3.9 in one step, as single diastereomers. Ozonolysis of (R,S)-
3.9 in accordance with the aforementioned procedure provides (R,S)-3.10. We were also able to 
apply the same reaction conditions to convert (R,R)-3.8 to acetonides (R,R)-3.9 and then 
ozonolysis to primary alcohol (R,R)-3.10 (Scheme 3.3).  
 
Scheme 3.3 Acetonide protection and ozonolyis of (R,S)-3.8 and (R,R)-3.8. 
With compounds (R,S)-3.10 and (R,R)-3.10, we have prepared the primary alcohols. 
Transfer hydrogenative carbonyl allylation of (R,S)-3.10 employing the catalyst modified by (S)-
Cl,MeO-BIPHEP at 100 
o
C delivers the products of carbonyl allylation (R,S,S)-3.11 and the 
catalyst modified by (R)-Cl,MeO-BIPHEP delivers (R,R,S)-3.11. Again, the allylation was 
performed with complete diastereoselectivity and the racemic catalyst resulted in a mixture of 




Scheme 3.4 Catalyst directed diastereoselectivity in the transfer hydrogenative carbonyl allylation of 
(R,S)-3.10. 
Likewise, using the enantiomeric catalyst modified by (S)-Cl,MeO-BIPHEP or (R)-
Cl,MeO-BIPHEP, (R,R)-3.10 were transformed to homoallylic alcohols (R,R,S)-3.11 and 
(R,R,R)-3.11, respectively. In each case, the minor diastereomer could not be detected by 
1
H 
NMR analysis. Upon use of the achiral iridium catalyst ligated BIPHEP, (R,R)-3.11 was 




Scheme 3.5 Catalyst directed diastereoselectivity in the transfer hydrogenative carbonyl allylation of 
(R,R)-3c. 
3.2.3 Bidirectional Elongation of 1,3-Polyol 
To show the utility of this approach in a related example, O-4-methoxybenzyl neopentyl 
glycol 3.12 was subjected to transfer hydrogenative carbonyl allylation employing the catalyst 
modified by (R)-Cl,MeO-BIPHEP at 120 
o
C. The homoallylic alcohol 3.13 was produced in 80% 
isolated yield and 95% enantiomeric excess. Conversion of 3.13 to the tert-butyldimethylsilyl 
ether, followed by removal of the p-methoxybenzyl ether delivers the primary neopentyl alcohol 
3.14. Transfer hydrogenative carbonyl allylation of 3.14 employing the catalyst modified by (R)-
Cl,MeO-BIPHEP at 120 
o
C provides the homoallyl alcohol (R,R)-3.15 in 78% isolated yield in a 
12:1 diastereomeric ratio. Using the catalyst modified by (S)-Cl,MeO-BIPHEP at 120 
o
C, 3.14 is 
converted to the homoallyl alcohol (S,R)-3.15 in 82% isolated yield in an 11:1 diastereomeric 
ratio. Using the achiral iridium catalyst modified by BIPHEP, (R,R)-3.15 and (S,R)-3.15 were 
formed in roughly equal proportion. Thus, catalyst-directed chain elongation may be conducted 




Scheme 3.6 Bidirectional transfer hydrogenative chain elongation from both termini of neopentyl glycol. 
3.3 Part Two: Elongation of 1,3-Polyol via Iterative Catalyst Directed Bis-allylation 
Reaction 
1,3-Dialdehydes are very unstable compounds and cannot be utilized in one pot addition 
reactions. For instance, malondialdehyde can be generated through the hydrolysis of 1,1,3,3-
tetramethoxypropane, capture of this dialdehyde is impeded by the fact that it is highly unstable 
and is generated under aqueous conditions, which promote hydration, oligomerization, and self-
condensation, and preclude the use of most organometallic reagents. As we illustrated the ability 
to bypass stoichiometric pre-formation of aldehyde electrophiles, in carbonyl allylation from the 
alcohol oxidation level, potentially enables allylation processes that cannot be performed 
efficiently from certain unstable aldehydes. We reasoned that 1,3-propanediol could serve as a 
synthetic equivalent to malondialdehyde via successive generation and capture of mono-






Scheme 3.7 Proposed bis-allylation reaction from alcohol oxidation level and catalyst directed 
diastereoselective C2-Symmetric 1,3-polyol synthesis. 
3.3.1 Reaction Optimization 
Hence, the asymmetric allylation of 1,3-propanediol was explored. Using the 
cyclometallated catalyst generated in situ from [Ir(cod)Cl]2, (S)-Cl,MeO-BIPHEP, 4-chloro-3-
nitrobenzoic acid, and Cs2CO3 in dioxane solvent, the coupling of allyl acetate to propanediol at 
90 
o
C for 24 h, delivers the C2-symmetric homoallylic diol (S,S)-3.17 in 56% yield, 99% ee and 
with better than 30:1 diastereoselectivity, as determined by chiral stationary-phase HPLC 
analysis.  
The high levels of enantioselectivity were observed (99% ee), as the minor enantiomer of 
the intermediate mono adduct is converted into the meso product.
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 Moreover, increasing the 
reaction time to 48 h and 72 h gave 63% and 74% product, respectively. A decrease in the 
loading of allyl acetate from 10 to 5 equivalents diminished the isolated yield of (S,S)-3.17 by 








Table 3.3 Reaction optimization for bis-allylation of 1,3-propanediol. 
 
3.3.2 Substrate Scope 
These conditions were applied to different propylene glycols. Although yields were 
slightly diminished in the case of 2-methyl-1,3-propanediol 3.21 and 2,2-dimethyl-1,3-
propanediol (neopentyl glycol) 3.20, uniformly high levels of enantioselectivity were observed in 
all cases. 
Finally, the iridium-catalyzed asymmetric transfer-hydrogenative allylation of higher 
glycols was explored. The outcome of such transformations was uncertain, as 1,4-butanediol and 
1,5-pentanediol are transformed into γ-butyrolactone and δ-valerolactone, respectively, under 
transfer hydrogenation conditions. Remarkably, upon exposure to conditions for iridium-
catalyzed asymmetric transfer-hydrogenative allylation, 1,4-butanediol and 1,5-pentanediol are 
transformed into the corresponding the C2-symmetric diols 3.22 and 3.23 in 68% and 56% 




Scheme 3.8 Substrate scope for bis-allylation of terminal diols. 
3.3.3 Application in C2-Symmetric Polyol Synthesis 
The step economy associated with the double allylation of propylene glycols is borne out 
by comparison to known methods for the synthesis of C2-symmetric homoallylic diols. For 
example, in the course of a synthetic approach to (+)-phorboxazole A, the mono-TBS (tert-
butyldimethylsilyl) derivative of C2-symmetric diol (S,S)-3.17 was prepared in 7 steps from 




To illustrate the utility of this method in the context of two-directional chain synthesis, 
the C2-symmetric diol (S,S)-3.17 prepared from propylene glycol was subjected to a second 
round of concomitant two-directional chain elongation (Scheme 3.9). Accordingly, (S,S)-3.17 
was converted into the acetonide in 91% isolated yield, and was then subjected to ozonolysis. 
Upon complete consumption of starting material, as revealed by the persistence of a light blue 
color, the reaction mixture was treated with sodium borohydride to deliver the C2-symmetric diol 
(S,S)-3.24 in 89% isolated yield. Exposure of diol (S,S)-3.24 to the iridium catalyst modified by 
(R)-Cl,MeO-BIPHEP at 110
o
C delivered the higher C2-symmetric diol (R,S,S,R)-3.25 in 75% 
isolated yield, accompanied by 14% of the orresponding monoallylation product. Using the 
enantiomeric catalyst modified by (S)-Cl,MeO-BIPHEP, (S,S,S,S)-3.25 is obtained in 81% 
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isolated yield, accompanied by 12% of the corresponding mono-allylation product. In both cases, 
diastereomeric bis-adduct could not be detected by 
1
H NMR analysis, signifying exceptional 
levels of catalyst-directed diastereoselectivity. The achiral iridium catalyst ligated by biphep 
converts (S,S)-3.17 into a statistical mixture of diastereomeric adducts. The assembly of either 
(R,S,S,R)-3.25 or (S,S,S,S)-3.25 in only four steps from propylene glycol illustrates the power of 
this new protocol for iterative two-directional chain elongation (Scheme 3.9). 
 
Scheme 3.9 Catalyst directed bidirectional bis-allylation polyol synthesis. 
3.4 Summary 
In summary, under the conditions of transfer hydrogenative carbonyl allylation, the 
stereochemical bias of enantiomeric iridium catalysts modified by (R)-or (S)-Cl,MeO-BIPHEP is 
found to override the intrinsic diastereofacial bias of transient β-chiral aldehyde substrates. 
Based on this finding, a concise iterative enantiospecific synthesis of 1,3-polyols was achieved 
by way of conventional (one direction) or two-directional chain extension. The step-economy 
associated with this approach stems from the ability to circumvent the use of chirally modified 
allylmetal reagents, which require multi-step preparation, and the ability to perform concomitant 
two-directional chain elongation directly from the alcohol oxidation level, which avoids 
protecting group and redox manipulations.  
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3.5 Experimental Section 
3.5.1 Part One: Elongation of 1,3-Polyol 
(S)-1-(Benzyloxy)hex-5-en-3-ol (3.5) 
 
To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with 3-
(benzyloxy)propanol 3.4 (3.324 g, 20.0 mmol), [Ir(cod)Cl]2 (335.8 mg, 0.5 mmol), (S)-Cl,MeO-
BIPHEP (651.5 mg, 1.0 mmol), Cs2CO3 (1.3 g, 4.0 mmol) and 4-chloro-3-nitrobenzoic acid 
(403.1 mg, 2.0 mmol) was added THF (100 mL, 0.2 M) followed by allyl acetate (4.0 g, 40.0 
mmol). The reaction mixture was allowed to stir at 120 
o
C for 20 hr, at which point the reaction 
mixture was evaporated onto silica gel. Purification of the residue by column chromatography 
(SiO2: ethyl acetate:hexanes:triethylamine, 1:15:0.01) provided 3.5 (3.625 g, 17.576 mmol) as a 
colorless oil in 88% yield. 
TLC (SiO2): Rf = 0.26 (ethyl acetate:hexanes, 1:15). 
1
H NMR (400 MHz, CDCl3): δ 7.38-7.25 
(m, 5H), 5.89-5.78 (m, 1H), 5.14-5.08 (m, 2H), 4.52 (s, 2H), 3.90-3.86 (m, 1H), 3.75-3.62 (m, 
2H), 2.88 (br s, 1H), 2.24 (dd, J = 7.2, 6.0 Hz, 2H), 1.79-1.74 (m, 2H). 
13
C NMR (100 MHz, 
CDCl3): δ 137.9, 134.8, 128.4, 127.7, 127.6, 117.6, 73.2, 70.4, 69.0, 41.9, 35.8. HPLC: 
(Chiralcel OD-H column, hexanes:i-PrOH = 99:1, 0.7 mL/min, 254 nm), tmajor = 23.0 min, tminor 
= 25.8 min; ee = 95%. 
(S)-(1-(Benzyloxy)hex-5-en-3-yloxy)(tert-butyl)dimethylsilane (3.6) 
 
To a solution of 3.5 (2.98 g, 14.446 mmol) in DMF (14.5 mL, 1.0 M) was added imidazole (2.46 
g, 36.116 mmol) and TBSCl (4.35 g, 28.892 mmol) at room temperature. The reaction mixture 
was allowed to stir overnight at 50 
o
C, at which point H2O (30 mL) was added. The reaction 
mixture was extracted with ether (60 mL x 3) and the combined organic extracts were dried 
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(Na2SO4), filtered and concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2: ethyl acetate:hexanes, 1:49) provided 3.6 (4.15 g, 12.947 mmol) as a 
colorless oil in 90% yield. 
TLC (SiO2): Rf = 0.60 (ethyl acetate:hexanes, 1:19). 
1
H NMR (400 MHz, CDCl3): δ 7.36-7.26 
(m, 5H), 5.86-5.76 (m, 1H), 5.06-5.00 (m, 2H), 4.51 (d, J = 12.0 Hz, 1H), 4.45 (d, J = 12.0 Hz, 
1H) 3.93-3.87 (m, 1H), 3.57-3.52 (m, 2H), 2.29-2.17 (m, 2H), 1.84-1.66 (m, 2H), 0.88 (s, 9H), 
0.05 (s, 3H), 0.04 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ 138.5, 134.9, 128.3, 127.6, 127.5, 
117.0, 72.9, 68.9, 67.0, 42.3, 36.7, 25.8, 18.0, -4.4, -4.7. 
(S)-5-(Benzyloxy)-3-(tert-butyldimethylsilyloxy)pentan-1-ol (3.7) 
 
To a solution of 3.6 (3.55 g, 11.075 mmol) in methanol (74 mL, 0.15 M) was added 3-5 drops of 
solution of Sudan III (1.5 nM in methanol) to make the solution pink-light pink. O3 (2.0 Lmin
-1
, 
15 V) was bubbled through the solution for 40 min (till the solution become colorless) at -78 
o
C. 
The reaction mixture was sparged with argon for 10 min at -78 
o
C to remove residual O3, at 
which point NaBH4 (4.2 g, 110.75 mmol) was added. The reaction mixture was allowed to reach 
room temperature over 2 hr. H2O (20 mL) was added and the reaction mixture was concentrated 
to ~25 mL in vacuo. H2O (50 mL) was added and the aqueous phase was extracted with ethyl 
acetate (100 mL x 3). The combined organic extracts were dried (Na2SO4), filtered and 
concentrated in vacuo. Purification of the residue by column chromatography (SiO2: ethyl 
acetate:hexanes, 1:6) provided 3.7 (3.30 g, 10.168 mmol) as a colorless oil in 92% yield. 
TLC (SiO2): Rf = 0.22 (ethyl acetate:hexanes, 1:4). 
1
H NMR (400 MHz, CDCl3): δ 7.36-7.25 
(m, 5H), 4.51 (d, J = 11.9 Hz, 1H), 4.45 (d, J = 11.9 Hz, 1H), 4.01 (m, 1H), 3.80 (m, 1H), 3.70 
(m, 1H), 3.52 (t, J = 6.3 Hz, 2H), 2.53 (br s, 1H), 1.91-1.78 (m, 3H), 1.70-1.62 (m, 1H) 0.89 (s, 
9H), 0.09 (s, 3H), 0.07 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ 138.3, 128.3, 127.6, 127.5, 73.0, 







To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with 3.7 (649.0 mg, 
2.0 mmol), [Ir(cod)Cl]2 (34.0 mg, 0.05 mmol), (S)-Cl,MeO-BIPHEP (65.1 mg, 0.1 mmol), 
Cs2CO3 (130.0 mg, 0.4 mmol) and 4-chloro-3-nitrobenzoic acid (40.0 mg, 0.2 mmol) was added 
THF (10 mL, 0.2 M) followed by allyl acetate (400.0 mg, 4.0 mmol). The reaction mixture was 
allowed to stir at 100 
o
C for 40 hr, at which point the reaction mixture was evaporated onto silica 
gel. Purification of the residue by column chromatography (SiO2: ethyl 
acetate:hexanes:triethylamine, 1:9:0.01) provided (R,S)-3.8 (576.0 mg, 1.58 mmol) as a colorless 
oil in 79% yield. 
TLC (SiO2): Rf = 0.41 (ethyl acetate:hexanes, 1:4). 
1
H NMR (400 MHz, CDCl3): δ 7.37-7.26 
(m, 5H), 5.87-5.76 (m, 1H), 5.13-5.07 (m, 2H), 4.50 (d, J = 12.0 Hz, 1H), 4.46 (d, J = 12.0 Hz, 
1H), 4.11-4.05 (m, 1H), 3.84-3.77 (m, 1H), 3.52 (t, J = 6.4 Hz, 2H), 2.98 (t, J = 1.6 Hz, 1H), 
2.23-2.19 (m, 2H), 1.91-1.77 (m, 2H), 1.69-1.64 (m, 1H), 1.60-1.52 (m, 1H), 0.89 (s, 9H), 0.11 
(s, 3H), 0.09 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ 138.3, 134.8, 128.3, 127.6, 127.5, 117.5, 
73.0, 70.1, 69.6, 66.5, 42.8, 42.6, 25.8, 17.8, -4.3, -4.68. FTIR (neat): υ 3448, 3067, 2949, 2928, 
2856, 2360, 1641, 1496, 1472, 1454, 1409, 1360, 1253, 1076, 1028, 1003, 912, 835, 774, 734, 
697, 667 cm
-1
. HRMS (CI) Calcd. for C21H37O3Si (M+1): 365.2512, Found: 365.2519. 
(4R,6R)-8-(Benzyloxy)-6-(tert-butyldimethylsilyloxy)oct-1-en-4-ol ((R,R)-3.8) 
 
To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with 3.7 (649.0 mg, 
2.0 mmol), [Ir(cod)Cl]2 (34.0 mg, 0.05 mmol), (R)-Cl,MeO-BIPHEP (65.1 mg, 0.1 mmol), 
Cs2CO3 (130.0 mg, 0.4 mmol) and 4-chloro-3-nitrobenzoic acid (40.0 mg, 0.2 mmol) was added 
THF (10 mL, 0.2 M) followed by allyl acetate (400.0 mg, 4.0 mmol). The reaction mixture was 
allowed to stir at 100 
o
C for 40 hr, at which point the reaction mixture was evaporated onto silica 
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gel. Purification of the residue by column chromatography (SiO2: ethyl 
acetate:hexanes:triethylamine, 1:9:0.01) provided (R,R)-3.8 (516.0 mg, 1.42 mmol) as a 
colorless oil in 71% yield. 
TLC (SiO2): Rf = 0.39 (ethyl acetate:hexanes, 1:4). 
1
H NMR (400 MHz, CDCl3): δ 7.37-7.25 
(m, 5H), 5.85-5.75 (m, 1H), 5.15-5.05 (m, 2H), 4.51 (d, J = 12.0 Hz, 1H), 4.45 (d, J = 12.0 Hz, 
1H), 4.22-4.17 (m, 1H), 4.02-3.95 (m, 1H), 3.54-3.46 (m, 2H), 3.36 (d, J = 2.0 Hz, 1H), 2.26-
2.12 (m, 2H), 1.98-1.80 (m, 2H), 1.69-1.55 (m, 1H), 0.89 (s, 9H), 0.10 (s, 3H), 0.08 (s, 3H). 
13
C 
NMR (100 MHz, CDCl3): δ 138.3, 134.8, 128.4, 127.6, 127.6, 117.5, 73.0, 70.2, 69.7, 66.5, 
42.7, 42.2, 37.7, 25.8, 17.9, -4.3, -4.6. FTIR (neat): υ 3457, 3071, 3021, 2949, 2928, 2889, 2856, 
1641, 1495, 1471, 1454, 1361, 1254, 1071, 1027, 1002, 911, 835, 733, 697, 665 cm
-1
. HRMS 
(CI) Calcd. for C21H37O3Si (M+1): 365.2512, Found: 365.2511. 
(4S,6R)-4-Allyl-6-(2-(benzyloxy)ethyl)-2,2-dimethyl-1,3-dioxane ((R,S)-3.9) 
 
To a solution of ((R,S)-3.8 (554.0 mg, 1.519 mmol) in methanol (15mL, 0.1 M) was added p-
toluenesulfonic acid monohydrate (29.0 mg, 0.152 mmol). The reaction mixture was stirred for 1 
h at room temperature. TLC analysis showed complete consumption of the starting material. The 
reaction mixture was diluted with 2,2-dimethoxypropane (12.60 g, 15 mL, 120.979 mmol) and 
was stirred for 1 hr at room temperature. After concentrated in vacuo, the residue was diluted 
with 2,2-dimethoxypropane (6.30 g, 7.5 mL, 60.489 mmol) and was again concentrated in vacuo. 
2,2-Dimethoxypropane (12.60 g, 15 mL, 120.979 mmol) was added and the reaction mixture was 
stirred for 15 min. The reaction mixture was diluted with dichloromethane (200 mL) and washed 
with saturated NaHCO3 (50 mL) and brine (50 mL). The organic layer was dried (Na2SO4), 
filtered and concentrated in vacuo. Purification of the residue by column chromatography (SiO2: 
ethyl acetate:hexanes:triethylamine, 1:9:0.01) provided (R,S)-3.9 (370.0 mg, 1.274 mmol) as a 
colorless oil in 84% yield. 
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 (400 MHz, CDCl3): δ 7.36-7.25 
(m, 5H), 5.85-5.74 (m, 1H), 5.11-5.03 (m, 2H), 4.52 (d, J = 12.0 Hz, 1H), 4.48 (d, J = 12.0 Hz, 
1H), 4.06-4.00 (m, 1H), 3.91-3.84 (m, 1H), 3.62-3.50 (m, 2H), 2.34-2.27 (m, 1H), 2.18-2.10 (m, 
1H), 1.82-1.68 (m, 2H), 1.50 (dt, J = 13.2, 2.4 Hz, 1H), 1.43 (s, 3H), 1.38 (s, 3H), 1.15 (dd, J = 
13.2, 11.6 Hz, 1H). 
13
C NMR (100 MHz, CDCl3): δ 138.5, 134.2, 128.4, 127.6, 127.6, 117.1, 
98.5, 73.0, 68.6, 66.2, 66.0, 40.8, 36.6, 36.5, 30.2, 19.9. FTIR (neat): υ 3071, 3025, 2991, 2942, 
2860, 1723, 1642, 1496, 1454, 1379, 1264, 1198, 1170, 1146, 1027, 997, 963, 913, 873, 801, 
734, 697 cm
-1
. HRMS (CI) Calcd. for C18H27O3 (M+1): 291.1960, Found: 291.1954. 
(4R,6R)-4-Allyl-6-(2-(benzyloxy)ethyl)-2,2-dimethyl-1,3-dioxane ((R,R)-3.9) 
 
To a solution of (R,R)-3.8 (497.0 mg, 1.363 mmol) in methanol (14mL, 0.1 M) was added p-
toluenesulfonic acid monohydrate (26.0 mg, 0.136 mmol). The reaction mixture was stirred for 1 
h at room temperature, at which point TLC analysis revealed complete consumption of the 
starting material. The reaction mixture was diluted with 2,2-dimethoxypropane (11.80 g, 14 mL, 
113.298 mmol) and stirred for 1 h at room temperature. After concentrated in vacuo, the residue 
was diluted with 2,2-dimethoxypropane (6.88 g, 7 mL, 56.457 mmol) and was again 
concentrated in vacuo. 2,2-Dimethoxypropane (11.80 g, 14 mL, 113.298 mmol) was added and 
the reaction mixture was stirred for 15 min. The reaction mixture was diluted with 
dichloromethane (200 mL) and washed with saturated NaHCO3 (50 mL) and brine (50 mL). The 
organic layer was dried (Na2SO4), filtered and concentrated in vacuo. Purification of the product 
by column chromatography (SiO2: ethyl acetate:hexanes:triethylamine, 1:9:0.01) provided (R,R)-
3.9 (341.0 mg, 1.174 mmol) as a colorless oil in 84% yield. 
TLC (SiO2): Rf = 0.48 (ethyl acetate:hexanes, 1:4). 
1
H NMR (400 MHz, CDCl3): δ 7.36-7.25 
(m, 5H), 5.84-5.74 (m, 1H), 5.12-5.02 (m, 2H), 4.51 (d, J = 12.0 Hz, 1H), 4.47 (d, J = 12.0 Hz, 
1H), 4.03-3.96 (m, 1H), 3.89-3.82 (m, 1H), 3.59-3.50 (m, 2H), 2.34-2.27 (m, 1H), 2.22-2.15 (m, 
1H), 1.80-1.74 (m, 2H), 1.66-1.55 (m, 2H), 1.34 (s, 3H), 1.33 (s, 3H). 
13
C NMR (100 MHz, 
CDCl3): δ 138.5, 134.5, 128.4, 127.7, 127.6, 116.8, 100.3, 73.1, 66.6, 66.2, 63.7, 40.2, 38.0, 36.0, 
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24.8. FTIR (neat): υ 3067, 3029, 2985, 2938, 2856, 1642, 1496, 1454, 1378, 1222, 1098, 1028, 
992, 912, 802, 735, 697 cm
-1




To a solution of (R,S)-3.9 (310.0 mg, 1.068 mmol) in methanol:dichloromethane (7:3 v/v, 11 
mL, 0.1 M) was added 3-5 drops of solution of Sudan III (1.5 nM in methanol) to make the 
solution pink-light pink. O3 (2.0 Lmin
-1
, 15 V) was bubble through the solution for 12 min (till 
the solution become colorless) at -78 
o
C. The reaction mixture was sparged with argon for 10 
min at -78 
o
C to remove residual O3, at which point NaBH4 (404.0 mg, 10.675 mmol) was added. 
The reaction mixture was allowed to reach room temperature over 2 hr. H2O (5 mL) was added 
and the reaction mixture was concentrated to ~5 mL in vacuo. H2O (10 mL) was added and the 
aqueous phase was extracted with ethyl acetate (30 mL x 3). The combined organic extracts were 
dried (Na2SO4), filtered and concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2: ethyl acetate:hexanes:triethylamine, 1:1:0.01) provided (R,S)-3.10 
(281.0 mg, 0.954 mmol) as a colorless oil in 89% yield. 
TLC (SiO2): Rf = 0.22 (ethyl acetate:hexanes, 1:1.5). 
1
H NMR (400 MHz, CDCl3): δ 7.37-7.26 
(m, 5H), 4.52 (d, J = 12.0 Hz, 1H), 4.48 (d, J = 12.0 Hz, 1H), 4.14-4.04 (m, 2H), 3.81-3.72 (m, 
2H), 3.62-3.50 (m, 2H), 2.57 (t, J = 4.8 Hz, 1H), 1.81-1.67 (m, 4H), 1.48-1.24 (m, 2H), 1.45 (s, 
3H), 1.37 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ 138.5, 128.4, 127.6, 98.7, 73.0, 69.5, 66.1, 
66.0, 61.0, 38.0, 36.8, 36.5, 30.2, 20.0. FTIR (neat): υ 3437, 3088, 3063, 3029, 2991, 2942, 
2864, 1496, 1454, 1380, 1264, 1198, 1165, 1106, 1053, 1227, 957 cm
-1
. HRMS (CI) Calcd. for 








To a solution of (R,R)-3.9 (312.0 mg, 1.074 mmol) in methanol:dichloromethane (7:3 v/v, 11 
mL, 0.1 M) was added 3-5 drops of solution of Sudan III (1.5 nM in methanol) to make the 
solution pink-light pink. O3 (2.0 Lmin
-1
, 15 V) was bubbled through the solution for 10 min (till 
the solution become colorless) at -78 
o
C. The reaction mixture was sparged with argon for 10 
min at -78 
o
C to remove residual O3, at which point NaBH4 (407.0 mg, 10.744 mmol) was added. 
The reaction mixture was allowed to reach room temperature over 2 hr. H2O (5 mL) was added 
and the solution was concentrated to ~5 mL in vacuo. H2O (10 mL) was added and the aqueous 
phase was extracted with ethyl acetate (30 mL x 3). The combined organic extracts were dried 
(Na2SO4), filtered and concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2: ethyl acetate:hexanes:triethylamine, 1:1:0.01) provided (R,R)-3.10 
(289.0 mg, 0.982 mmol) as a colorless oil in 91% yield. 
TLC (SiO2): Rf = 0.22 (ethyl acetate:hexanes, 1:1.5). 
1
H NMR (400 MHz, CDCl3): δ 7.37-7.26 
(m, 5H), 4.51 (d, J = 12.0 Hz, 1H), 4.47 (d, J = 12.0 Hz, 1H), 4.08-3.98 (m, 2H), 3.81-3.71 (m, 
2H), 3.60-3.51 (m, 2H), 2.58 (br s, 1H), 1.82-1.72 (m, 4H), 1.71-1.60 (m, 2H), 1.37 (s, 3H), 1.33 
(s, 3H). 
13
C NMR (100 MHz, CDCl3): δ 138.4, 128.4, 127.7, 127.6, 100.5, 73.1, 67.0, 66.5, 63.7, 
61.2, 38.3, 37.6, 35.9, 24.8, 24.7. FTIR (neat): υ 3451, 3084, 3063, 3025, 3985, 3938, 3862, 
1496, 1454, 1379, 1124, 1096, 1053, 1027, 979, 902, 880, 794, 736, 697 cm
-1
. HRMS (CI) 









To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with (R,S)-3.10 
(59.0 mg, 0.2 mmol), [Ir(cod)Cl]2 (3.4 mg, 0.005 mmol), (S)-Cl,MeO-BIPHEP (6.5 mg, 0.01 
mmol), Cs2CO3 (13.0 mg, 0.04 mmol) and 4-chloro-3-nitrobenzoic acid (4.0 mg, 0.02 mmol) 
was added THF (1.0 mL, 0.2 M) followed by allyl acetate (40 mg, 0.4 mmol). The reaction 
mixture was allowed to stir at 100 
o
C for 40 hr, at which point the reaction mixture was 
evaporated onto silica gel. Purification of the residue by column chromatography (SiO2: ethyl 
acetate:hexanes:triethylamine, 1:3:0.01) provided (R,S,S)-3.11 (55.5 mg, 0.166 mmol) as a 
colorless oil in 83% yield. 
TLC (SiO2): Rf = 0.30 (ethyl acetate:hexanes, 1:2). 
1
H NMR (400 MHz, CDCl3): δ 7.37-7.26 
(m, 5H), 5.89-5.78 (m, 1H), 5.13-5.06 (m, 2H), 4.51 (d, J = 12.0 Hz, 1H), 4.47 (d, J = 12.0 Hz, 
1H), 4.14-4.03 (m, 2H), 3.90-3.84 (m, 1H), 3.61-3.49 (m, 3H), 2.29-2.15 (m, 2H), 1.81-1.68 (m, 
2H), 1.60-1.56 (m, 2H), 1.50-1.19 (m, 2H), 1.46 (s, 3H), 1.37 (s, 3H). 
13
C NMR (100 MHz, 
CDCl3): δ 138.4, 134.8, 128.4, 127.7, 127.6, 117.4, 98.7, 73.0, 71.0, 70.3, 66.0, 65.9, 42.2, 42.0, 
36.4, 30.2, 20.0. FTIR (neat): υ 3507, 3029, 2991, 2941, 2863, 1720, 1641, 1496, 1453, 1432, 
1380, 1314, 1269, 1199, 1166, 1027, 996, 957, 914, 874, 794, 714, 698 cm
-1
. HRMS (CI) Calcd. 






To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with (R,S)-3.10 
(59.0 mg, 0.2 mmol), [Ir(cod)Cl]2 (3.4 mg, 0.005 mmol), (R)-Cl,MeO-BIPHEP (6.5 mg, 0.01 
mmol), Cs2CO3 (13.0 mg, 0.04 mmol) and 4-chloro-3-nitrobenzoic acid (4.0 mg, 0.02 mmol) 
was added THF (1.0 mL, 0.2 M) followed by allyl acetate (40 mg, 0.4 mmol). The reaction 
mixture was allowed to stir at 100 
o
C for 40 hr, at which point the reaction mixture was 
evaporated onto silica gel. Purification of the residue by column chromatography (SiO2: ethyl 
acetate:hexanes:triethylamine, 1:3:0.01) provided (R,S,R)-3.11 (60.9 mg, 0.182 mmol) as a 
colorless oil in 91% yield. 
TLC (SiO2): Rf = 0.30 (ethyl acetate:hexanes, 1:2). 
1
H NMR (400 MHz, CDCl3): δ 7.37-7.26 
(m, 5H), 5.88-5.78 (m, 1H), 5.14-5.09 (m, 2H), 4.52 (d, J = 12.0 Hz, 1H), 4.47 (d, J = 12.0 Hz, 
1H), 4.22-4.16 (m, 1H), 4.10-4.03 (m, 1H), 3.97-3.90 (m, 1H), 3.62-3.50 (m, 2H), 2.83 (d, J = 
4.0 Hz, 1H),  2.23 (t, J = 7.2 Hz, 2H), 1.82-1.68 (m, 2H), 1.62 (t, J = 5.6 Hz, 2H), 1.46-1.26 (m, 
2H), 1.44 (s, 3H), 1.37 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ 138.5, 135.0, 128.4, 127.7, 
127.6, 117.6, 98.7, 73.0, 67.5, 67.1, 66.1, 42.0, 41.6, 36.52, 36.50, 30.2, 19.7. FTIR (neat): υ 
3459, 3071, 3029, 2992, 2941, 1721, 1641, 1496, 1453, 1432, 1380, 1266, 1165, 1198, 1146, 
1099, 1027, 997, 958, 913, 874, 713, 698 cm
-1
. HRMS (CI) Calcd. for C20H31O4 (M+1): 




To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with (R,R)-3.10 
(59.0 mg, 0.2 mmol), [Ir(cod)Cl]2 (3.4 mg, 0.005 mmol), (S)-Cl,MeO-BIPHEP (6.5 mg, 0.01 
mmol), Cs2CO3 (13.0 mg, 0.04 mmol) and 4-chloro-3-nitrobenzoic acid (4.0 mg, 0.02 mmol) 
was added THF (1.0 mL, 0.2 M) followed by allyl acetate (40 mg, 0.4 mmol). The reaction 
mixture was allowed to stir at 100 
o
C for 40 hr, at which point the reaction mixture was 
evaporated onto silica gel. Purification of the residue by column chromatography (SiO2: ethyl 
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acetate:hexanes:triethylamine, 1:3:0.01) provided (R,R,S)-3.11 (50.0 mg, 0.149 mmol) as a 
colorless oil in 74% yield. 
TLC (SiO2): Rf = 0.24 (ethyl acetate:hexanes, 1:2.3). 
1
H NMR (400 MHz, CDCl3): δ 7.36-7.26 
(m, 5H), 5.88-5.78 (m, 1H), 5.14-5.09 (m, 2H), 4.52 (d, J = 12.0 Hz, 1H), 4.47 (d, J = 12.0 Hz, 
1H), 4.19-4.12 (m, 1H), 4.05-3.97 (m, 1H), 3.94-3.87 (m, 1H), 3.59-3.50 (m, 2H), 2.64 (d, J = 
4.1 Hz, 1H),  2.28-2.19 (m, 2H), 1.81-1.75 (m, 2H), 1.72-1.55 (m, 4H), 1.36 (s, 3H), 1.32 (s, 
3H). 
13
C NMR (100 MHz, CDCl3): δ 138.4, 134.9, 128.4, 127.7, 127.5, 117.7, 100.5, 73.1, 67.7, 
66.5, 64.3, 63.8, 41.9, 41.1, 38.0, 35.9, 24.7, 24.6. FTIR (neat): υ 3456, 3067, 3029, 2985, 2938, 
1721, 1641, 1496, 1254, 1380, 1274, 1223, 1098, 1027, 996, 910, 841, 800, 713, 698 cm
-1
. 




To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with (R,R)-3.10 
(59.0 mg, 0.2 mmol), [Ir(cod)Cl]2 (3.4 mg, 0.005 mmol), (S)-Cl,MeO-BIPHEP (6.5 mg, 0.01 
mmol), Cs2CO3 (13.0 mg, 0.04 mmol) and 4-chloro-3-nitrobenzoic acid (4.0 mg, 0.02 mmol) 
was added THF (1.0 mL, 0.2 M) followed by allyl acetate (40 mg, 0.4 mmol). The reaction 
mixture was allowed to stir at 100 
o
C for 40 hr, at which point the reaction mixture was 
evaporated onto silica gel. Purification of the residue by column chromatography (SiO2: ethyl 
acetate:hexanes:triethylamine, 1:3:0.01) provided (R,R,R)-3.11 (57.2 mg, 0.171 mmol) as a 
colorless oil in 85% yield. 
TLC (SiO2): Rf = 0.33 (ethyl acetate:hexanes, 1:2.3). 
1
H NMR (400 MHz, CDCl3): δ 7.36-7.26 
(m, 5H), 5.88-5.78 (m, 1H), 5.12-5.07 (m, 2H), 4.50 (d, J = 12.0 Hz, 1H), 4.47 (d, J = 12.0 Hz, 
1H), 4.09-3.98 (m, 2H), 3.86-3.80 (m, 1H), 3.58-3.49 (m, 3H), 2.29-2.15 (m, 2H), 1.79-1.74 (m, 
2H), 1.69-1.54 (m, 4H), 1.38 (s, 3H), 1.32 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ 138.3, 134.8, 
128.3, 127.6, 127.5, 117.3, 100.6, 73.1, 71.2, 67.9, 66.4, 63.5, 41.9, 41.6, 38.6, 35.8, 24.8, 24.6. 
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FTIR (neat): υ 3639, 3507, 3025, 2985, 2937, 2857, 2358, 1721, 1641, 1496, 1454, 1380, 1313, 
1274, 1223, 1168, 1095, 1027, 994, 908, 796, 697 cm
-1
. HRMS (CI) Calcd. for C20H31O4 (M+1): 
335.2222, Found: 335.2228. 
3-(4-Methoxybenzyloxy)-2,2-dimethylpropan-1-ol (3.12) 
 
To a solution of 2,2-dimethylpropane-l,3-diol (2.08 g, 20.0 mmol) in DMF (20 mL, 1.0 M) was 
added sodium hydride (60% w/w in mineral oil, 0.96 g, 24.0 mmol) in portions at 0 °C. The 
reaction mixture was allowed to stir for 30 min at 0 °C, at which point 4-methoxybenzyl chloride 
(3.13 g, 20.0 mmol) and TBAI (0.74 g, 2.0 mmol) were added. The reaction mixture was allowed 
to reach room temperature over 2 hr and was then allowed to stir overnight. Saturated aqueous 
NH4Cl solution (50 mL) was added and the reaction mixture was extracted with diethyl ether (60 
mL x 3). The combined organic extracts were washed with brine, dried (Na2SO4), filtered and 
concentrated. Purification of the residue by column chromatography (SiO2: ethyl acetate:hexane, 
1:6 to 1:2) provided 3.12 (3.78 g, 16.90 mmol) as a colorless oil in 84% yield. 
TLC (SiO2): Rf = 0.46 (ethyl acetate:hexane, 1:2). 
1
H NMR (400 MHz, CDCl3): δ 7.24 (d, J = 
8.4 Hz, 2H), 6.88 (d, J = 8.4 Hz, 2H), 4.44 (s, 2H), 3.81 (s, 3H), 3.44 (s, 2H), 3.29 (s, 2H), 2.48 
(br s, 1H), 0.92 (s, 6H). 
13
C NMR (100 MHz, CDCl3): δ 159.4, 130.6, 129.3, 114.0, 78.7, 73.3, 
71.3, 55.4, 36.5, 22.1. 
(R)-1-(4-Methoxybenzyloxy)-2,2-dimethylhex-5-en-3-ol (3.13) 
 
To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with [Ir(cod)Cl]2 
(3.4 mg, 0.005 mmol), (R)-Cl,MeO-BIPHEP (6.9 mg, 0.01 mmol), Cs2CO3 (13.1 mg, 0.04 
mmol) and 4-chloro-3-nitrobenzoic acid (4.1 mg, 0.02 mmol) was added THF (1.0 mL, 0.2 M) 
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followed by allyl acetate (40 mg, 0.4 mmol). The reaction mixture was allowed to stir at 90 °C 
for 0.5 hr and was cooled to room temperature. 3.12 (44.9 mg, 0.2 mmol) was added to the 
reaction mixture and the reaction was allowed to stir at 120 °C for 48 hr, at which point the 
reaction mixture was evaporated onto silica gel. Purification of the residue by column 
chromatography (SiO2: ethyl acetate:hexane, 1:20 to 1:8) provided 3.13 (42.3 mg, 0.16 mmol) as 
a colorless oil in 80% yield. 
TLC (SiO2): Rf = 0.48 (ethyl acetate:hexane, 1:4). 
1
H NMR (400 MHz, CDCl3): δ 7.23 (d, J = 
8.4 Hz, 2H), 6.87 (d, J = 8.4 Hz, 2H), 5.97-5.87 (m, 1H), 5.12-5.06 (m, 2H), 4.43 (s, 2H), 3.80 
(s, 3H), 3.51 (dd, J = 10.8, 2.4 Hz, 1H), 3.35 (d, J = 8.8 Hz, 1H), 3.26 (d, J = 8.8 Hz, 1H), 2.96 
(br s, 1H), 2.29-2.24 (m, 1H), 2.09-2.01 (m, 1H), 0.92 (s, 3H), 0.90 (s, 3H). 
13
C NMR (100 
MHz, CDCl3): δ 159.4, 137.1, 130.2, 129.4, 116.8, 114.0, 79.5, 77.8, 73.4, 55.5, 38.5, 36.8, 22.9, 
19.9. HPLC: (Chiralcel AD-H column, hexanes:i-PrOH = 99:1, 0.5 mL/min, 254 nm), tmajor = 




To a solution of 3.13 (0.68 g, 2.580 mmol) in dichloromethane (26 mL, 0.1 M) was added 2,6-
lutidine (1.10 g, 10.320 mmol) and TBSOTf (1.36 g, 5.160 mmol) was added dropwise at -78 
o
C.  
The resulting solution was stirred for 1 hr at -78 °C. The reaction mixture was quenched with 
saturated NH4C1 solution (60 mL and was extracted with dichloromethane (60 mL x 3). The 
organic layer was washed with brine, dried (MgSO4), filtered and concentrated in vacuo. 
Purification of the product by column chromatography (SiO2: ethyl acetate:hexane, 1:20) 
provided 3.13a (0.90 g, 2.38 mmol) as a colorless oil in 92% yield. 
TLC (SiO2): Rf = 0.50 (ethyl acetate:hexane, 1:15). 
1
H NMR (400 MHz, CDCl3): δ 7.25 (d, J = 
8.4 Hz, 2H), 6.88 (d, J = 8.4 Hz, 2H), 5.93-5.83 (m, 1H), 5.02-4.95 (m, 2H), 4.45 (d, J = 12.0 
Hz, 1H), 4.34 (d, J = 12.0 Hz, 1H), 3.81 (s, 3H), 3.70-3.67 (dd, J = 6.0, 4.8 Hz, 1H), 3.23 (d, J = 
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8.4 Hz, 1H), 3.11 (d, J = 8.4 Hz, 1H), 2.39-2.32 (m, 1H), 2.18-2.11 (m, 1H), 0.90 (s, 3H), 0.89 
(s, 9H), 0.87 (s, 3H), 0.04 (s, 3H), 0.03 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ 159.2, 137.8, 
131.3, 129.2, 115.8, 113.9, 76.0, 73.0, 55.5, 40.5, 38.2, 26.4, 21.9, 21.4, 18.5, -3.1, -4.2. FTIR 
(neat): υ 3072, 2955, 2927, 2895, 2851, 1610, 1518, 1249, 1078, 1033, 903, 834, 770, 660 cm
-1
. 
HRMS (ESI) Calcd. for C22H38NaO3Si [M+Na]
+
: 401.2485, Found: 401.2482. 
(R)-3-(tert-Butyldimethylsilyloxy)-2,2-dimethylhex-5-en-l-ol (3.14) 
 
To a solution of compound 3.13a (866 mg, 2.29 mmol) in dichloromethane:pH 7 buffer (10:1 
v/v, 22 mL) was added DDQ (642 mg, 2.74 mmol) in portions at 0 °C. The reaction mixture was 
stirred for 2 hr at 0 °C and quenched with H2O (20 mL). The aqueous layer was extracted with 
dichloromethane (30 mL x 3). The combined organic extracts were washed with brine, dried 
(MgSO4), filtered and concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2: ethyl acetate:hexanes 1:20) provided 3.14 (500.0 mg, 1.934 mmol) as a 
colorless oil in 85% yield. 
TLC (SiO2): Rf = 0.47 (ethyl acetate:hexanes, 1:6). 
1
H NMR (400 MHz, CDCl3): δ 5.94-5.83 
(m, 1H), 5.08-5.00 (m, 1H), 3.72 (d, J = 10.8 Hz, 1H), 3.60 (t, J = 5.6 Hz, 1H), 3.25 (d, J = 10.8 
Hz, 1H), 2.77 (s, 1H), 2.50-2.42 (m, 1H), 2.30-2.23 (m, 1H), 1.12 (s, 3H), 0.89 (s, 9H), 0.79 (s, 
3H), 0.08 (s, 3H), 0.07 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ 136.7, 116.7, 80.1, 70.4, 39.9, 
38.4, 26.2, 23.9, 22.0, 18.3, -3.4, -4.2. FTIR (neat): υ 3430, 3075, 2955, 2923, 2885, 2854, 1473, 
1249, 1090, 1043, 1002, 910, 834, 770, 660 cm
-1
. HRMS (ESI) Calcd. for C14H30O2SiNa 
[M+Na]
+





To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with [Ir(cod)Cl]2 
(3.4 mg, 0.005 mmol), (R)-Cl,MeO-BIPHEP (6.9 mg, 0.01 mmol), Cs2CO3 (13.1 mg, 0.04 
mmol) and 4-chloro-3-nitrobenzoic acid (4.1 mg, 0.02 mmol) was added THF (1.0 mL, 0.2 M) 
followed by allyl acetate (40 mg, 0.4 mmol). The reaction mixture was allowed to stir for 0.5 hr 
at 90 °C and was cooled to room temperature. 3.14 (51.7 mg, 0.2 mmol) was added and the 
reaction mixture was allowed to stir for 48 hr at 120 °C, at which point the reaction mixture was 
evaporated onto silica gel. Purification of the product by column chromatography (SiO2: ethyl 
acetate:hexane, 1:40) provided (R,R)-15 (46.7 mg, 0.156 mmol) as a colorless oil in 78% yield. 
TLC (SiO2): Rf = 0.38 (ethyl acetate:hexane, 1:20). 
1
H NMR (400 MHz, CDCl3): δ 6.00-5.83 
(m, 2H), 5.15-5.02 (m, 4H), 4.19 (s, 1H), 3.88-3.85 (dd, J = 8.8, 3.2 Hz, 1H), 3.58-3.55 (dd, J = 
6.4, 4.4 Hz, 1H), 2.56-2.49 (m, 1H), 2.37-2.30 (m, 1H), 2.15-2.12 (m, 2H), 1.00 (s, 3H), 0.90 (s, 
9H), 0.80 (s, 3H), 0.10 (s,3H), 0.09 (s,3H). 
13
C NMR (100 MHz, CDCl3): δ 142.5, 142.1, 122.4, 




To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with [Ir(cod)Cl]2 
(3.4 mg, 0.005 mmol), (S)-Cl,MeO-BIPHEP (6.9 mg, 0.01 mmol), Cs2CO3 (13.1 mg, 0.04 mmol) 
and 4-chloro-3-nitrobenzoic acid (4.1 mg, 0.02 mmol) was added THF (1.0 mL, 0.2 M) followed 
by allyl acetate (40 mg, 0.4 mmol). The reaction mixture was allowed to stir for 0.5 hr at 90 °C 
and was cooled to room temperature. 3.14 (51.7 mg, 0.2 mmol) was added and the reaction 
mixture was allowed to stir for 48 hr at 120 °C, at which point the reaction mixture was 
evaporated onto silica gel. Purification of the residue by column chromatography (SiO2: ethyl 
acetate:hexane, 1:40) provided (S,R)-3.15 (48.9 mg, 0.164 mmol) as a colorless oil in 82% yield. 
TLC (SiO2): Rf = 0.34 (ethyl acetate:hexane, 1:20). 
1
H NMR (400 MHz, CDCl3): δ 5.96-5.80 
(m, 2H), 5.16-4.98 (m, 4H), 3.72-3.70 (t, J = 5.2 Hz, 1H), 3.58-3.54 (dt, J = 10.4, 2.4 Hz, 1H), 
2.52-2.45 (m, 1H), 2.40-2.35 (m, 1H), 2.25-2.18 (m, 1H), 2.04-2.00 (m, 1H), 1.91 (d, J = 3.6 Hz, 
88 
 
1H), 0.92 (s, 3H), 0.90 (s, 9H), 0.82 (s, 3H), 0.07 (s, 3H), 0.06 (s, 3H). 
13
C NMR (100 MHz, 
CDCl3): δ 137.7, 136.7, 118.0, 116.1, 78.0, 74.9, 43.0, 38.4, 37.0, 26.3, 19.7, 19.4, 18.5, -3.0, -
4.1. FTIR (neat): υ 3497, 3079, 2958, 2930, 2885, 2857, 1723, 1255, 1090, 1055, 1002, 910, 
834, 774, 672 cm
-1
. HRMS (ESI) Calcd. for C17H34NaO2Si [M+Na]
+
: 321.2226, Found: 
321.2224. 
3.5.2 Part Two: Elongation via Bis-allylation Reaction 
(4R,6R)-5,5-Dimethylnona-l,8-diene-4,6-diol ((R,R)-3.17) 
 
To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with [Ir(cod)Cl]2 
(6.8 mg, 0.01 mmol), (R)-Cl,MeO-BIPHEP (13.6 mg, 0.02 mmol), Cs2CO3 (26.2 mg, 0.08 
mmol) and 4-chloro-3-nitrobenzoic acid (8.2 mg, 0.04 mmol) was added THF (1.0 mL, 0.2 M) 
followed by allyl acetate (100 mg, 1.0 mmol). The reaction mixture was allowed to stir for 0.5 hr 
at 90 °C and was cooled to room temperature. 3.16b (20.8 mg, 0.2 mmol) was added and the 
reaction mixture was allowed to stir for 4 days at 110 °C, at which point the reaction mixture was 
evaporated onto silica gel. Purification of the residue by column chromatography (SiO2: ethyl 
acetate:hexane, 1:10 to 1:4) provided (R,R)-3.17 (17.0 mg, 0.092 mmol) as a colorless oil in 46% 
yield. 
TLC (SiO2): Rf = 0.34 (ethyl acetate:hexane, 1:4). 
1
H NMR (400 MHz, CDCl3): δ 5.94-5.83 (m, 
2H), 5.18-5.13 (m, 4H), 3.58-3.55 (dd, J = 10.4, 2.0 Hz, 2H), 2.97 (s, 2H), 2.35-2.30 (m, 2H), 
2.19-2.07 (m, 2H), 0.93 (s, 6H). 
13
C NMR (100 MHz, CDCl3): δ 136.2, 117.8, 77.4, 40.0, 36.5, 
20.9. HPLC: Enantiomeric excess was determined by HPLC analysis of the mono 4-
nitrobenzoate derivative of the product. (Chiralcel AD-H column, hexanes:i-PrOH = 90:10, 0.5 







To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with [Ir(cod)Cl]2 
(13.6 mg, 0.02 mmol), (S)-Cl,MeO-BIPHEP (27.4 mg, 0.04 mmol), Cs2CO3 (52.4 mg, 0.16 
mmol) and 4-chloro-3-nitrobenzoic acid (16.2 mg, 0.08 mmol) was added THF (1.0 mL, 0.2 M) 
followed by allyl acetate (200 mg, 2.0 mmol). The reaction mixture was allowed to stir for 0.5 hr 
at 90 °C and was cooled to room temperature. 3.16b (30.5 mg, 0.2 mmol) was added and the 
reaction mixture was allowed to stir for 48 hr at 110 °C, at which point the reaction mixture was 
evaporated onto silica gel. Purification of the residue by column chromatography (SiO2: ethyl 
acetate:hexane, 1:4 to 1:1) provided (S,S)-3.17 (43.4 mg, 0.28 mmol) as a colorless oil in 70% 
yield. 
TLC (SiO2): Rf = 0.44 (ethyl acetate:hexane, 1:1). 
1
H NMR (400 MHz, CDCl3): δ 5.86-5.77 (m, 
2H), 5.16-5.10 (m, 4H), 4.02-3.96 (m, 2H), 2.59 (s, 2H), 2.28-2.24 (m, 4H), 1.64-1.62 (t, J = 6.0 
Hz, 2H). 
13
C NMR (100 MHz, CDCl3): δ 134.6, 118.1, 68.1, 42.0, 41.5. HPLC: Enantiomeric 
excess was determined by HPLC analysis of the mono 4-nitrobenzoate derivative of the product. 
(Chiralcel OJ-H column, hexanes:i-PrOH = 92:8, 0.8 mL/min, 254 nm), tmajor = 12.5 min, tminor 
=21.9 min; ee > 99%. 
(4S,6S)-4,6-Diallyl-2,2-dimethyl-l,3-dioxane ((S,S)-3.24a) 
 
To a solution of (S,S)-3.17 (52.2 mg, 0.334 mmol) in dichloromethane (3.4 mL, 0.1 M) was 
added 2,2-dimethoxypropane (0.64 mL, 5.01 mmol) and PPTS (8.6 mg, 0.034 mmol) at room 
temperature. The reaction mixture was stirred for 30 min, at which point saturated NaHCO3 (10 
mL) was added and the reaction mixture was extracted with dichloromethane (15 mL x 3). The 
combined organic layers were dried (MgSO4), filtered and concentrated in vacuo. Purification of 
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the residue by column chromatography (SiO2: ethyl acetate:hexane, 1:20 to 1:15, with 0.1% 
TEA) provided (S,S)-3.24a (59.6 mg, 0.304 mmol) as a colorless oil in 91% yield. 
TLC (SiO2): Rf = 0.40 (ethyl acetate:hexane, 20:1). 
1
H NMR (400 MHz, CDCl3): δ 5.85-5.74 
(m, 2H), 5.12-5.03 (m, 4H), 3.89-3.82 (m, 2H), 2.34-2.26 (m, 1H), 2.23-2.15 (m, 1H), 1.63-1.59 
(t, J = 8.0 Hz, 2H), 1.35 (s, 6H). 
13
C NMR (100 MHz, CDCl3): δ 134.5, 116.8, 100.3, 66.2, 40.1, 
37.4, 24.8. FTIR (neat): υ 3074, 2985, 2932, 2883, 1735, 1637, 1428, 1383, 1223, 1160, 1121, 





Ozone was bubbled through a solution of (S,S)-3.24a (53.0 mg, 0.27 mmol) in 
dichloromethane:methanol (1:1 v/v, 2.7 mL, 0.1 M) at -78 °C until a blue color persisted. The 
excess O3 was then purged with argon for 5 min. The reaction was warmed to 0 °C, and NaBH4 
(102.0 mg, 2.70 mmol) was added in one portion. The mixture was stirred at room temperature 
for 3 hr, at which point water (3 mL) was added. The reaction mixture was concentrated and 
extracted with dichloromethane (5 mL x 3). The combined organic extracts were dried (MgSO4), 
filtered and concentrated in vacuo. Purification of the residue by column chromatography (SiO2: 
ethyl acetate to methanol:ethyl acetate, 1:20 with 0.1% triethylamine) provided (S,S)-24 (49.0 
mg, 0.240 mmol) as a colorless oil in 89% yield. 
TLC (SiO2): Rf = 0.39 (methanol:ethyl acetate, 1:20). 
1
H NMR (400 MHz, CDCl3): δ 4.11-4.04 
(m, 2H), 3.76-3.74 (m, 4H), 2.42 (s, 2H), 1.78-1.68 (m, 6H), 1.38 (s, 6H). 
13
C NMR (100 MHz, 
CDCl3): δ 100.6, 66.8, 61.1, 38.0, 37.6, 24.9. FTIR (neat): υ 3355, 2985, 2941, 2888, 1650, 









To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with [Ir(cod)Cl2 (6.8 
mg, 0.01 mmol), (R)-Cl,MeO-BIPHEP (13.7 mg, 0.02 mmol), Cs2CO3 (26.2 mg, 0.08 mmol) and 
4-chloro-3-nitrobenzoic acid (8.1 mg, 0.04 mmol) was added THF (1.0 mL, 0.2 M) followed by 
allyl acetate (l00 mg, 1.0 mmol). The reaction mixture was allowed to for 0.5 hr stir at 90 °C and 
was cooled to room temperature. (S,S)-3.24 (40.9 mg, 0.2 mmol) was added and the reaction 
mixture was allowed to stir for 48 hr at 110 °C, at which point the reaction mixture was 
evaporated onto silica gel. Purification of the residue by column chromatography (SiO2: ethyl 
acetate:hexane, 1:4 to 1:1, with 0.5% TEA)
8
 provided (R,S,S,R)-3.25 (41.8 mg, 0.150 mmol) as a 
colorless oil in 74% yield and the corresponding mono-allylation product (8.0 mg, 0.030 mmol) 
as a colorless oil in 16% yield. 
TLC (SiO2): Rf = 0.45 (ethyl acetate:hexane, 1:1). 
1
H NMR (400 MHz, CDCl3): δ 5.88-5.77 (m, 
2H), 5.14-5.10 (m, 4H), 4.20-4.13 (m, 2H), 3.93-3.86 (m, 2H), 2.53 (d, J = 4.8 Hz, 2H), 2.26-
2.22 (m, 4H), 1.69-1.62 (m, 6H), 1.37(s, 6H). 
13
C NMR (100 MHz, CDCl3): δ 134.8, 117.8, 
100.7, 67.7, 64.4, 42.0, 41.3, 37.7, 24.8. FTIR (neat): υ 3413, 3070, 2990, 2941, 2919, 2852, 





To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with [Ir(cod)Cl2 (6.8 
mg, 0.01 mmol), (S)-Cl,MeO-BIPHEP (13.7 mg, 0.02 mmol), Cs2CO3 (26.2 mg, 0.08 mmol) and 
4-chloro-3-nitrobenzoic acid (8.1 mg, 0.04 mmol) was added THF (1.0 mL, 0.2 M) followed by 
allyl acetate (l00 mg, 1.0 mmol). The reaction mixture was allowed to stir for 0.5 hr at 90 °C and 
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was cooled to room temperature. (S,S)-3.24 (40.9 mg, 0.2 mmol) was added and the reaction 
mixture was allowed to stir for 48 hr at 110 °C, at which point the reaction mixture was 
evaporated onto silica gel. Purification of the residue by column chromatography (SiO2: ethyl 
acetate:hexane, 1:4 to 1:1, with 0.5% TEA)
8 
provided (S,S,S,S)-3.25 (46.0 mg, 0.16 mmol) as a 
colorless oil in 81% yield, and the corresponding mono-allylation product (5.8 mg, 0.023 mmol) 
as a colorless oil in 12% yield. 
TLC (SiO2): Rf = 0.50 (ethyl acetate:hexane, 1:1).  
1
H NMR (400 MHz, CDCl3): δ 5.88-5.78 (m, 
2H), 5.12-5.07 (m, 4H), 4.11-4.04 (m, 2H), 3.86-3.80 (m, 2H), 3.30 (s, 2H), 2.28-2.16 (m, 4H), 
1.69-1.55 (m, 6H), 1.39 (s, 6H). 
13
C NMR (100 MHz, CDCl3): δ 134.7, 117.5, 100.8, 71.0, 67.7, 
41.9, 41.6, 38.8, 24.9. FTIR (neat): υ 3430, 3070, 2985, 2936, 2914, 2848, 1646, 1428, 1375, 









Chapter 4: Progress in Iridium Catalyzed Transfer Hydrogenation Allylation Reaction: 
Effects of β- and γ-Substitution on Carbonyl Coupling from Alcohol and Aldehyde 
Oxidation Level 
4.1 Background 
Under transfer hydrogenation conditions using ortho-cyclometallated iridium catalysts 
generated in situ from allyl acetate, 3-nitrobenzoic acid and a chiral bis-phosphine ligand, 
enantioselective carbonyl allylation is achieved from the alcohol or aldehyde oxidation level 
using allyl acetate as the allyl donor. Aliphatic, allylic and benzylic alcohols are transformed to 
the corresponding homoallylic alcohols with uniformly high levels of enantioselectivity. In the 
presence of isopropanol, but under otherwise identical conditions, aldehydes are converted to an 
equivalent set of adducts. This protocol avoids cryogenic conditions and the stoichiometric use 








Our research group find out that the cyclometallated iridium π-allyl C,O-benzoate 
complexes can be pre-formed which have been characterized by single crystal x-ray diffraction 
and used in transfer hydrogenative coupling with better reactivity than in situ generated 





Scheme 4.2 Synthesis and isolation of iridium cyclometallated catalyst. 
Using the column purified ortho-cyclometallated iridium catalysts our research group 
was able to developed diverse processes beyond allylation. The first important extension relating 
to this chemistry was enantioselective carbonyl crotylation using α-methyl allyl 4.8 acetate as the 
crotyl donor. The isolated catalyst enables carbonyl crotylation from alcohol and aldehyde 
oxidation level at lower temperature (60 
o
C) compare to in situ generated catalyst (90 
o
C) in 
higher levels anti-diseteo- and enantioselecctivity (Scheme 4.3, entry 1).
75
 Related processes 
were established for example, diastereo- and enantioselective α-(trifluromethyl)allylation 
employing α-trifluoromethyl allyl benzoate 4.9 as allyl donor to get the trifluoroallylation 
product in high levels of anti-diastereo- and enantioselectivity.
76a





 which also have been performed 
from the alcohol or aldehyde oxidation level (Scheme 4.3, entries 3 and 5). Finally, α-
(hydroxy)allylation
76d
 was performed using allylic gem-dibenzoate 4.11 under the conditions of 
iridium catalyzed transfer hydrogenation to provide anti-1-ene-2,3-diols with excellent relative 
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and absolute stereocontrol. The latter process can only be performed from aldehyde oxidation 
level as the alcohol starting material mostly undergoes trans-esterification (Scheme 4.3, entry 4). 
 
Scheme 4.3 Summary of diastereo- and enantioselective allylation methods availed through use of ortho-
cyclometallated iridium catalysts. 
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All of the above processes take place by means of substituted π-allyl iridium 
intermediates results in complete branched regioselectivities, accompanied by good to complete 
levels of anti-diastereoselectivity. This suggested carbonyl addition occurs with allylic inversion 
from the primary (E)-σ-allyl haptomer. Conversely, we believe 1,1- or 1,2-substituent renders the 
alkene a poor ligand for iridium center and as a result they did not participate in carbonyl 
addition processes. It has been established that the stability of late transition metal-olefin π-
complex decreases with increasing degree of olefin substitution.
77
 As olefin coordination is a 
prerequisite to ionization, the requirement of allyl donors that incorporate monosubstituted 
olefins likely stems from the shorter lifetime of more highly substituted iridium-olefin π-
complexes.The goal of this research was to understand the reactivity pattern of iridium transfer 
hydrogenation coupling using allylating agents with different higher substitution pattern (Scheme 
4.4). In the next two parts of this chapter we will described how we were able to perform 
transformation using 1,1- or 1,2-substited allylating agent using cyclometallated iridium π-allyl 
C,O-benzoate complexes as catalyst. 
 
 




4.2 Part One: 1,1-Disubstituted Olefins as Allyl Donors in Iridium Catalyzed Transfer 
Hydrogenation Transformation. Enantioselective Grignard Nozaki-Hiyama Methallylation 
Reaction 
4.2.1 Introduction 
 As indicated in scheme 4.4, higher degree of olefin substitution result in poor 
coordination ability towards iridium metal center, as a result the ionization prospects. To enable 
efficient reaction of substituted allyl donors in the absence of any other stabilizing effects, we 
can compensate for the shorter lifetime of the iridium-olefin π-complex by employing a relative 
reactive leaving group. Given the paucity of studies devoted exclusively to enantioselective 
carbonyl methallylation
78,79 
it can serve as testing ground for irdium catalyzed carbonyl addition 
beyond α-substituted allylation. 
To test our premise, methallyl acetate, carbonate and sulfonate (4.24-4.27) were reacted 
under iridium catalyzed transfer hydrogenation allylation conditions did not participate in 
carbonyl addition. However, under identical conditions, much higher conversions were observed 
using methallyl chloride 4.28, an inexpensive commercial material. Employing (rac)-VIII as 
catalyst which is prepared from [Ir(cod)Cl]2, BIPHEP, allyl acetate and 4-cyano-3-nitrobenzoic 
acid, methylallyl chloride react with benzylic alcohol give rise to methallylation product 4.22 in 
72% yield. However, these initial experiments, which were conducted at 70 
o
C over 48 hours, 
also revealed a major side-reaction: oxidation of the initially formed methallylation product 4.22 
to form the conjugated dimethyl enone 4.23. The formation of enone 4.23 corroborates the poor 
coordinating ability of the methyl-substituted homoallylic olefin which induces β-hydride 






Table 4.1 Discovery of Iridium catalyzed methallylation reaction using methallyl chloride as allylating 
agent. 
 
4.2.2 Reaction Optimization 
 A comprehensive reaction optimization was carried out, varying each facet of reaction 
conditions. By changing the reaction temperature it was found out that oxidation of the initially 
formed methallylation product 4.22 to form enone 4.23 can be suppressed at lower temperature 
(50 
o
C) to only 5%, compare to >20% at higher temperature (Table 4.2). However, further 
reaction optimization was carried out at 70 
o
C in order to clearly observe the difference between 








Table 4.2 Temperature effect on Iridium catalyzed methallylation. 
 
 
Subsequently, we observed effect of reaction solvent, it was found that non-polar solvent 
like toluene and hexane give practical amount of product but were ineffective in suppressing 
over oxidation (table 4.3, entries 1 and 2) and chlorinated solvent such as, dichloroethane was 
likewise not effective (table 4.3, entry 3). On the other hand, oxygenated solvent 1,4-dixane with 
comparision with THF give rise to low over oxidized side product but with diminished yield. As 
a result, we use THF as it gave the best conversion among the solvent screened (table 4.3, entries 
4 and 5). We looked at different bases and found out that tribasic potassium phosphate was the 
best than any other organic and inorganic base screen, some of the results are shown in (table 







Table 4.3 Solvent and base effect on Iridium catalyzed methallylation reaction. 
 
 It was interesting to note that potassium phosphate was the best as it was effective related 
chemistry. However, the amount of base also effects the reaction in great yield. Lower amount of 
potassium phosphate (50 mol% and 75 mol%) resulted in less oxidation product (none and 12%, 
respectively, table 4.4 entries 2 and 3) nevertheless at the expense of product yield. The initial 
100 mol% base loading was optimal loading as higher amount resulted in diminished yield as a 
result of product decomposition. Methallyl chloride amount was also screen, and higher loadings 
(300 mol%) suppressed over oxidation to only 16%, higher loading with respect to cost of 
reaction was not an issue as methyl chloride is very inexpensive. Finally, carrying out the 
reaction at 50 
o
C with 300 mol% methallyl chloride summed up the best reaction condition 






Table 4.4 Effect of K3PO4 and methallyl chloride loading on Iridium catalyzed methallylation reaction. 
 
 With optimal reaction conditions in hands, we look at the enantioselective methallylation. 
Generally, the chiral ortho-cyclometallated iridium C,O-benzoates catalyze carbonyl additions 
are very effective in asymmetric discrimination. Indeed, the reaction carried out with chiral 
modified catalyst gave excellent enantioselectivity. Catalyst modified by (R)-SEGPHOS (R)-IV, 
provided the methallylation product 4.22 in 63% and 96% enantiomeric purity accompanied by 
32% over oxidized enone product 4.23. (R)-BINAP modified catalyst, (R)-VI suppress the over 
oxidation but resulted in lower enantioselectivity (85% ee). Since (R)-BINAP is readily available 
inexpensive and highly desirable ligand, yet, we were not able to improve the enantioselectivity 
by changing the reaction conditions. Finally, with (R)-Cl,MeO-BIPHEP ligated catalyst (R)-II, 
we were able to retain high enantioselectivity (94% ee) and highly practical yield (84%) 
accompanied with small amount (12%) of over oxidized product. Meanwhile, we also found out 
that the chiral catalyst (R)-II was more effective in methallylation reaction than (rac)-VIII, we 
were able to get comparable yields using shorter the reaction time (24 h). In other substrates, 




Table 4.5 Enantioselective Iridium catalyzed methallylation reaction, screening of chiral ligands. 
 
4.2.3 Substrate Scope 
  Under these optimal conditions including catalyst (R)-II (5 mol%), methallyl chloride 
(300 mol%) and potassium phosphate (100 mol%) in THF (1 M) at 50 
o
C the reaction displayed 
very general reactivity. Benzylic alcohols were transformed to the desired methallylation product 
in good yields, beside the 4-bromobenzyl alcohol, piperonyl alcohol resulted in 78% isolated 
yield of product 4.31 and 95% enantiomeric excess. Heteroaryl alcohol 2-benzotheinyl alcohol 
gave methallylation product 4.37 in 87% and 96% enantiomeric excess. These conditions were 
applied to aliphatic alcohols, nonanol, mono-protected propanediol and neopentyl alcohol 
resulted in the corresponding products of methallylation (4.29, 4.32 and 4.35, respectively) in 
good to excellent yields and with uniformly high levels of enantioselectivity. The aliphatic 
alcohols were particularly well behaved substrates in view of their ability to undergo 
methallylation to form adducts with virtually complete suppression of further oxidation to form 
enones. The same is true for cyclohexane methanol. On the hand, allylic alcohols undergo 
competing enone formation more evidently much like benzylic alcohols which are more 
susceptible to β-hydride elimination. To suppress over oxidation in allylic systems, the reaction 
of cinnamyl alcohol and geraniol reactions were carried out with additional 200 mol% 
isopropanol to give the products 4.33 and 4.36 in  80% yield. In the presence of isopropanol (200 
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mol%), but under otherwise identical conditions an equivalent set of adducts can be generated 
from aldehydes. In most cases, comparable isolated yields and enantioselectivities are observed. 
Thus, carbonyl Grignard-Nozaki-Hiyama methallylation is achieved with equal facility from the 
alcohol or aldehyde oxidation level (table 4.6). 
Table 4.6 Substrate scope of Iridium catalyzed methallylation reaction. 
 
  The absolute stereochemistry of methallylation products was made in analogy to that 
determined for bromide containing adduct 4.34 by single crystal X-ray diffraction analysis using 
the anomalous dispersion method. 
4.2.4 Bis-methallylation of 1,3-Propanediol 
  To showcase the utility of this methodology, double enantioselective methallylation of 
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1,3-propanediol 4.38 was attempted under standard conditions.
 
The corresponding C2-symmetric 
diol 4.39 is produced in 66% isolated yield as a single enantiomer, as the minor enantiomer of 
the mono-adduct is transformed to the meso-stereoisomer of the product. Diol 4.39 was 
converted to acetonide 4.40 and subjected to ozonolysis to provide the formal product of double 
acetone aldol addition 4.41 (Scheme 4.5). 
 
Scheme 4.5 Bis-methallylation of 1,3-propanediol and synthesis of C2-symmetric bis-acetone adduct. 
4.2.5 Summary 
  In summary, we found out that methallyl acetate does not serve as an efficient allyl donor 
due to the lower stability and, therefore, shorter lifetime of the iridium-olefin π-complex that 
precedes formation of the requisite π-allyliridium complex. Through the use of more reactive 
leaving group in methallyl chloride, the ionization to form the π-allyliridium complex is more 
rapid, hence compensating for the shorter lifetime of the more highly substituted olefin π-
complex. Based on this insight into the requirements of the catalytic process, highly 
enantioselective Grignard-Nozaki-Hiyama methallylation is achieved from the alcohol or 
aldehyde oxidation levels in the absence of stoichiometric metallic reagents or reductants. 
Further, double enantioselective methallylation of 1,3-propanediol was carried out in good yield 
to obtained C2-symmetric bis-methallylation product as a single enantiomer, as the minor 
enantiomer of the mono-adduct is transformed to the meso-stereoisomer of the product. 
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4.3 Part Two: 1,2-Disubstituted Olefins as Allyl Donors in Iridium Catalyzed Transfer 
Hydrogenation Transformation. Enantioselective Vinylogous Aldol-Reformatsky Addition 
4.3.1 Introduction 
 Vinylogues of the aldol reaction represent an important class of carbonyl addition 
processes.
80
 The vast majority of enantioselective vinylogous aldol additions employ dienolates 
and dienol ethers derived from β-ketoester esters
81





 or chiral H-bond donors.
80n
 Dienolates and dienol ethers derived from 
simple α,-unsaturated carbonyl compounds75k-m,76 and 2-siloxy furans82 also participate in 
enantioselective vinylogous aldol additions. While excellent regio- and enantioselectivities have 
been obtained in certain cases, the formation and tractability of the requisite dienol ethers pose a 
barrier to their use. Additionally, chiral Lewis acid catalyzed reactions of silyl dienol ethers often 
suffer from competing racemic silyl cation catalyzed background reactions, requiring slow 
addition of the dienol ether, cryogenic conditions and high catalyst loadings. Vinylogous direct 
aldol additions of unmodified α,-unsaturated carbonyl compounds potentially address these 
limitations,
83
 however, to date, such transformations are restricted to the use of 2-(5H)-furanones 
as aldol donors.
 
In a significant departure from prior art, Shibasaki and Kanai devised a reductive 
vinylogous aldol reaction of allenic esters mediated by pinacolborane.
84
 A related reductive 
process, the vinylogous Reformatsky reaction, could potentially deliver identical products, 
however, enantioselective variants are unknown. 
As deliberated in the beginning of this chapter, we have found that chiral ortho-
cyclometallated iridium C,O-benzoates catalyze carbonyl transformations take place by way of 
substituted π-allyl iridium intermediates, resulted in complete branched regioselectivities, 
accompanied by good to complete levels of anti-diastereoselectivity, suggesting carbonyl 
addition occurs with allylic inversion from the primary (E)-σ-allyl haptomer. We discussed the 
degree of olefin substitution result in interference between iridium and olefin and hence, 
decrease the ionization prospects of allylating agent. We also discussed, how a better leaving 
group enabled us to perform transformation with 1,1-disubstituted olefin in allylating agent.  
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For 1,2-disubstituted system, the linear carbonyl addition products might be availed upon 
stabilization of the secondary σ-allyl haptomer through introduction of a stabilizing effect. 







Scheme 4.6 Differential π-allyl stabilization by substituent X may lead to new reactivity pattern. 
The veracity of this analysis is borne out by the exposure of the -acyloxy crotonate 4.45 
to benzyl alcohol 4.21 in the presence of the ortho-cyclometallated iridium C,O-benzoate 
complex modified by BIPHEP, designated as (rac)-VIII. While potassium phosphate was used 
as base and the products of carbonyl addition was obtained in 15% yield. The more labile 
benzoate ester 4.46 leads to slight improvement in yield. Though, due to practical problem of 
product isolation further optimizations were carried out with metyl 4-(hydroxymethyl)benzoate 
4.49. Pivaloyl crotonate 4.47 on the other hand did not participate in coupling reaction. However, 
to our delight tert-butyl carbonate 4.48 of -hydroxy crotonate resulted in 26% isolated yield. 
The Boc-carbonate 4.48 is better allylating agent as it did not participate in acyl transfer reaction 





Table 4.7 Discovery of vinylogous aldol reaction and screening of effect of leaving group on reactivity. 
 
Before we carried out an extensive reaction optimization, it was suspected that the 
product of vinylogous Reformatsky-aldol addition might be formed as a base catalyzed 
background reaction of ethyl crotonate, which might have produced from -acyloxy crotonate 
reduction. Control experiments were performed where ethyl crotonate 4.52 was exposed to 
otherwise similar reaction conditions deprived of any addition product (table 4.8).  





4.3.2 Reaction Optimization 
We started optimization by changing the electronic character of ortho-cyclometallated 
iridium C,O-benzoate complex, by means of changing the substituent at 4-position of the benzoic 
acid. The reactivity pattern was not very different from electron donating to withdrawing group, 
however, electron withdrawing substituent give uniformly good reactivity. The 4-chloro-3-
nitrobenzoate based catalyst (rac)-VII was chosen for any further reaction optimization due to 
readily availability and well behaved reactivity pattern (Table 4.9, entry 6). 
Table 4.9 Iridium C,O-benzoate complex modified, effects on vinylogous aldol reaction. 
 
 However, observing the reaction temperature, it was found that at lower temperature the 
vinylogous Reformatsky-aldol addition suffer from regioselectivity issues. At lower temperature, 
the primary (E)-δ-allyl haptomer (Scheme 4.6) is the reactive specie, which resulted in the 
observed branched selectivity by α-addition of the enolate to aldehyde. However, at higher 
temperature the secondary δ-allyl haptomer is more reactive giving rise to novel linear selectivity 
by virtue of γ-addition. This reactivity pattern suggests a Curtin-Hammett scenario wherein the 
equilibrating mixture of primary and secondary σ-allyl haptomers selectively reacts with 
aldehyde at different temperature. We were mostly interested in the new reactivity character and 




Table 4.10 Temperature and regionselectivity correlation in Iridium catalyst vinylogous aldol reaction. 
 
It was found out that the reaction works better at lower concentration and 0.5 M was 
superior than 1 M (48% and 40%, respectively, table 4.11). The solvent screen was very 
interesting and it was found out that chlorinated solvent dichlorethane was not as effective. 
Toluene was slight better than THF and 2-methyltetrahydrofuran, but 1,4-dioxane was the best 
among the solvents (Table 4.11, entry 8). 




 As we have discussed, benzylic alcohol have resulted in indiscriminate regioselectivity, it 
was interesting to look at aliphatic example. To find out substrate-regioselectivity relationship, 
O-4-methoxybenzyl-1,3-propanediol 4.56, cyclohexanemethanol 4.58  and corresponding 
aldehyde (4.57 and 4.59, respectively) were examined under optimized condition. The former O-
4-methoxybenzyl-1,3-propanediol 4.56, was found to be completely unselective towards 
regioselectivity giving the product in equal amount of regioselectivity however, the 
corresponding aldehyde was slightly favorable to linear product (2:1 rr). Conversely, by 
increasing the steric hindrance at the reactive carbonyl center, as by α-substitution in 
cyclohexanemethanol 4.58 the reacted to deliver the product in higher level of linear regioisomer 
(4:1 rr). The corresponding aldehyde gave slightly better selectivity (5:1) (Table 4.12). Any 
further optimization to improve regioselectivity was unsuccessful.  
Table 4.12 Aliphatic alcohol in Iridium catalyst vinylogous aldol reaction. Regioselectivity effect due to 





4.3.3 Enantioselective Vinylogous Reformatsky Aldol Reaction 
In spite of regioselectivity limitation, the enantioselective coupling was desirable. 
Screening of Chiral catalyst were performed however, most of the chiral catalyst resulted in poor 
enantioselectivity. (R)-Cl,MeO-BIPHEP modified catalyst, (R)-I was the best catalyst in the 
series (Table 4.13, entry 5). Excitingly, for the same reaction conditions, it was noted that the 
enantioselectivity was slightly higher for shorter reaction time. This anomaly can be explained 
by invoking oxidation reduction of the coupling product which results in scrambling of 
enantiomeric purity. This analysis bode with assumption that the additional substituent on double 
bond of the product renders it poor coordinating ability which in turn makes it susceptible to 
iridium catalyzed β-hydride elimination. Since, the benzylic alcohols are more reactive towards 
β-hydride elimination and therefore, would give poor enantiomeric excess. However, aliphatic 
alcohols and un-activated allylic and benzylic substrate can potentially provide better 
enantioselectivity. 
Table 4.13 Ligand screen in asymmetric vinylogous aldol reaction. 
 
 As discussed above, the hypothesis was put to test when cyclohexanemethanol was use as 
substrate in enantioselective vinylogous Reformatsky addition reaction, which resulted in good 
yield, regio- and excellent enantioselectivity employing either alcohol or aldehyde oxidation 
level (table 4.14). 
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Table 4.14 Enantioselective vinylogous aldol addition in cyclohexanemethanol and 
cyclohexanecarboxaldehyde. 
 
4.3.4 Substrate Scope 
Diverse range of substrate was screen to examine the scope of enantioselective 
vinylogous Reformatsky-aldol addition. Similar to cyclohexanemethanol, in the presence of the 
chiral ortho-cyclometallated iridium C,O-benzoate complex modified by (R)-Cl,MeO-BIPHEP, 
[2,2'-bis(diphenylphosphino)-5,5'-dichloro-6,6'-dimethoxy-1,1'-biphenyl], designated as (R)-I, 
O-benzyloxypropanediol undergo carbonyl addition giving rise to mixture of regioisomer in a 
combined 87% yield as a 1:2 mixture of linear (88% ee) and branched regioisomers, favoring 
formation of the branched adduct. However, primary neopentyl alcohols deliver products of C-C 
coupling with complete linear regioselectivity and exceptional enantioselectivity. In all cases, 
roughly equivalent yields and selectivities are observed when the C-C coupling is performed 
using aldehydes. Finally, benzylic alcohols and the corresponding aldehydes engage in C-C 
coupling to furnish adduct 4.64, 4.67 and 4.69 in good yield. Here, as suggested, slight erosion in 
optical purity of is observed over the course of the reaction, due to reversible oxidation-reduction 





Table 4.15 Substrate scope of enantioselective vinylogous Reformatsky-aldol addition from the alcohol or aldehyde 
oxidation level. 
 
Linear regioselectivity in response to increased steric demand of the aldehyde suggests a 
Curtin-Hammett scenario wherein carbonyl addition occurs selectively from an equilibrating 
mixture of primary and secondary σ-allyl haptomers.
86
 Beyond electronic effects, it is likely that 
carbonyl addition from the α-C-bound iridium enolate to form the less substituted C-C bond is 
favored due to the absence of gauche interactions in the transition state. For sterically demanding 






4.3.5 Catalyst-directed Vinylogous Reformatsky-aldol Addition 
To further explore the scope of the vinylogous Reformatsky-aldol addition, catalyst-
directed diastereoselectivity was explored in the coupling of allylic carbonate 4.48 to α-chiral 
alcohol 4.70.
87
 Under standard conditions employing (R)-I as precatalyst, the linear adduct 4.71 
was isolated as a single regio- and stereoisomer. Using the enantiomeric precatalyst (S)-I, the 
linear adduct epi-4.71 is isolated as a single regio- and stereoisomer. Thus, complete levels of 
catalyst-directed diastereoselectivity are observed. In contrast, using the analogous achiral 
iridium complex modified by BIPHEP, (2,2'-bis(diphenylphosphino)biphenyl), diastereomers 
4.71 and epi-4.71 are produced in 58% yield in a 1:1.5 ratio, respectively, along with a 9% yield 
of the branched regioisomer (Table 4.16). 
Table 4.16 Catalyst-directed diastereoselectivity in vinylogous Reformatsky-aldol addition from the 
alcohol oxidation level. 
 
4.3.6 Summary 
 In this study we report a catalytic method for enantioselective vinylogous Reformatsky- 
type aldol addition in which asymmetric carbonyl addition occurs with equal facility from the 
alcohol or aldehyde oxidation level. Good to excellent levels of regioselectivity and uniformly 
high levels of enantioselectivity were observed across a range of alcohols and aldehydes. 
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Additionally, exceptional levels of catalyst-directed diastereoselectivity may be achieved. Insight 
into the structural-interactional features of the catalytic system via partitioning of linear and 
branched adducts suggests a Curtin-Hammett scenario, wherein carbonyl addition occurs 
selectively from an equilibrating mixture of primary and secondary σ-allyl haptomers. The 
collective data are consistent with carbonyl addition from the secondary α-C-bound iridium 
enolate to form the less substituted C-C bond due to the absence of gauche interactions in the 
transition state. Notably, in reactions conducted from the alcohol oxidation level, the only 




4.4 Experimental Section 
4.4.1 Part One: 1,1-Disubstituted Olefins as Allyl Donors in Iridium Catalyzed Transfer 
Hydrogenation Transformation. Enantioselective Grignard Nozaki-Hiyama Methallylation 
Reaction 
4.4.1 Representative Synthesis of Catalyst: Synthesis of (R)-II 
To a mixture of [Ir(cod)Cl]2 (134.3 mg, 0.20 mmol, 100 mol%), (R)-Cl,MeO-BIPHEP (260.6 
mg, 0.40 mmol, 200 mol%), Cs2CO3 (260.6 mg, 0.80 mmol, 400 mol%), 4-Cl-3-NO2BzOH 
(161.2 mg, 0.89 mmol, 400 mol%) and allyl acetate (100.1 mg, 1.0 mmol, 500 mol%) in a sealed 
tube under N2 atmosphere was added THF (4.0 mL, 0.05 M). The reaction mixture was stirred 
for 30 min at ambient temperature and heated for 1.5 hr at 80 
o
C, at which point the reaction 
mixture was allowed to cool to ambient temperature. The reaction mixture was filtered and 
washed with THF (10 mL). The filtrate was concentrated in vacuo and purified by flash column 
chromatography (dichloromethane:ether, 3:1). The purified catalyst was precipitated from THF 
(2 mL) and hexane (50 mL) to give a yellow precipitate, which was collected by filtration and 
dried under vacuum to provide (R)-II (344.0 mg, 0.320 mmol) in 80% yield.  
4.4.2 Experiment details of Methallylation from Alcohol Oxidation Level  
(S)-2-methyldodec-1-en-4-ol (4.29) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-II (10.7 mg, 0.01 
mmol, 5 mol%) and dry potassium phosphate (42.4 mg, 0.20 mmol, 100 mol%). The tube was 
sealed with a rubber septum and purged with nitrogen. THF (0.2 mL, 1.0 M), alcohol 4.29a (28.5 
mg, 0.20 mmol, 100 mol%) and β-methallyl chloride (54.3 mg, 0.60 mmol, 300 mol%) were 
added and the rubber septum was quickly replaced with a screw cap. The mixture was placed in 
an oil bath at 50 
o
C and was allowed to stir for 24 hr. The reaction mixture was concentrated in 
vacuo. Purification of by column chromatography (SiO2; ethyl acetate: hexanes, 1:40 to 1:20) 
provided the desired product 4.29 (31.7 mg, 0.160 mmol) as a colorless oil in 80% yield. 
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TLC (SiO2): Rf = 0.38 (ethyl acetate: hexanes, 1:9). [ α ]D
25 
= -8.0 (c = 1, CH2Cl2), literature 
value for ent 3a, +11.2 (c = 3.02, CCl4).
  1
H NMR (400 MHz, CDCl3): δ 4.90-4.87 (m, 1H), 
4.81-4.78 (m, 1H), 3.75-3.68 (m, 1H), 2.21 (dd J = 13.5, 3.3 Hz, 1H), 2.08 (ddd, J = 13.7, 9.4, 
0.7 Hz, 1H), 1.76 (s 3H), 1.68 (d, J = 1.7, 1H), 1.46-1.27 (m, 14H), 0.88 (t, J = 6.9 Hz, 3H). 
13
C 
NMR (100 MHz, CDCl3): δ 142.9, 113.4, 68.6, 46.2, 37.1, 31.9, 29.7, 29.6, 29.3, 25.7, 22.7, 
22.4, 14.1 FTIR (neat): 3315, 2921, 2859, 2367, 2331, 1842, 1739, 1647, 1563, 1534, 1456, 
1375, 1261, 1230, 1216, 1072, 1018, 887, 867, 846, 804, 758, 750, 721, 703, 669, 655 cm
-1
. 
HPLC: Enantiomeric excess was determined by HPLC analysis of the 4-nitrobenzoate derivative 
of the product, (Chiralcel OD-H-OD-H column, hexanes:i-PrOH = 99.5:0.5, 1 mL/min, 254 nm), 
tmajor = 35.8 min tminor = 41.9 min,; ee = 95%. 
(R)-1-(benzyloxy)-5-methylhex-5-en-3-ol (4.32) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-II (10.7 mg, 0.01 
mmol, 5 mol%) and dry potassium phosphate (42.4 mg, 0.20 mmol, 100 mol%). The tube was 
sealed with a rubber septum and purged with nitrogen. THF (0.2 mL, 1.0 M), alcohol 4.32a (33.2 
mg, 0.20 mmol, 100 mol%) and β-methallyl chloride (54.3 mg, 0.60 mmol, 300 mol%) were 
added and the rubber septum was quickly replaced with a screw cap. The mixture was placed in 
an oil bath at 50 
o
C and was allowed to stir for 24 hr. The reaction mixture was concentrated in 
vacuo. Purification of by column chromatography (SiO2; ethyl acetate: hexanes, 1:10 to 1:5) 
provided the desired product 4.32 (30.4 mg, 0.138 mmol) as a colorless oil in 69% yield. 
TLC (SiO2): Rf = 0.35 (ethyl acetate: hexanes, 1:4). [ α ]D
25 
= -2.0 (c = 1, CH2Cl2), literature 
value -3.39
o 
(c = 0.5, CHCl3). 
1
H NMR (400 MHz, CDCl3): δ 7.37-7.27 (m, 5H), 4.85-4.84 (m, 
1H), 4.78-4.77 (m, 1H), 4.53 (s, 2H), 4.01-3.94 (m, 1H), 3.75-3.70 (m, 1H), 3.68-3.63 (m, 1H) 
2.73 (d, J = 2.5 Hz, OH), 2.24-2.14 (m, 2H), 1.82-1.70 (m, 2H), 1.75 (s, 3H). 
13
C NMR (100 
MHz, CDCl3): δ 142.7, 138.0, 128.4, 127.7, 127.6, 113.1, 73.3, 68.7, 68.2, 46.0, 36.2, 22.5. 
FTIR (neat): 3441, 3066, 3025, 2920, 2859, 2347, 2335, 1722, 1495, 1453, 1365, 1275, 1205, 
1166, 1028, 891, 736, 697, 668 cm
-1
. HPLC: (Chiralcel AS-H column, hexanes:i-PrOH = 95:05, 





To a resealable pressure tube equipped with a magnetic stir bar was added (R)-II (10.7 mg, 0.01 
mmol, 5 mol%) and dry potassium phosphate (42.4 mg, 0.20 mmol, 100 mol%). The tube was 
sealed with a rubber septum and purged with nitrogen. THF (0.2 mL, 1.0 M), alcohol 4.35a (44.9 
mg, 0.20 mmol, 100 mol%) and β-methallyl chloride (54.3 mg, 0.60 mmol, 300 mol%) were 
added and the rubber septum was quickly replaced with a screw cap. The mixture was placed in 
an oil bath at 50 
o
C and was allowed to stir for 24 hr. The reaction mixture was concentrated in 
vacuo. Purification of by column chromatography (SiO2; ethyl acetate: hexanes, 1:10 to 1:5) 
provided the desired product 4.35 (50.1 mg, 0.180 mmol) as a colorless oil in 90% yield. 
TLC (SiO2): Rf = 0.31 (ethyl acetate: hexanes, 1:10). [ α ]D
25 
= +2.0 (c = 1, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ 7.25-7.22 (m, 2H), 6.89-6.85 (m, 2H), 4.86-4.84 (m, 1H), 4.80-4.78 (m, 
1H), 4.44 (s, 2H), 2.94 (s, 3H), 3.64-3.60 (m, 1H), 3.35 (d, J = 8.86, 1H), 3.27 (d, J = 8.86, 1H), 
3.47 (d, J = 3.47, 1H), 2.17 (d, J = 13.7 Hz, 1H), 2.03 (ddd, J = 13.72, 10.66, 0.47 Hz, 1H), 1.77 
(s, 3H), 0.92 (s,  3H), 0.91 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ 159.1, 143.8, 130.2, 129.1, 
113.7, 112.6, 78.9, 74.9, 73.2, 55.3, 40.3, 38.3, 22.5, 22.3, 19.7. FTIR (neat): 3484, 3068, 2958, 
2933, 2914, 2857, 1646, 1612, 1586, 1513, 1465, 1439, 1362, 1301, 1247, 1207, 1173, 1088, 
1036, 889, 820, 756 cm
-1
. HRMS (ESI) Calcd. for C17H26O3Na [M+Na]
+
: 301.17742, Found: 
301.1773. HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 220 nm), tminor 
= 13.2 min, tmajor = 13.8 min; ee = 94%. 
(R)-1-cyclohexyl-3-methylbut-3-en-1-ol (4.30) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-II (10.7 mg, 0.01 
mmol, 5 mol%) and dry potassium phosphate (42.4 mg, 0.20 mmol, 100 mol%). The tube was 
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sealed with a rubber septum and purged with nitrogen. THF (0.2 mL, 1.0 M), alcohol 4.30a (22.8 
mg, 0.20 mmol, 100 mol%) and β-methallyl chloride (54.3 mg, 0.60 mmol, 300 mol%) were 
added and the rubber septum was quickly replaced with a screw cap. The mixture was placed in 
an oil bath at 50 
o
C and was allowed to stir for 24 hr. The reaction mixture was concentrated in 
vacuo. Purification of by column chromatography (SiO2; ethyl acetate: hexanes, 1:20 to 1:10) 
provided the desired product 4.30 (24.3 mg, 0.144 mmol) as a colorless oil in 72% yield. 




 (c = 1, CH2Cl2), literature 
value for ent 3d, +2.0 (c = 1.4, CCl4). 
1
H NMR (400 MHz, CDCl3): δ 4.90-4.88 (m, 1H), 4.81-
4.80 (m, 1H), 3.50-3.45 (m, 1H), 2.24 (ddd, J = 13.6, 20.0, 0.4 Hz, 1H) 2.06 (ddd, J = 13.6, 10, 
0.4 Hz, 1H), 1.89-1.84 (m, 1H), 1.80-1.73 (m, 2H), 1.76 (dd, J = 0.4, 0.4 Hz, 3H), 1.71-1.64 (m, 
3H), 1.40-1.30 (m, 1H), 1.28-0.99 (m, 5H). 
13
C NMR (100 MHz, CDCl3): δ 143.3, 113.5, 72.4, 
43.4, 43.0, 29.0, 28.2, 26.6, 26.3, 26.2, 22.2. FTIR (neat): 3422, 3074, 2978, 2852, 1644, 1449, 
1396, 1374, 1259, 1173, 1142, 1100, 1086, 1060, 1044, 986, 953, 864, 842 cm
-1
. HPLC: 
Enantiomeric excess was determined by HPLC analysis of the 4-nitrobenzoate derivative of the 
product, (Chiralcel AS-H column, hexanes:i-PrOH = 99:01, 0.5 mL/min, 254 nm), tmajor = 9.1 
min, tminor = 10.1 min; ee = 92%. 
 (R,E)-5-methyl-1-phenylhexa-1,5-dien-3-ol (4.33) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-II (10.7 mg, 0.01 
mmol, 5 mol%) and dry potassium phosphate (42.4 mg, 0.20 mmol, 100 mol%). The tube was 
sealed with a rubber septum and purged with nitrogen. THF (0.2 mL, 1.0 M), alcohol 4.33a (26.8 
mg, 0.20 mmol, 100 mol%), β-methallyl chloride (54.3 mg, 0.60 mmol, 300 mol%), and 
isopropanol (31 L, 0.40 mmol, 200 mol %) were added and the rubber septum was quickly 
replaced with a screw cap. The mixture was placed in an oil bath at 50 
o
C and was allowed to stir 
for 24 hr. The reaction mixture was concentrated in vacuo. Purification of by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:12 to 1:7) provided the oxidized product (4.5 
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mg, 0.024 mmol) as a colorless oil in 12% yield and the desired product 4.33 (30.1 mg, 0.160 
mmol) as a colorless oil in 80% yield. 
TLC (SiO2): Rf = 0.31 (ethyl acetate: hexanes, 1:4). [ α ]D
25 
= +24.0 (c = 1, CH2Cl2), literature 
value +19.0 (c = 1.44, CH2Cl2).
1
H NMR (400 MHz, CDCl3): δ 7.4-7.22 (m, 5H), 6.64 (dd, J = 
15.9, 1.2 Hz, 1H), 6.24 (dd, J = 15.9, 6.3 Hz, 1H), 4.94-4.86 (m, 2H), 4.47-4.42 (m, 1H), 2.39-
2.29 (m, 2H), 1.87 (bs, 1H), 1.81 (t, J = 1.1 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ 142.0, 
136.7, 131.7, 130.1, 128.5, 127.6, 126.4, 114.1, 69.9, 46.2, 22.5. FTIR (neat): 3371, 3076, 3026, 
2931, 1647, 1599, 1494, 1448, 1274, 1099, 1070, 1046, 965, 891, 747, 740 cm
-1
. HPLC: 
(Chiralcel OD-H column, hexanes:i-PrOH = 90:10, 1 mL/min, 254 nm), tmajor = 7.1 min, tminor = 
12.0 min; ee = 94%. 
 (R,E)-2,6,10-trimethylundeca-1,5,9-trien-4-ol (4.36) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-II (10.7 mg, 0.01 
mmol, 5 mol%) and dry potassium phosphate (42.4 mg, 0.20 mmol, 100 mol%). The tube was 
sealed with a rubber septum and purged with nitrogen. THF (0.2 mL, 1.0 M), alcohol 4.36a (30.9 
mg, 0.20 mmol, 100 mol%), β-methallyl chloride (54.3 mg, 0.60 mmol, 300 mol%), and 
isopropanol (31 L, 0.40 mmol, 200 mol %) were added and the rubber septum was quickly 
replaced with a screw cap. The mixture was placed in an oil bath at 50 
o
C and was allowed to stir 
for 24 hr. The reaction mixture was concentrated in vacuo. Purification of by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:40 to 1:20) provided the desired product 4.36 
(33.3 mg, 0.160 mmol) as a colorless oil in 80% yield. 
TLC (SiO2): Rf = 0.40 (ethyl acetate: hexanes, 1:10). [ α ]D
25 
= +13.0 (c = 1, CH2Cl2), literature 
value +19.2 (c = 6.5, CH2Cl2).
 1
H NMR (400 MHz, CDCl3): δ 5.19 (dq, J = 8.4, 1.3 Hz, 1H), 
5.11-5.06 (m, 1H), 4.88-4.80 (m, 2H), 4.51 (dt, J = 8.5, 4.8 Hz, 1H), 4.45 (ddd, J = 13.7, 8.6, 0.9, 
1H), 2.19-2.14 (m, 1H), 2.13-1.99 (m, 4H), 1.78 (t, J = 0.9, 3H), 1.70 (d, J = 1.4 Hz, 3H), 1.68 
(d, J = 1.1 Hz, 3H), 1.60 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ 142.4, 138.6, 131.6, 127.1, 
123.9, 66.0, 46.2, 39.5, 26.3, 25.7, 22.5, 17.7, 16.6. FTIR (neat): 3362, 3074, 2967, 2916, 2855, 
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2322, 1647, 1442, 1375, 1261, 1201, 1139, 1105, 1046, 1008, 979, 887 cm
-1
. HPLC: 
Enantiomeric excess was determined by HPLC analysis of the 4-nitrobenzoate derivative of the 
product, (Chiralcel OJ-H/AS-H column, hexanes:i-PrOH = 99:1, 0.4 mL/min, 254 nm), tmajor = 
22.6 min, tminor = 24.2 min; ee = 94%. 
(R)-1-(4-bromophenyl)-3-methylbut-3-en-1-ol (4.34) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added alcohol 4.34a (37.4 
mg, 0.20 mmol, 100 mol%), (R)-II (10.7 mg, 0.01 mmol, 5 mol%) and dry potassium phosphate 
(42.4 mg, 0.20 mmol, 100 mol%). The tube was sealed with a rubber septum and purged with 
nitrogen. THF (0.2 mL, 1.0 M) and β-methallyl chloride (54.3 mg, 0.60 mmol, 300 mol%) were 
added and the rubber septum was quickly replaced with a screw cap. The mixture was placed in 
an oil bath at 50 
o
C and was allowed to stir for 24 hr. The reaction mixture was concentrated in 
vacuo. Purification of by column chromatography (SiO2; ethyl acetate: hexanes, 1:10 to 1:5) 
provided the oxidized product (6.7 mg, 0.028 mmol) as white solid in 14% yield and the desired 
product 4.34 (40.0 mg, 0.166 mmol) as white solid in 83% yield. 
TLC (SiO2): Rf = 0.30 (ethyl acetate: hexanes, 1:5). m.p.: 72-73 
o




 (c = 1, 
CH2Cl2). 
1
H NMR (400 MHz, CDCl3): δ 7.47 (d, J = 8.8 Hz, 2H), 7.25 (d, J = 8.8 Hz 2H), 4.94-
4.93 (m, 1H), 4.85-4.84 (m, 1H), 4.78-4.75 (m, 1H), 2.39-2.36 (m, 2H), 2.18 (d, J = 2.4 Hz, 1H), 
1.79 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ 143.0, 142.0, 131.5, 127.5, 121.2, 114.5, 70.7, 
48.4, 22.3. FTIR (neat): 3358, 3075, 2976, 2934, 1900, 1803, 1648, 1592, 1488, 1472, 1406, 
1373, 1336, 1304, 1202, 1169, 1046, 1008, 902, 874, 822, 803, 718 cm
-1
. HPLC: (Chiralcel OJ-






 (R)-1-(benzo[d][1,3]dioxol-5-yl)-3-methylbut-3-en-1-ol (4.31) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added alcohol 4.31a (30.4 
mg, 0.20 mmol, 100 mol%), (R)-II (10.7 mg, 0.01 mmol, 5 mol%) and dry potassium phosphate 
(42.4 mg, 0.20 mmol, 100 mol%). The tube was sealed with a rubber septum and purged with 
nitrogen. THF (0.2 mL, 1.0 M) and β-methallyl chloride (54.3 mg, 0.60 mmol, 300 mol%) were 
added and the rubber septum was quickly replaced with a screw cap. The mixture was placed in 
an oil bath at 50 
o
C and was allowed to stir for 24 hr. The reaction mixture was concentrated in 
vacuo. Purification of by column chromatography (SiO2; ethyl acetate: hexanes, 1:20 to 1:10) 
provided the oxidized product (2.0 mg, 0.010 mmol) as a colorless oil in 5% yield and the 
desired product 4.31 (32.2 mg, 0.156 mmol) as a colorless oil in 78% yield. 
TLC (SiO2): Rf = 0.28 (ethyl acetate: hexanes, 1:4). [ α ]D
25 
= +50.0 (c = 1, CH2Cl2).
1
H NMR 
(400 MHz, CDCl3): δ 6.90 (dt, J = 1.69, 0.44 Hz, 1H), 6.82 (ddd, J = 8.0, 1.7, 0.57 Hz, 1H), 6.77 
(dd, J = 8.0, 0.32 Hz, 1H), 5.95 (s, 2H), 4.93-4.83 (m, 2H), 4.73 (dd, J = 8.4, 5.1, 1H), 2.44-2.34 
(m, 2H), 2.07 (bs, 1H), 1.79 (t, J = 1.0, 3H). 
13
C NMR (100 MHz, CDCl3): δ 147.7, 146.8, 
142.3, 138.1, 119.1, 114.1, 108.0, 106.3, 101.0, 71.2, 48.3, 22.3. FTIR (neat): 3408, 3076, 2897, 
1726, 1646, 1609, 1503, 1487, 1442, 1376, 1187, 1124, 1094, 1209, 1186, 1124, 1094, 1010, 
932, 896, 810, 783, 750, 727 cm
-1
. HPLC: (Chiralcel OJ-H column, hexanes:i-PrOH = 95:5, 1 
mL/min, 280 nm), tminor = 15.3 min, tmajor = 16.6 min; ee = 94%. 
 (R)-1-(benzo[b]thiophen-2-yl)-3-methylbut-3-en-1-ol (4.37) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added alcohol 4.37a (32.8 
mg, 0.20 mmol, 100 mol%), (R)-II (10.7 mg, 0.01 mmol, 5 mol%) and dry potassium phosphate 
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(42.4 mg, 0.20 mmol, 100 mol%). The tube was sealed with a rubber septum and purged with 
nitrogen. THF (0.2 mL, 1.0 M) and β-methallyl chloride (54.3 mg, 0.60 mmol, 300 mol%) were 
added and the rubber septum was quickly replaced with a screw cap. The mixture was placed in 
an oil bath at 50 
o
C and was allowed to stir for 24 hr. The reaction mixture was concentrated in 
vacuo. Purification of by column chromatography (SiO2; ethyl acetate: hexanes, 1:20 to 1:10) 
provided the oxidized product (2.2 mg, 0.010 mmol) as a white solid in 5% yield and the desired 
product 4.37 (38.0 mg, 0.174 mmol) as a white solid in 87% yield. 
TLC (SiO2): Rf = 0.25 (ethyl acetate: hexanes, 1:4). m.p.: 78-80 
o
C. [ α ]D
25 
= +36.1 (c = 1, 
CH2Cl2). 
1
H NMR (400 MHz, CDCl3): δ 7.83-7.81 (m, 1H), 7.73-7.71 (m, 1H), 7.36-7.28 (m, 
2H), 7.22 (t, J = 0.74, 1H), 5.16 (t, J = 6.76, 1H), 4.97-4.90 (m, 2H), 2.65-2.57 (m, 2H), 2.32 
(bs, 1H), 1.12 (t, J = 1.1 Hz, 1H). 
13
C NMR (100 MHz, CDCl3): δ 148.6, 141.5, 139.5, 139.2, 
124.2, 124.1, 123.4, 122.4, 120.0, 114.7, 68.1, 47.9, 22.4. FTIR (neat): 3556, 3069, 2966, 2937, 
1643, 1457, 1438, 1376, 1326, 1275, 1261, 1155, 1118, 1054, 973, 946, 899, 876, 845, 831, 754, 
728, 669 cm
-1
. HRMS (CI) Calcd. for C13H14OS [M]
+
: 218.0766, Found: 218.0765. HPLC: 
(Chiralcel OJ-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 254 nm), tminor = 19.8 min, tmajor = 




4.4.3 Experiment details of Methallylation from Aldehyde Oxidation Level  
(S)-2-methyldodec-1-en-4-ol (4.29) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-II (10.7 mg, 0.01 
mmol, 5 mol%) and dry potassium phosphate (42.4 mg, 0.20 mmol, 100 mol%). The tube was 
sealed with a rubber septum and purged with nitrogen. THF (0.2 mL, 1.0 M), aldehyde 4.29b 
(28.4 mg, 0.20 mmol, 100 mol%), β-methallyl chloride (54.3 mg, 0.60 mmol, 300 mol%), and 
isopropanol (31 L, 0.40 mmol, 200 mol%) were added and the rubber septum was quickly 
replaced with a screw cap. The mixture was placed in an oil bath at 50 
o
C and was allowed to stir 
for 24 hr. The reaction mixture was concentrated in vacuo. Purification of by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:40 to 1:20) provided the desired product 4.29 
(29.8 mg, 0.150 mmol) as a colorless oil in 75% yield. 
HPLC: Enantiomeric excess was determined by HPLC analysis of the 4-nitrobenzoate derivative 
of the product, (Chiralcel OD-H-OD-H column, hexanes:i-PrOH = 99.5:0.5, 1 mL/min, 254 nm), 
tmajor = 36.2 min tminor = 42.3 min,; ee = 97%. 
 (R)-1-(benzyloxy)-5-methylhex-5-en-3-ol (4.32) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-II (10.7 mg, 0.01 
mmol, 5 mol%) and dry potassium phosphate (42.4 mg, 0.20 mmol, 100 mol%). The tube was 
sealed with a rubber septum and purged with nitrogen. THF (0.2 mL, 1.0 M), aldehyde 4.32b 
(32.8 mg, 0.20 mmol, 100 mol%), β-methallyl chloride (54.3 mg, 0.60 mmol, 300 mol%) and 
isopropanol (31 L, 0.40 mmol, 200 mol%) were added and the rubber septum was quickly 
replaced with a screw cap. The mixture was placed in an oil bath at 50 
o
C and was allowed to stir 
for 24 hr. The reaction mixture was concentrated in vacuo. Purification of by column 
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chromatography (SiO2; ethyl acetate: hexanes, 1:9 to 1:5) provided the desired product 4.32 
(24.2 mg, 0.110 mmol) as a colorless oil in 55% yield. 
HPLC: (Chiralcel AS-H column, hexanes:i-PrOH = 95:05, 0.5 mL/min, 254 nm), tminor = 10.0 
min, tmajor = 11.0 min; ee = 97%. 
(R)-1-(4-methoxybenzyloxy)-2,2,5-trimethylhex-5-en-3-ol (4.35) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-II (10.7 mg, 0.01 
mmol, 5 mol%) and dry potassium phosphate (42.4 mg, 0.20 mmol, 100 mol%). The tube was 
sealed with a rubber septum and purged with nitrogen. THF (0.2 mL, 1.0 M), aldehyde 4.35b 
(44.5 mg, 0.20 mmol, 100 mol%), β-methallyl chloride (54.3 mg, 0.60 mmol, 300 mol%), and 
isopropanol (31 L, 0.40 mmol, 200 mol%) were added and the rubber septum was quickly 
replaced with a screw cap. The mixture was placed in an oil bath at 50 
o
C and was allowed to stir 
for 24 hr. The reaction mixture was concentrated in vacuo. Purification of by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:10 to 1:5) provided the desired product 4.35 
(50.7 mg, 0.182 mmol) as a colorless oil in 91% yield. 
HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 220 nm), tminor = 12.0 
min, tmajor = 12.6 min; ee = 97%. 
(R)-1-cyclohexyl-3-methylbut-3-en-1-ol (4.30) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-II (10.7 mg, 0.01 
mmol, 5 mol%) and dry potassium phosphate (42.4 mg, 0.20 mmol, 100 mol%). The tube was 
sealed with a rubber septum and purged with nitrogen. THF (0.2 mL, 1.0 M), aldehyde 4.30b 
(22.4 mg, 0.20 mmol, 100 mol%), β-methallyl chloride (54.3 mg, 0.60 mmol, 300 mol%) and 
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isopropanol (31 L, 0.40 mmol, 200 mol%) were added and the rubber septum was quickly 
replaced with a screw cap. The mixture was placed in an oil bath at 50 
o
C and was allowed to stir 
for 24 hr. The reaction mixture was concentrated in vacuo. Purification of by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:20) provided the desired product 4.30 (24.9 mg, 
0.148 mmol) as a colorless oil in 74% yield. 
HPLC: Enantiomeric excess was determined by HPLC analysis of the 4-nitrobenzoate derivative 
of the product, (Chiralcel AS-H column, hexanes:i-PrOH = 99:01, 0.5 mL/min, 254 nm), tmajor = 
8.9 min, tminor = 9.7 min; ee = 91%. 
(R,E)-5-methyl-1-phenylhexa-1,5-dien-3-ol (4.33) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-II (10.7 mg, 0.01 
mmol, 5 mol%) and dry potassium phosphate (42.4 mg, 0.20 mmol, 100 mol%). The tube was 
sealed with a rubber septum and purged with nitrogen. THF (0.2 mL, 1.0 M), aldehyde 4.33b 
(26.4 mg, 0.20 mmol, 100 mol%), β-methallyl chloride (54.3 mg, 0.60 mmol, 300 mol%), and 
isopropanol (62 L, 0.80 mmol, 400 mol%) were added and the rubber septum was quickly 
replaced with a screw cap. The mixture was placed in an oil bath at 50 
o
C and was allowed to stir 
for 24 hr. The reaction mixture was concentrated in vacuo. Purification of by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:12 to 1:7) provided the oxidized product 4e (4.8 
mg, 0.026 mmol) as a colorless oil in 13% yield and the desired product 4.33 (30.9 mg, 0.164 
mmol) as a colorless oil in 82% yield. 
HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 90:10, 1 mL/min, 254 nm), tmajor = 7.1 min, 







To a resealable pressure tube equipped with a magnetic stir bar was added (R)-II (10.7 mg, 0.01 
mmol, 5 mol%) and dry potassium phosphate (42.4 mg, 0.20 mmol, 100 mol%). The tube was 
sealed with a rubber septum and purged with nitrogen. THF (0.2 mL, 1.0 M), aldehyde 4.36b 
(30.4 mg, 0.20 mmol, 100 mol%), β-methallyl chloride (54.3 mg, 0.60 mmol, 300 mol%), and 
isopropanol (62 L, 0.80 mmol, 400 mol%) were added and the rubber septum was quickly 
replaced with a screw cap. The mixture was placed in an oil bath at 50 
o
C and was allowed to stir 
for 24 hr. The reaction mixture was concentrated in vacuo. Purification of by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:40 to 1:20) provided the oxidized product (2.5 
mg, 0.012 mmol) as a colorless oil in 6% yield and the desired product 4.36 (31.3 mg, 0.150 
mmol) as a colorless oil in 75% yield. 
HPLC: Enantiomeric excess was determined by HPLC analysis of the 4-nitrobenzoate derivative 
of the product, (Chiralcel OJ-H/AS-H column, hexanes:i-PrOH = 99:1, 0.4 mL/min, 254 nm), 
tmajor = 25.0 min, tminor = 27.0 min; ee = 93%. 
(R)-1-(4-bromophenyl)-3-methylbut-3-en-1-ol (4.34) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added aldehyde 4.34b (37.0 
mg, 0.20 mmol, 100 mol%), (R)-II (10.7 mg, 0.01 mmol, 5 mol%) and dry potassium phosphate 
(42.4 mg, 0.20 mmol, 100 mol%). The tube was sealed with a rubber septum and purged with 
nitrogen. THF (0.2 mL, 1.0 M), β-methallyl chloride (54.3 mg, 0.60 mmol, 300 mol%) and 
isopropanol (31 L, 0.40 mmol, 200 mol%) were added and the rubber septum was quickly 
replaced with a screw cap. The mixture was placed in an oil bath at 50 
o
C and was allowed to stir 
for 24 hr. The reaction mixture was concentrated in vacuo. Purification of by column 
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chromatography (SiO2; ethyl acetate: hexanes, 1:10 to 1:5) provided the oxidized product (3.8 
mg, 0.016 mmol) as white solid in 14% yield and the desired product 4.34 (43.5 mg, 0.180 
mmol) as white solid in 83% yield. 
HPLC: (Chiralcel OJ-H column, hexanes:i-PrOH = 95:05, 1 mL/min, 254 nm), tminor = 8.7 min, 
tmajor = 9.5 min; ee = 95%. 
(R)-1-(benzo[d][1,3]dioxol-5-yl)-3-methylbut-3-en-1-ol (4.31) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added aldehyde 4.31b (30.0 
mg, 0.20 mmol, 100 mol%), (R)-II (10.7 mg, 0.01 mmol, 5 mol%) and dry potassium phosphate 
(42.4 mg, 0.20 mmol, 100 mol%). The tube was sealed with a rubber septum and purged with 
nitrogen. THF (0.2 mL, 1.0 M), β-methallyl chloride (54.3 mg, 0.60 mmol, 300 mol%), and 
isopropanol (31 L, 0.40 mmol, 200 mol%) were added and the rubber septum was quickly 
replaced with a screw cap. The mixture was placed in an oil bath at 50 
o
C and was allowed to stir 
for 24 hr. The reaction mixture was concentrated in vacuo. Purification of by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:20 to 1:10) provided the oxidized product (4.0 
mg, 0.020 mmol) as a colorless oil in 10% yield and the desired product 4.31 (35.1 mg, 0.170 
mmol) as a colorless oil in 85% yield. 
HPLC: (Chiralcel OJ-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 280 nm), tminor = 14.3 min, 





To a resealable pressure tube equipped with a magnetic stir bar was added aldehyde 4.37b (32.4 
mg, 0.20 mmol, 100 mol%), (R)-II (10.7 mg, 0.01 mmol, 5 mol%) and dry potassium phosphate 
(42.4 mg, 0.20 mmol, 100 mol%). The tube was sealed with a rubber septum and purged with 
nitrogen. THF (0.2 mL, 1.0 M), β-methallyl chloride (54.3 mg, 0.60 mmol, 300 mol%), and 
isopropanol (31 L, 0.40 mmol, 200 mol%) were added and the rubber septum was quickly 
replaced with a screw cap. The mixture was placed in an oil bath at 50 
o
C and was allowed to stir 
for 24 hr. The reaction mixture was concentrated in vacuo. Purification of by column 
chromatography (SiO2; ethyl acetate: hexanes, 1:20 to 1:10) provided the oxidized product (2.2 
mg, 0.010 mmol) as white solid in 5% yield and the desired product 4.37 (39.7 mg, 0.182 mmol) 
as a white solid in 91% yield. 
HPLC: (Chiralcel OJ-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 254 nm), tminor = 19.8 min, 
tmajor = 26.3 min; ee = 96%. 
4.4.4 Experiment details of Bis-methallylation of Propanediol 
 (4R,6R)-2,8-dimethylnona-1,8-diene-4,6-diol (4.39) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-II (32.2 mg, 0.03 
mmol, 10 mol%) and dry potassium phosphate (127.4 mg, 0.60 mmol, 200 mol%). The tube was 
sealed with a rubber septum and purged with nitrogen. THF (0.6 mL, 0.5 M), alcohol 4.28 (22.8 
mg, 0.30 mmol, 100 mol%) and β-methallyl chloride (135.8 mg, 1.50 mmol, 500 mol%) were 
added and the rubber septum was quickly replaced with a screw cap. The mixture was placed in 
an oil bath at 50 
o
C and was allowed to stir for 24 hr. The reaction mixture was concentrated in 
vacuo. Purification of by column chromatography (SiO2; ethyl acetate: hexanes, 1:5 to 1:3) 
provided the desired product 4.38 (36.5 mg, 0.198 mmol) as a white solid in 66% yield. 
TLC (SiO2): Rf = 0.20 (ethyl acetate: hexanes, 1:4). m.p.: 75-76 
o




 (c = 1, 
CH2Cl2). 
1
H NMR (400 MHz, CDCl3): δ 4.89-4.87 (m, 2H), 4.80-4.79 (m, 2H), 4.14-4.07 (m, 
2H), 2.52 (s, 2H), 2.27-2.16 (m, 4H), 1.77 (s, 6H), 1.62 (t, J = 6.0 Hz, 2H). 
13
C NMR (100 MHz, 
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CDCl3): δ 142.5, 113.5, 66.0, 46.1, 42.3, 22.4. FTIR (neat): 3370, 3293, 3075, 2968, 2939, 1778, 
1651, 1438, 1397, 1371, 1325, 1292, 1244, 1212, 1183, 1100, 1062, 1038, 989, 974 cm
-1
. 
HRMS (ESI) Calcd. for C11H20O2Na [M+Na]
+
: 207.13555, Found: 207.1356. HPLC: 
Enantiomeric excess was determined by HPLC analysis of the bis-4-nitrobenzoate derivative of 
the product, (Chiralcel OD-H column, hexanes:i-PrOH = 95:05, 1 mL/min, 254 nm), tminor = 12.7 
min, tmeso = 12.8 and tmajor = 20.7 min; ee = 99%. 
 (4R,6R)-2,2-dimethyl-4,6-bis(2-methylallyl)-1,3-dioxane (4.40) 
 
To a stirred solution of diol 6 (33 mg, 0.179 mmol, 100 mol%) in dichloromethane (1.8 mL, 0.1 
M) was added 2,2-dimethoxypropane (278 mg, 2.685 mmol, 1500 mol%) and pyridinium p-
toluenesulfonate (4.5 mg, 0.018 mmol, 10 mol%). The reaction mixture was stirred for 2 hr at 
ambient temperature at which TLC comparison show complete conversion. The reaction mixture 
was quenched with saturated aq. NaHCO3 (4 mL) and extracted with dichloromethane (5 mL x 
3). The combined organic extracts were dried with (MgSO4), filtered and concentrated in vacuo. 
The residue was purified by column chromatography (SiO2: ethyl acetate:hexanes, 1:20 with 
0.1% TEA) to give the acetonide 4.40 (30.4 g, 0.135 mmol) as a colorless oil in 76% yield. 




 (c = 1, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ 4.79-4.78 (m, 2H), 4.75-4.74 (m, 2H), 4.03-3.96 (m, 2H), 2.31-2.25 (m, 
2H), 2.15-2.10 (m, 2H), 1.74 (s, 6H), 1.60 (t, 2H), 1.37 (s, 6H). 
13
C NMR (100 MHz, CDCl3): δ 
142.3, 112.1, 100.3, 65.0, 44.0, 38.1, 24.8, 22.8. FTIR (neat): 3075, 2986, 2937, 1650, 1443, 
1376, 1230, 1166, 1114, 1025, 987, 939, 821 cm
-1
. HRMS (CI) Calcd. for C14H24O2 [M]
+
: 







To a stirred solution of acetonide 7 (39 mg, 0.174 mmol, 100 mol%) in dichloromethane (3.5 
mL, 0.05 M) was bubbled ozone at -78 
o
C for around 5 min till a blue color persisted. O2 was 
bubbled for 2 min followed by argon for 10 min. Triphenylphosphine (183 mg, 0.696 mmol, 400 
mol%) was added and the reaction mixture was slowly warmed to ambient temperature 
overnight. The reaction mixture was concentrated in vacuo and residue was purified by column 
chromatography (SiO2: ethyl acetate:hexanes, 1:2 with 0.1% TEA) to give the diketone 4.41 
(26.0 mg, 0.114 mmol) as a colorless oil in 65% yield. 




 (c = 1, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ 4.27 (ddd, , J = 15.6, 7.6, 4.8 Hz, 2H), 2.75-2.69 (m, 2H), 2.50-2.45 (m, 
2H), 2.17 (s, 6H), 1.68 (t, , J = 7.6 Hz, 2H), 1.33 (s, 6H). 
13
C NMR (100 MHz, CDCl3): δ 206.6, 
100.7, 62.8, 49.4, 37.7, 30.8, 24.5. FTIR (neat): 3753, 3504, 2988, 2937, 2854, 2370, 2331, 
1698, 1423, 1380, 1367, 1306, 1223, 1170, 1121, 1092, 1032, 1011, 930 cm
-1
. HRMS (ESI) 
Calcd. for C12H20O4Na [M+Na]
+
: 251.1254, Found: 251.1254. 
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4.4.5. Absolute Stereochemical determination 
The absolute stereochemistry was determined by single crystal x-ray analysis of product 4.34 and 
was found to be R, see figure 4.1. 
Figure 4.1.  View of 4.34 showing the atom labeling scheme.  Displacement ellipsoids are scaled 


















4.4.6 Part Two: 1,2-Disubstituted Olefins as Allyl Donors in Iridium Catalyzed Transfer 
Hydrogenation Transformation. Enantioselective Vinylogous Aldol-Reformatsky Addition 
Synthesis of Catalyst of (R)-I and (S)-I 
Preparation of (R)-I 
To a mixture of [Ir(cod)Cl]2 (134.3 mg, 0.20 mmol, 100 mol%), (R)-Cl,MeO-BIPHEP (260.6 
mg, 0.40 mmol, 200 mol%), Cs2CO3 (260.6 mg, 0.80 mmol, 400 mol%), 4-Cl-3-NO2BzOH 
(161.2 mg, 0.89 mmol, 400 mol%) and allyl acetate (100.1 mg, 1.0 mmol, 500 mol%) in a sealed 
tube under N2 atmosphere was added THF (4.0 mL, 0.05 M). The reaction mixture was allowed 
to stir for 30 min at ambient temperature and was then heated at 80 
o
C for 1.5 hr, at which point 
the reaction mixture was allowed to cool to ambient temperature. The reaction mixture was 
filtered and washed with THF (10 mL). The filtrate was concentrated in vacuo and desolved in 
THF (2 mL) and hexane (50 mL) was added. A yellow precipitate formed which was sonicated 
for 5 minutes, collected by filtration and dried under vacuum to provide (R)-I (342.0 mg, 0.316 
mmol) in 79% yield. 
Preparation of (S)-I 
To a mixture of [Ir(cod)Cl]2 (87.3 mg, 0.13 mmol, 100 mol%), (S)-Cl,MeO-BIPHEP (169.4 mg, 
0.26 mmol, 200 mol%), Cs2CO3 (169 mg, 0.52 mmol, 400 mol%), 4-Cl-3-NO2BzOH (104.8 mg, 
0.52 mmol, 400 mol%) and allyl acetate (65 mg, 0.65 mmol, 500 mol%) in a sealed tube under 
an atmosphere of N2 was added THF (2.6 mL, 0.05 M). The reaction mixture was allowed to stir 
for 30 min at ambient temperature and was then heated at 80 
o
C for 1.5 hr, at which point the 
reaction mixture was allowed to cool to ambient temperature. The reaction mixture was filtered 
and washed with THF (8 mL). The filtrate was concentrated in vacuo and desolved in THF (2 
mL) and hexane (40 mL) was added. A yellow precipitate formed which was sonicated for 5 
minutes, collected by filtration and dried under vacuum to provide (S)-I (228.3 mg, 0.211 mmol) 




Synthesis of starting material 4.48 
 
(Z)-but-2-ene-1,4-diyl tert-butyl dicarbonate 
 
A 500 mL round bottom flask was charged with cis-2-butenediol (5.27 g, 60 mmol, 100 mol%), 
tetrabutylammonium hydrogen sulfate (3.46 g, 10.2 mmol, 17 mol%) and the mixture was 
dissolved in 6N NaOH (70 mL, 0.85 M) and CH2Cl2 (150 mL, 0.4 M). Boc-Anhydride (34.83 g, 
159.6 mmol, 266 mol%) was added as a solid and the reaction mixture was allowed to stir at 
ambient temperature overnight. The reaction mixture was transferred to seperatory funnel, 
diluted with CH2Cl2 and washed with water (3 x 300 mL). The organic layer was dried (Na2SO4), 
filtered and concentrated to give the title compound (17.13 g, 59.40 mmol) in 99% yield as 
colorless oil and was used without further purification. 
TLC (SiO2): Rf = 0.60 (ethyl acetate: hexanes, 1:9). 
1
H NMR (400 MHz, CDCl3): δ 5.80-5.78 
(m, 2H), 4.68-4.66 (m, 4H), 1.49 (s, 18H). 
13
C NMR (100 MHz, CDCl3): δ 153.2, 128.0, 82.4, 
62.2, 27.9. FTIR (neat): 2981, 2928, 1739, 1458, 1394, 1369, 1347, 1270, 1250, 1156, 1089, 
966, 929, 859, 792 cm
-1
. HRMS (CI) Calcd. for C14H25O6 [M+H]
+




(E)-ethyl 4-(tert-butoxycarbonyloxy)but-2-enoate (4.48) 
 
To (Z)-but-2-ene-1,4-diyl tert-butyl dicarbonate (10 g, 34.68 mmol, 100 mol%) was added 
CH2Cl2 (115 mL, 0.3 M) and the temperature was lowered to -78 
o
C. Ozone was passed through 
the solution (~ 3h) until a deep blue color persisted, at which point TLC analysis revealed 
complete consumption of starting material. Argon was passed through solution for 30 min and 
dimethyl sulfide (21.56 g, 347.03 mmol, 1000 mol%) was added at -78 
o
C. The cooling bath was 
removed and the reaction mixture was allowed to stir overnight. The reaction mixture was 
concentrated in vacuo to give crude aldehyde, which was used immediately without further 
purification. 
To the aldehyde in a 500 mL round bottom flask was added THF (180 mL, 0.2M) and Ethyl 
(triphenylphosphoranylidene)acetate (26.58 g, 76.29 mmol, 220 mol%). The reaction vessel was 
equipped with a reflux condenser and the reaction mixture was heated to reflux for 2 h. The 
reaction mixture was allowed to cool to ambient temperature and was concentrated in vacuo, 
diluted with hexane (180 mL), which resulted in precipitation and the suspension was filtered 
through a pad of celite. The filtrate was concentrated in vacuo and purified by flash column 
chromatography (SiO2; ethyl acetate: hexanes, 0:100 to 5:95) to furnish the title compound 
(10.86 g, 47.16 mmol) as a colorless oil in 68% yield over two steps. 
TLC (SiO2): Rf = 0.45 (ethyl acetate: hexanes, 1:4). 
1
H NMR (400 MHz, CDCl3): δ 6.94 (dt, J = 
15.6, 4.8 Hz, 1H), 6.06 (dt, J = 15.6, 2 Hz, 1H), 4.73 (dd, J = 4.4, 2.0 Hz, 2H), 2.09 (q, J = 7.2 
Hz, 2H), 1.50 (s, 9H), 1.29 (t, J = 7.2 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ 165.8, 152.9, 
140.9, 122.3, 82.7, 64.9, 60.6, 27.7, 14.2. FTIR (neat): 2981, 2936, 2905, 1743, 1721, 1667, 
1457, 1394, 1369, 1275, 1251, 1157, 1120, 1094, 1037, 968, 934, 851, 792, 769 cm
-1
. HRMS 
(CI) Calcd. for C11H19O5 [M+H]
+





4.4.7 Experiment details and Spectral Data of Reaction from Alcohol Oxidation Level 
(R)-(E)-ethyl 5-hydroxy-7-(4-methoxybenzyloxy)hept-2-enoate (4.69) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-I (16.3 mg, 0.015 
mmol, 5 mol%). The tube was sealed with a rubber septum and purged with nitrogen. Dioxane 
(0.6 mL, 0.5 M), alcohol 4.69a (58.9 mg, 0.30 mmol, 100 mol%) and (E)-ethyl 4-(tert-
butoxycarbonyloxy)but-2-enoate 4.48 (138.2 mg, 0.60 mmol, 200 mol%) were added and the 
rubber septum was quickly replaced with a screw cap. The mixture was placed in an oil bath at 
90 
o
C and was allowed to stir for 48 hr. The reaction mixture was concentrated in vacuo. 
Purification of by column chromatography (SiO2; ethyl acetate: hexanes, 1:4 to 1:2) provided the 
branched product (55.5 mg, 0.180 mmol, 1:1 dr) as a colorless oil in 60% yield, and the desired 
linear product 4.69 (24.6 mg, 0.080 mmol) as a colorless oil in 27% yield. 
TLC (SiO2): Rf = 0.25 (ethyl acetate: hexanes, 1:2). [ α ]D
25 
= +13.0 (c = 1, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ 7.24 (dt, J = 8.8, 2.8 Hz, 2H), 6.97 (dt, J = 15.6, 7.2 Hz, 1H), 6.88 (dt, J = 
8.8, 2.8 Hz, 2H), 5.88 (dt, 15.6, 1.2 Hz, 1H), 4.45 (s, 2H), 4.18 (q, J = 7.2, 2H), 3.98-3.95 (m, 
1H), 3.81 (s, 3H), 3.73-3.70 (m, 1H), 3.65-3.59 (m, 1H), 3.16 (d, J = 2.8 Hz, 1H), 2.40-2.34 (m, 
2H), 1.79-1.73 (m, 2H), 1.28 (t, J = 7.2 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ 166.3, 159.3, 
145.1, 129.7, 129.4, 123.6, 113.9, 73.0, 70.4, 68.7, 60.2, 55.3, 40.1, 35.8, 14.2. FTIR (neat): 
3484, 3453, 3431, 2976, 2935, 2861, 1714, 1654, 1612, 1586, 1513, 1464, 1367, 1302, 1246, 
1204, 1171, 1091, 1034, 980, 820, 756, 708 cm
-1
. HRMS (CI) Calcd. for C17H24O5 [M]
+
: 
308.1624, Found: 308.1613. HPLC: (Chiralcel AS-H column, hexanes:i-PrOH = 90:10, 1 






(R)-(E)-ethyl 5-cyclohexyl-5-hydroxypent-2-enoate (4.60) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-I (16.3 mg, 0.015 
mmol, 5 mol%). The tube was sealed with a rubber septum and purged with nitrogen. Dioxane 
(0.6 mL, 0.5 M), alcohol 4.60a (34.2 mg, 0.30 mmol, 100 mol%) and (E)-ethyl 4-(tert-
butoxycarbonyloxy)but-2-enoate 4.48 (138.2 mg, 0.60 mmol, 200 mol%) were added and the 
rubber septum was quickly replaced with a screw cap. The mixture was placed in an oil bath at 
90 
o
C and was allowed to stir for 48 hr. The reaction mixture was concentrated in vacuo. 
Purification of by column chromatography (SiO2; ethyl acetate: hexanes, 1:10 to 1:5) provided 
the branched product (9.5 mg, 0.042 mmol, 1:1 dr) as a colorless oil in 14% yield, and the 
desired linear product 4.60 (42.5 mg, 0.188 mmol) as a colorless oil in 63% yield. 
TLC (SiO2): Rf = 0.25 (ethyl acetate: hexanes, 1:4). [ α ]D
25 
= -11.0 (c = 1.0, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ 7.01 (ddd, J = 15.6, 7.6, 6.8 Hz, 1H), 5.91 (dt, J = 15.6, 1.6 Hz, 1H), 4.19 
(q, J = 7.2 Hz, 2H), 3.51 (dt, J = 14, 4.8 Hz, 1H), 2.46-2.28 (m, 2H), 1.87-1.74 (m, 4H), 1.73-
1.65 (m, 2H), 1.29 (t, J = 6.8 Hz, 3H), 1.41-0.97 (m, 6H). 
13
C NMR (100 MHz, CDCl3): δ 166.4, 
146.0, 123.5, 74.6, 60.2, 43.2, 37.1, 29.0, 27.8, 26.3, 26.1, 25.9, 14.2 Hz. FTIR (neat): 3434, 
2972, 2851, 1718, 1702, 1652, 1449, 1393, 1368, 1318, 1265, 1206, 1162, 1695, 1039, 977, 892, 
828, 712 cm
-1
. HRMS (CI) Calcd. for C13H23O3 [M+H]
+
: 227.1647, Found: 227.1646. HPLC: 
(Chiralcel AD-H column, hexanes:i-PrOH = 90:10, 0.5 mL/min, 254 nm), tmajor = 14.2 min, tminor 







(R)-(E)-ethyl 5-hydroxy-6,6-dimethylhept-2-enoate (4.62) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-I (16.3 mg, 0.015 
mmol, 5 mol%) and alcohol 4.62a (26.5 mg, 0.30 mmol, 100 mol%). The tube was sealed with a 
rubber septum and purged with nitrogen. Dioxane (0.6 mL, 0.5 M) and (E)-ethyl 4-(tert-
butoxycarbonyloxy)but-2-enoate 4.48 (138.2 mg, 0.60 mmol, 200 mol%) were added and the 
rubber septum was quickly replaced with a screw cap. The mixture was placed in an oil bath at 
90 
o
C and was allowed to stir for 48 hr. The reaction mixture was concentrated in vacuo. 
Purification of by column chromatography (SiO2; ethyl acetate: hexanes, 1:20 to 1:10) provided 
the desired linear product 4.62 (35.5 mg, 0.177 mmol) as a colorless oil in 59% yield. 
TLC (SiO2): Rf = 0.20 (ethyl acetate: hexanes, 1:6). [ α ]D
25 
= +37.0 (c = 1.0, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ 7.04 (ddd, J = 15.6, 8, 6.4 Hz, 1H), 5.92 (dt, , J = 15.6, 1.2 Hz, 1H), 4.19 
(q, , J = 6.8 Hz, 2H), 3.39-3.35 (m, 1H), 2.48-2.41 (m, 1H), 2.23-2.14 (m, 1H), 1.67 (br s, 1H), 
1.29 (t, , J = 6.8 Hz, 3H), 0.93 (s, 9H). 
13
C NMR (100 MHz, CDCl3): δ 166.4, 147.1, 123.4, 
78.3, 60.2, 35.0, 34.8, 25.6, 14.2. FTIR (neat): 3471, 2956, 2871, 1702, 1652, 1478, 1393, 1366, 
1267, 1245, 1158, 1095, 1067, 1041, 1009, 976, 934, 914, 771, 704 cm
-1
. HRMS (CI) Calcd. for 
C11H21O3 [M+H]
+
: 201.1491, Found: 201.1491. HPLC: (Chiralcel OD-H column, hexanes:i-
PrOH = 95:5, 0.5 mL/min, 254 nm), tminor = 11.4 min, tmajor = 12.3 min; ee = 96%. 
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(R)-(E)-ethyl 5-hydroxy-6-(4-methoxybenzyloxy)-6-methylhept-2-enoate (4.68) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-I (16.3 mg, 0.015 
mmol, 5 mol%). The tube was sealed with a rubber septum and purged with nitrogen. Dioxane 
(0.6 mL, 0.5 M), alcohol 4.68a (62.8 mg, 0.30 mmol, 100 mol%) and (E)-ethyl 4-(tert-
butoxycarbonyloxy)but-2-enoate 4.48 (138.2 mg, 0.60 mmol, 200 mol%) were added and the 
rubber septum was quickly replaced with a screw cap. The mixture was placed in an oil bath at 
90 
o
C and was allowed to stir for 48 hr. The reaction mixture was concentrated in vacuo. 
Purification by column chromatography (SiO2; ethyl acetate: hexanes, 0:1 to 3:7) provided the 
desired linear product 4.68 (85.0 mg, 0.264 mmol) as a colorless oil in 88% yield. 
TLC (SiO2): Rf = 0.33 (ethyl acetate: hexanes, 3:7). [ α ]D
25 
= +18 (c = 1.0, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3 J = 8.8 Hz, 2H), 7.07 (dt, J = 15.6, 1.2 Hz, 1H), 6.88 (d, J = 8.8 
Hz, 2H), 5.92 (dt, J = 15.6, 1.2 Hz, 1H), 4.40 (s, 2H), 4.18 (q, J = 7.2 Hz, 2H), 3.80 (s, 3H), 3.67 
- 3.63 (m, 1H), 2.54 (d, J = 3.2 Hz, 1H), 2.46 – 2.28 (m, 2H), 1.30 – 1.23 (m, 9H). 
13
C NMR 
(100 MHz, CDCl3): δ 166.4, 159.1, 146.6, 131.0, 128.9, 123.1, 113.8, 77.6, 76.0, 63.5, 60.2, 
55.3, 34.4, 21.5, 20.1, 14.3. FTIR (neat): 3488, 2976, 1714, 1653, 1612, 1586, 1513, 1464, 1386, 
1367, 1321, 1300, 1246, 1212, 1170, 1148, 1035, 978, 893, 821, 749, 705 cm
-1
. HRMS (CI) 
Calcd. for C18H26O5 [M]
+
: 322.1780, Found: 322.1780. HPLC: (Chiralcel OD-H column, 








(R)-(E)-ethyl 5-hydroxy-7-(4-methoxybenzyloxy)-6,6-dimethylhept-2-enoate (4.65) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-I (16.3 mg, 0.015 
mmol, 5 mol%). The tube was sealed with a rubber septum and purged with nitrogen. Dioxane 
(0.6 mL, 0.5 M), alcohol 4.65a (67.2 mg, 0.30 mmol, 100 mol%) and (E)-ethyl 4-(tert-
butoxycarbonyloxy)but-2-enoate 4.48 (138.2 mg, 0.60 mmol, 200 mol%) were added and the 
rubber septum was quickly replaced with a screw cap. The mixture was placed in an oil bath at 
90 
o
C and was allowed to stir for 48 hr. The reaction mixture was concentrated in vacuo. 
Purification by column chromatography (SiO2; ethyl acetate: hexanes, 0:1 to 3:7) provided the 
desired linear product 4.65 (76.0 mg, 0.226 mmol) as a colorless oil in 75% yield. 
TLC (SiO2): Rf = 0.33 (ethyl acetate: hexanes, 3:7). [ α ]D
25 
= +25 (c = 1.0, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3 J = 8.4 Hz, 2H), 7.07 (dt, J = 16.0, 1.2 Hz, 1H), 6.87 (d, J = 8.4 
Hz, 2H), 5.88 (dt, J = 16.0, 1.2 Hz, 1H), 4.43 (d, J = 8.4 Hz, 2H), 4.17 (q, J = 7.2 Hz, 2H), 3.80 
(s, 3H), 3.62 – 3.56 (m, 1H), 3.36 (d, J = 3.6 Hz, 1H), 3.35 (d, J = 9.2 Hz, 1H), 3.27 (d, J = 9.2 
Hz, 1H), 2.40 – 2.30 (m, 1H), 2.25 – 2.15 (m, 1H), 1.27 (t, J = 7.2 Hz, 3H), 0.92 (s, 3H), 0.91 (s, 
3H). 
13
C NMR (100 MHz, CDCl3): δ 166.4, 159.3, 147.4, 129.7, 129.2, 122.8, 113.8, 79.3, 77.4, 
73.3, 60.1, 55.2, 38.3, 35.0, 22.8, 19.6, 14.3. FTIR (neat): 3482, 2959, 2872, 1714, 1653, 1612, 
1586, 1513, 1465, 1366, 1321, 1301, 1246, 1209, 1172, 1083, 1035, 978, 912, 819, 755, 706 cm
-
1
. HRMS (CI) Calcd. for C19H28O5 [M]
+
: 336.1937, Found: 336.1937. HPLC: (Chiralcel OD-H 








 (R)-(E)-ethyl 5-hydroxy-5-(1-phenylcyclopropyl)pent-2-enoate (4.63) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-I (16.3 mg, 0.015 
mmol, 5 mol%) and alcohol 4.63a (44.5 mg, 0.30 mmol, 100 mol%). The tube was sealed with a 
rubber septum and purged with nitrogen. Dioxane (0.6 mL, 0.5 M), and (E)-ethyl 4-(tert-
butoxycarbonyloxy)but-2-enoate 4.48 (138.2 mg, 0.60 mmol, 200 mol%) were added and the 
rubber septum was quickly replaced with a screw cap. The mixture was placed in an oil bath at 
90 
o
C and was allowed to stir for 48 hr. The reaction mixture was concentrated in vacuo. 
Purification of by column chromatography (SiO2; ethyl acetate: hexanes, 1:10 to 1:5) provided 
the desired linear product 4.63 (54.9.9 mg, 0.211 mmol) as a colorless oil in 70% yield. 
TLC (SiO2): Rf = 0.30 (ethyl acetate: hexanes, 1:4). [ α ]D
25 
= -60.0 (c = 1.0, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ 7.38-7.35 (m, 2H), 7.33-7.29 (m, 2H), 7.27-7.23 (m, 1H), 6.96 (dt, J = 
15.6, 7.6 Hz, 1H), 5.83 (dt, J = 15.6, 1.6 Hz, 1H), 4.17 (q, J = 7.2 Hz, 2H), 3.31-3.26 (m, 1H), 
2.47-2.40 (m, 1H), 2.19-2.11 (m, 1H), 1.73 (d, J = 5.6 Hz, 1H), 1.27 (t, J = 7.2 Hz, 3H), 0.90-
0.86 (m, 2H), 0.84-0.80 (m, 2H). 
13
C NMR (100 MHz, CDCl3): δ 166.3, 145.7, 140.6, 131.0, 
128.2, 127.0, 123.4, 77.3, 60.2, 38.1, 31.3, 14.2, 11.1, 10.2. FTIR (neat): 3455, 3079, 3057, 
2981, 2901, 1699, 1652, 1601, 1496, 1445, 1426, 1392, 1368, 1315, 1268, 1205, 1040, 977, 936, 
762, 701 cm
-1
. HRMS (CI) Calcd. for C16H21O3 [M+H]
+
: 261.1491, Found: 261.1490. HPLC: 
(Chiralcel AD-H column, hexanes:i-PrOH = 90:10, 1 mL/min, 254 nm), tmajor = 8.6 min, tminor = 







(R)-(E)-ethyl 5-hydroxy-5-(3-methyloxetan-3-yl)pent-2-enoate (4.66) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-I (16.3 mg, 0.015 
mmol, 5 mol%). The tube was sealed with a rubber septum and purged with nitrogen. Dioxane 
(0.6 mL, 0.5 M), alcohol 4.66a (30.6 mg, 0.30 mmol, 100 mol%) and (E)-ethyl 4-(tert-
butoxycarbonyloxy)but-2-enoate 4.48 (138.2 mg, 0.60 mmol, 200 mol%) were added and the 
rubber septum was quickly replaced with a screw cap. The mixture was placed in an oil bath at 
90 
o
C and was allowed to stir for 24 hr. The reaction mixture was concentrated in vacuo. 
Purification of by column chromatography (SiO2; ethyl acetate: hexanes, 1:3 to 1:1) provided the 
desired linear product 4.68 (48.2.9 mg, 0.225 mmol) as a colorless oil in 61% yield. 
TLC (SiO2): Rf = 0.30 (ethyl acetate: hexanes, 1:1). [ α ]D
25 
= +06.0 (c = 1.0, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ 6.99 (ddd, J = 15.6, 8, 7.2 Hz, 1H), 5.94 (dt, J = 15.6, 1.6 Hz, 1H), 4.64 (d, 
J = 6 Hz, 1H), 4.51 (d, J = 6 Hz, 1H), 4.35 (d, J = 6 Hz, 1H), 4.32 (d, J = 6 Hz, 1H), 4.20 (d, J = 
7.2 Hz, 2H), 4.04 (m, 1H), 2.44 (br s, 1H), 2.33-2.20 (m, 2H), 1.33 (s, 3H), 1.30 (t, J = 6.8 Hz, 
3H). 
13
C NMR (100 MHz, CDCl3): δ 166.2, 145.0, 124.1, 80.5, 79.5, 74.2, 60.4, 43.3, 35.0, 18.6, 
14.2. FTIR (neat): 3419, 2962, 2928, 2873, 1715, 1653, 1456, 1369, 1321, 1265, 1215, 1159, 
1040, 975, 827, 699 cm
-1
. HRMS (CI) Calcd. for C11H19O4 [M+H]
+
: 215.1283, Found: 
215.1286. HPLC: (Chiralcel OB-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 254 nm), tminor = 








(R)-(E)-ethyl 5-hydroxy-5-(1-tosyl-1H-indol-3-yl)pent-2-enoate (4.67) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-I (16.3 mg, 0.015 
mmol, 5 mol%). The tube was sealed with a rubber septum and purged with nitrogen. Dioxane 
(0.6 mL, 0.5 M), alcohol 4.67a (90.4 mg, 0.30 mmol, 100 mol%) and (E)-ethyl 4-(tert-
butoxycarbonyloxy)but-2-enoate 4.48 (138.2 mg, 0.60 mmol, 200 mol%) were added and the 
rubber septum was quickly replaced with a screw cap. The mixture was placed in an oil bath at 
90 
o
C and was allowed to stir for 48 hr. The reaction mixture was concentrated in vacuo. 
Purification of by column chromatography (SiO2; ethyl acetate: hexanes, 1:10 to 1:5) provided 
the branched product (16.0 mg, 0.039 mmol, 1:1 dr) as a colorless oil in 13% yield and the 
desired linear product 4.68 (83.3 mg, 0.201 mmol) as a light brown gummy solid in 67% yield. 
TLC (SiO2): Rf = 0.30 (ethyl acetate: hexanes, 1:4). [ α ]D
25 
= -37.0 (c = 1.0, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ 8.10 (dt, J = 8.4, 0.8 Hz, 1H), 7.64 (dt, J = 8.4, 2 Hz, 2H), 7.47 (dt J = 7.2, 
0.8 Hz, 1H), 7.32-7.28 (m, 1H), 7.23 (dt, J = 8.4, 0.8 Hz, 1H), 7.18 (app d, J = 8.8 Hz, 2H), 7.05 
(dt, J = 15.6, 6.8 Hz, 1H), 6.68 (t, J = 0.8 Hz, 1H), 5.95 (dt, J = 15.6, 1.6 Hz, 1H), 5.37-5.33 (m, 
1H), 4.18, (q, J = 6.8Hz, 2H), 3.34 (d, J = 4.8 Hz, 1H), 2.98-2.82 (m, 2H), 2.32 (s 3H), 1.28 (t, J 
= 6.8 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ 166.2, 145.2, 144.4, 142.6, 137.2, 135.4, 129.9, 
129.0, 126.2, 125.1, 124.0, 123.9, 121.2, 114.8, 109.6, 65.9, 60.3, 38.4, 21.5, 14.2. FTIR (neat): 
3449, 3061, 2981, 2926, 1715, 1655, 1596, 1451, 1451, 1367, 1306, 1274, 1213, 1188, 1173, 
1149, 1120, 1090, 1044, 978, 813, 750, 704, 675, 655 cm
-1
. HRMS (CI) Calcd. for C22H24NO5S 
[M+H]
+
: 414.1375, Found: 414.1356. HPLC: (Chiralcel AS-H column, hexanes:i-PrOH = 






(R)-(E)-ethyl 5-hydroxy-5-(2-methoxyphenyl)pent-2-enoate (4.64) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-I (16.3 mg, 0.015 
mmol, 5 mol%). The tube was sealed with a rubber septum and purged with nitrogen. Dioxane 
(0.6 mL, 0.5 M), alcohol 4.64a (41.4 mg, 0.30 mmol, 100 mol%) and (E)-ethyl 4-(tert-
butoxycarbonyloxy)but-2-enoate 4.48 (138.2 mg, 0.60 mmol, 200 mol%) were added and the 
rubber septum was quickly replaced with a screw cap. The mixture was placed in an oil bath at 
90 
o
C and was allowed to stir for 48 hr. The reaction mixture was concentrated in vacuo. 
Purification by column chromatography (SiO2; ethyl acetate: hexanes, 0:1 to 3:7) provided the 
desired linear product 4.64 (60.0 mg, 0.240 mmol) as a colorless oil in 80% yield. 
TLC (SiO2): Rf = 0.25 (ethyl acetate: hexanes, 3:7). [ α ]D
25 
= +25 (c =1.0, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3 J = 7.6, 1.8 Hz, 1H), 7.26 (dd, J = 15.6, 1.8 Hz, 1H), 7.05 – 6.95 
(m, 2H), 6.88 (d, J = 8.4 Hz, 1H), 5.85 (dt, J = 15.6, 1.6 Hz, 1H), 5.03 (q, J = 6.8 Hz, 1H), 4.17 
(q, J = 6.8 Hz, 2H), 3.85 (s, 3H), 2.70 – 2.65 (m, 3H), 1.25 (t, J = 7.2 Hz, 3H). 
13
C NMR (100 
MHz, CDCl3): δ 166.4, 156.3, 145.6, 131.2, 128.7, 126.7, 123.5, 120.9, 110.4, 69.6, 60.2, 55.3, 
40.1, 14.3. FTIR (neat): 3447, 2937, 2837, 1714, 1652, 1600, 1588, 1490, 1463, 1439, 1392, 
1368, 1238, 1189, 1157, 1114, 1040, 977, 936, 782, 753, 706 cm
-1
. HRMS (CI) Calcd. for 
C14H18O4 [M-1]
+
: 249.1127, Found: 249.1127. HPLC: (Chiralcel AD-H column, hexanes:i-








4.4.8 Experiment details of Reaction from Aldehyde Oxidation Level 
(R)-(E)-ethyl 5-hydroxy-7-(4-methoxybenzyloxy)hept-2-enoate (4.69) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-I (16.3 mg, 0.015 
mmol, 5 mol%). The tube was sealed with a rubber septum and purged with nitrogen. Dioxane 
(0.6 mL, 0.5 M), freshly distilled aldehyde 4.69b (58.3 mg, 0.30 mmol, 100 mol%), (E)-ethyl 4-
(tert-butoxycarbonyloxy)but-2-enoate 4.48 (138.2 mg, 0.60 mmol, 200 mol%) and isopropyl 
alcohol (36.1 mg, 0.6 mmol, 200 mol%) were added and the rubber septum was quickly replaced 
with a screw cap. The mixture was placed in an oil bath at 90 
o
C and was allowed to stir for 24 
hr. The reaction mixture was concentrated in vacuo. Purification of by column chromatography 
(SiO2; ethyl acetate: hexanes, 1:4 to 1:2) provided the branched product (42.5 mg, 0.138 mmol, 
1:1 dr) as a colorless oil in 46% yield and the desired linear product 4.69 (17.8 mg, 0.058 mmol) 
as a colorless oil in 19% yield. 
HPLC: (Chiralcel AS-H column, hexanes:i-PrOH = 90:10, 1 mL/min, 254 nm), tminor = 10.0 min, 
tmajor = 11.1 min; ee = 83%. 
 (R)-(E)-ethyl 5-cyclohexyl-5-hydroxypent-2-enoate (4.60) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-I (16.3 mg, 0.015 
mmol, 5 mol%). The tube was sealed with a rubber septum and purged with nitrogen. Dioxane 
(0.6 mL, 0.5 M), freshly distilled aldehyde 4.60b (33.6 mg, 0.30 mmol, 100 mol%), (E)-ethyl 4-
(tert-butoxycarbonyloxy)but-2-enoate 4.48 (138.2 mg, 0.60 mmol, 200 mol%) and isopropyl 
alcohol (36.1 mg, 0.6 mmol, 200 mol%) were added and the rubber septum was quickly replaced 
with a screw cap. The mixture was placed in an oil bath at 90 
o
C and was allowed to stir for 48 
hr. The reaction mixture was concentrated in vacuo. Purification of by column chromatography 
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(SiO2; ethyl acetate: hexanes, 1:10 to 1:5) provided the branched product (8.0 mg, 0.035 mmol, 
1:1 dr) as a colorless oil in 12% yield and the desired linear product 4.60 (51.6 mg, 0.228 mmol) 
as a colorless oil in 76% yield. 
HPLC: (Chiralcel AD-H column, hexanes:i-PrOH = 90:10, 0.5 mL/min, 254 nm), tmajor = 14.2 
min, tminor = 14.9 min; ee = 92%. 
(R)-(E)-ethyl 5-hydroxy-6,6-dimethylhept-2-enoate (4.62) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-I (16.3 mg, 0.015 
mmol, 5 mol%). The tube was sealed with a rubber septum and purged with nitrogen. Dioxane 
(0.6 mL, 0.5 M), freshly distilled aldehyde 4.62a (25.8 mg, 0.30 mmol, 100 mol%), (E)-ethyl 4-
(tert-butoxycarbonyloxy)but-2-enoate 4.48 (138.2 mg, 0.60 mmol, 200 mol%) and isopropyl 
alcohol (36.1 mg, 0.6 mmol, 200 mol%) were added and the rubber septum was quickly replaced 
with a screw cap. The mixture was placed in an oil bath at 90 
o
C and was allowed to stir for 48 
hr. The reaction mixture was concentrated in vacuo. Purification of by column chromatography 
(SiO2; ethyl acetate: hexanes, 1:20 to 1:10) provided the desired linear product 4.62 (50.9 mg, 
0.254 mmol) as a colorless oil in 85% yield. 
HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 254 nm), tminor = 11.5 
min, tmajor = 12.3 min; ee = 97%. 
(R)-(E)-ethyl 5-hydroxy-6-(4-methoxybenzyloxy)-6-methylhept-2-enoate (4.65) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-I (16.3 mg, 0.015 
mmol, 5 mol%). The tube was sealed with a rubber septum and purged with nitrogen. Dioxane 
(0.6 mL, 0.5 M), aldehyde 4.65b (62.5 mg, 0.30 mmol, 100 mol%), (E)-ethyl 4-(tert-
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butoxycarbonyloxy)but-2-enoate 4.48 (138.2 mg, 0.60 mmol, 200 mol%) and isopropyl alcohol 
(36.1 mg, 0.6 mmol, 200 mol%) were added and the rubber septum was quickly replaced with a 
screw cap. The mixture was placed in an oil bath at 90 
o
C and was allowed to stir for 48 hr. The 
reaction mixture was concentrated in vacuo. Purification by column chromatography (SiO2; ethyl 
acetate: hexanes, 0:100 to 3:7) provided the desired linear product 4.65 (68.0 mg, 0.211 mmol) 
as a colorless oil in 70% yield. 
HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 96:4, 0.75 mL/min, 210 nm), tminor = 21.6 
min; tmajor = 26.4 min, ee = 99%. 
(R)-(E)-ethyl 5-hydroxy-7-(4-methoxybenzyloxy)-6,6-dimethylhept-2-enoate (4.65) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-I (16.3 mg, 0.015 
mmol, 5 mol%). The tube was sealed with a rubber septum and purged with nitrogen. Dioxane 
(0.6 mL, 0.5 M), aldehyde 4.68b (66.6 mg, 0.30 mmol, 100 mol%), (E)-ethyl 4-(tert-
butoxycarbonyloxy)but-2-enoate 4.48 (138.2 mg, 0.60 mmol, 200 mol%) and isopropyl alcohol 
(36.1 mg, 0.6 mmol, 200 mol%) were added and the rubber septum was quickly replaced with a 
screw cap. The mixture was placed in an oil bath at 90 
o
C and was allowed to stir for 48 hr. The 
reaction mixture was concentrated in vacuo. Purification by column chromatography (SiO2; ethyl 
acetate: hexanes, 0:100 to 3:7) provided the desired linear product 4.68 (84.0 mg, 0.250 mmol) 
as a colorless oil in 83% yield. 
HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 96:4, 0.75 mL/min, 280 nm), tmajor = 23.3 
min, tminor = 22.4 min; ee = 99%. 




To a resealable pressure tube equipped with a magnetic stir bar was added (R)-I (16.3 mg, 0.015 
mmol, 5 mol%). The tube was sealed with a rubber septum and purged with nitrogen. Dioxane 
(0.6 mL, 0.5 M), aldeyde 4.63b (43.9 mg, 0.30 mmol, 100 mol%), (E)-ethyl 4-(tert-
butoxycarbonyloxy)but-2-enoate 4.48 (138.2 mg, 0.60 mmol, 200 mol%) and isopropyl alcohol 
(46 36.1 mg, 0.6 mmol, 200 mol%) were added and the rubber septum was quickly replaced with 
a screw cap. The mixture was placed in an oil bath at 90 
o
C and was allowed to stir for 48 hr. The 
reaction mixture was concentrated in vacuo. Purification of by column chromatography (SiO2; 
ethyl acetate: hexanes, 1:10 to 1:5) provided the desired linear product 4.63 (46.7 mg, 0.179 
mmol) as a colorless oil in 60% yield. 
HPLC: (Chiralcel AD-H column, hexanes:i-PrOH = 90:10, 1 mL/min, 254 nm), tmajor = 8.7 min, 
tminor = 10.2 min; ee = 93%. 
(R)-(E)-ethyl 5-hydroxy-5-(3-methyloxetan-3-yl)pent-2-enoate (4.66) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-I (16.3 mg, 0.015 
mmol, 5 mol%). The tube was sealed with a rubber septum and purged with nitrogen. Dioxane 
(0.6 mL, 0.5 M), aldehyde 4.66b (30.0 mg, 0.30 mmol, 100 mol%), (E)-ethyl 4-(tert-
butoxycarbonyloxy)but-2-enoate 4.48 (138.2 mg, 0.60 mmol, 200 mol%) and isopropyl alcohol 
(36.1 mg, 0.6 mmol, 200 mol%) were added and the rubber septum was quickly replaced with a 
screw cap. The mixture was placed in an oil bath at 90 
o
C and was allowed to stir for 48 hr. The 
reaction mixture was concentrated in vacuo. Purification of by column chromatography (SiO2; 
ethyl acetate: hexanes, 1:3 to 1:1) provided the desired linear product 4.66 (37.2 mg, 0.174 
mmol) as a colorless oil in 58% yield. 
HPLC: (Chiralcel OB-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 254 nm), tminor = 9.6 min, 




 (R)-(E)-ethyl 5-hydroxy-5-(1-tosyl-1H-indol-3-yl)pent-2-enoate (4.67) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-I (16.3 mg, 0.015 
mmol, 5 mol%). The tube was sealed with a rubber septum and purged with nitrogen. Dioxane 
(0.6 mL, 0.5 M), aldehyde 4.67b (89.9 mg, 0.30 mmol, 100 mol%), (E)-ethyl 4-(tert-
butoxycarbonyloxy)but-2-enoate 4.48 (138.2 mg, 0.60 mmol, 200 mol%) and isopropyl alcohol 
(36.1 mg, 0.6 mmol, 200 mol%) were added and the rubber septum was quickly replaced with a 
screw cap. The mixture was placed in an oil bath at 90 
o
C and was allowed to stir for 48 hr. The 
reaction mixture was concentrated in vacuo. Purification of by column chromatography (SiO2; 
ethyl acetate: hexanes, 1:10 to 1:5) provided the branched product (20.0 mg, 0.048 mmol, 1:1 dr) 
as a light brown solid in 16% yield and the desired linear product 4.67 (97.2 mg, 0.235 mmol) as 
a light brown gummy solid in 78% yield. 
HPLC: (Chiralcel AS-H column, hexanes:i-PrOH = 90:10, 1.0 mL/min, 254 nm), tmajor = 11.0 
min, tminor = 16.4 min; ee = 96%. 
(R)-(E)-ethyl 5-hydroxy-5-(2-methoxyphenyl)pent-2-enoate (4.64) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-I (16.3 mg, 0.015 
mmol, 5 mol%). The tube was sealed with a rubber septum and purged with nitrogen. Dioxane 
(0.6 mL, 0.5 M), aldehyde 4.64b (40.8 mg, 0.30 mmol, 100 mol%), (E)-ethyl 4-(tert-
butoxycarbonyloxy)but-2-enoate 4.48 (138.2 mg, 0.60 mmol, 200 mol%) and isopropyl alcohol 
(36.1 mg, 0.6 mmol, 200 mol%) were added and the rubber septum was quickly replaced with a 
screw cap. The mixture was placed in an oil bath at 90 
o
C and was allowed to stir for 48 hr. The 
reaction mixture was concentrated in vacuo. Purification by column chromatography (SiO2; ethyl 
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acetate: hexanes, 0:100 to 3:7) provided the desired linear product 4.64 (60.0 mg, 0.240 mmol) 
as a colorless oil in 80% yield. 
HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 90:10, 1 mL/min, 254 nm), tmajor = 16.9 
min, tminor = 18.7 min; ee = 94%. 
4.4.9 Experiment Details Catalyst-Directed Diastereoafacial Selection 
(R), (E)-ethyl 5-hydroxy-5-[(4R,5R)-2,2,4,5-tetramethyl-1,3-dioxolan-4-yl]pent-2-enoate 
(4.71) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (R)-I (16.3 mg, 0.015 
mmol, 5 mol%). The tube was sealed with a rubber septum and purged with nitrogen. Dioxane 
(0.6 mL, 0.5 M), alcohol 4.70 (48.1 mg, 0.30 mmol, 100 mol%) and (E)-ethyl 4-(tert-
butoxycarbonyloxy)but-2-enoate 4.48 (138.2 mg, 0.60 mmol, 200 mol%) were added and the 
rubber septum was quickly replaced with a screw cap. The mixture was placed in an oil bath at 
90 
o
C and was allowed to stir for 72 hr. The reaction mixture was concentrated in vacuo. 
Purification of by column chromatography (SiO2; ethyl acetate: hexanes, 1:10 to 1:5) provided 
the desired linear product 4.71 (55.4 mg, 0.203 mmol) as a colorless oil in 68% yield. 
TLC (SiO2): Rf = 0.25 (ethyl acetate: hexanes, 1:4). [ α ]D
25 
= +11.0 (c = 2.0, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ 7.01 (dt, J = 15.6, 7.2 Hz, 1H), 5.94 (dt, J = 15.6, 1.6 Hz, 1H), 4.22 (q, J = 
6.4 Hz, 1H), 4.19 (q, J = 7.2 Hz, 2H), 3.67 (dt, J = 10.8, 2.8 Hz, 1H), 2.48-2.42 (m, 2H), 2.26-
2.17 (m, 1H), 1.45 (s, 3H), 1.36 (s, 3H), 1.29 (t, 3H, J = 7.2 Hz, 3H), 1.27 (d, J = 6.4 Hz, 3H), 
1.11 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ 166.3, 145.6, 123.6, 106.9, 83.9, 74.6, 74.4, 60.3, 
34.4, 28.7, 26.6, 17.3, 15.6, 14.2. FTIR (neat): 3477, 2983, 2938, 2879, 1720, 1654, 1457, 1370, 
1324, 1249, 1217, 1190, 1095, 1040, 1000, 979, 909, 860, 818, 721, 680 cm
-1
. HRMS (CI) 
Calcd. for C14H25O5 [M+H]
+
: 273.1702, Found: 273.1703. 
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 (S), (E)-ethyl 5-hydroxy-5-[(4R,5R)-2,2,4,5-tetramethyl-1,3-dioxolan-4-yl]pent-2-enoate 
(epi-4.71) 
 
To a resealable pressure tube equipped with a magnetic stir bar was added (S)-I (16.3 mg, 0.015 
mmol, 5 mol%). The tube was sealed with a rubber septum and purged with nitrogen. Dioxane 
(0.6 mL, 0.5 M), alcohol 4.70 (48.1 mg, 0.30 mmol, 100 mol%) and (E)-ethyl 4-(tert-
butoxycarbonyloxy)but-2-enoate 4.48 (138.2 mg, 0.60 mmol, 200 mol%) were added and the 
rubber septum was quickly replaced with a screw cap. The mixture was placed in an oil bath at 
90 
o
C and was allowed to stir for 48 hr. The reaction mixture was concentrated in vacuo. 
Purification of by column chromatography (SiO2; ethyl acetate: hexanes, 1:10 to 1:5) provided 
the desired linear product epi-4.71 (46.0 mg, 0.169 mmol) as a colorless oil in 56% yield. 
TLC (SiO2): Rf = 0.24 (ethyl acetate: hexanes, 1:4). [ α ]D
25 
= -44.0 (c = 1.0, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ 7.04 (dt, J = 15.6, 7.2 Hz, 1H), 5.92, (dt, J = 15.6, 1.6 Hz, 1H), 4.23 (q, J = 
6.0 Hz, 1H), 4.19 (q, J = 7.2 Hz, 2H), 3.53 (ddd, J = 10.4, 7.6, 3.2 Hz, 1H), 2.44-2.38 (m, 1H), 
2.34-2.26 (m, 1H), 2.20 (d, J = 7.6 Hz, 1H), 1.45 (s, 3H), 1.37 (s, 3H), 1.29 (t, J = 7.2 Hz, 3H), 
1.22 (d, J = 6.0 Hz, 3H), 1.09 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ δ 166.2, 145.5, 123.6, 
107.2, 84.4, 74.4, 72.8, 60.2, 35.1, 28.6, 26.8, 17.2, 14.6, 14.2. FTIR (neat): 3499, 2984, 2936, 
1717, 1654, 1456, 1370, 1321, 1251, 1216, 1178, 1095, 1042, 1008, 979, 929, 862, 822, 714 cm
-
1
. HRMS (CI) Calcd. for C14H25O5 [M+H]
+







4.4.10 Determination of Absolute Stereochemistry 
The absolute stereochemistry of the vinylogous Aldol-Reformatsky addition product was 
determined by comparision of the optical rotation with the reported compound. Compound 4.60 
was converted to diol 4.60c by ozonolysis and NaBH4 reduction of the corresponding ozonide. 



















Chapter 5: Total Synthesis of (+)-Roxaticin via Iridium Catalyzed Transfer Hydrogenation 
Allylation Protocols 
5.1 Introduction 
 Polyketide natural products represent a broad class of secondary metabolites used 
extensively in human medicine.
90,91
 Approximately 20% of the top-selling small molecule drugs 
are polyketides,
91
 and it is estimated that polyketides are five times more likely to possess drug 
activity compared to other natural product families.
92e
 As investigations into polyketide 
biosynthesis
92
 and chemical biology continue to uncover important biological pathways and 




 methods for polyketide 
construction remains at the forefront of research. Roxaticin is a member of oxopolyene
95
 
macrolide antibiotic natural product. It was isolated from soil bacteria genus Steptpmyces.
96
 
Roxaticin has interesting biological activities as shown by other members of this class like RK-
397 and mycoticin A, the latter being the first isolated member of this class (Figure 5.1).  
 
Figure 5.1 Oxo-polyene macrolide natural products. 
The complex issues of stereoselectivity posed by polyketides are most often addressed 
through the use of chiral auxiliaries, chiral reagents and premetallated nucleophiles.
97
 Although 
such methods are highly effective, their use mandates multi-stage preactivation and excessive 
byproduct generation. Inspired by the atom-economy of asymmetric hydrogenation, we have 
developed a broad family of C-C bond forming hydrogenations,
98
 which provide an alternative to 
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stoichiometric organometallic reagents in certain carbonyl and imine additions, as we have 
discussed some of the method in this volume of study. Specially in chapter 3, we have discussed 
the application of iridium catalyzed carbonyl allylation under transfer hydrogenation condition in 
the synthesis of 1,3-polyols.
99
 Here, we showcase the utility of this methodology in a total 
synthesis of the oxo-polyene macrolide (+)-roxaticin. Notably, our approach to this complex 
polyketide is achieved in the absence of chiral reagents or chiral auxiliaries, with minimal use of 
premetallated C-nucleophiles. 
5.2 Retrosynthetic Analysis 
The retrosynthetic analysis is presented in Scheme 5.1. The macrocyclic ring was formed 
according to the Yamaguchi lactonization. Installation of the oxopentaene fragment exploited a 
sequence involving cross metathesis-Horner-Wadsworth-Emmons olefination, which led to 
fragments A, acrolein and 5.2. C27-28 olefin of 5.2 was prepared using cross metathesis 
reaction. Elaboration of the protected 1,3-polyol 5.3 to (+)-roxaticin required  differential 
elongation of the homotopic diol termini, which was achieved via sequential dehydration-cross-
metathesis at C28 and direct carbonyl crotylation from the alcohol oxidation level at C14. 
Iterative two-directional carbonyl allylation of 1,3- diols was envisioned to deliver the requisite 




Scheme 5.1 Retrosynthetic analysis of the oxo-polyene macrolide (+) roxaticin. 
5.3 Synthesis of (+)-Roxaticin 
Our approach to (+)-roxaticin takes advantage of carbonyl allylation and crotylation
 
protocols recently developed in our laboratory, wherein primary alcohol dehydrogenation 
triggers reductive generation of allyliridium nucleophiles, thus enabling asymmetric carbonyl 
allylation and crotylation directly from the alcohol oxidation level. The convergent synthesis of 
roxaticin was performed by synthesis of the three fragments A, B and C.  
5.3.1 Synthesis of Fragment A: Triene Phosphonate Ester 
The fragment A, phosphonate ester was the Horner-Wadsworth-Emmons intermediate 
which would desirably couple to the aldehyde prepared from 5.2 and acrolein metathesis 
product. The fragment A was previously synthesized by Roush in 11 steps, for the synthetic 
studies towards tetrafibricin.
100
 Conversely, we were able to synthesize the same intermediate in 
7 steps. Our approach started with LiAlH4 reduction of commercially 1,6-hexadiyne 5.5 to 
symmetric 2,4-hexadiene-1,6-diol 5.6 in 72% yield. This diol was subjected to TBS protection 
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conditions resulted in mono TBS silly ether 5.7 in 67% yield. However, the unreacted starting 
material was resubmitted to the same conditions for a combined 76% yield. The primary alcohol 
5.7 was submitted to Swern oxidation produce aldehyde 5.8 in 64% yield. For synthesis of 
fragment A, from this point onwards, all reactions were performed in dark due to instability of 
polyene part. The aldehyde was subjected to Horner-Wadsworth-Emmons olefination conditions 
with triethyl phosphonoacetate and LiHMDS, the reaction afforded intermediate trienoate ester 
5.9 in 73% yield. Deprotection of silyl ether 5.9 using TBAF in THF afforded alcohol 5.10 in 
quantitative yield. The alcohol 5.10 is a solid and can be store in freezer in dark. This allylic 
alcohol 5.10 was subjected to brominating condition, resulting in allylic bromide using PBr3. The 
allylic bromide was very unstable and was directly treated with triethylphosphite and catalytic 
pyridine, in refluxing toluene to produce the phosphonate fragment A in 70% yield over two 
steps (Scheme 5.2). 
 





5.3.2 Synthesis of Fragment B: syn-Crotyl Alcohol 
 The fragment B is essentially a syn-crotylation product of isobutryraldehyde. As 
discussed earlier our approach to (+)-roxaticin takes advantage of carbonyl allylation and 
crotylation protocols
10
 developed in our laboratory, wherein primary alcohol dehydrogenation 
triggers reductive generation of allyliridium nucleophiles, thus enabling asymmetric carbonyl 
allylation and crotylation directly from the alcohol oxidation level. This redox economy can be 
utilized in proficient synthesis of roxaticin.  The synthesis of fragment B commence with the 
crotylation of the iso-butyralalcohol to give the crotyl product 5.14 in 57% yield and 6:1 dr and 
98% ee. However, we found out that crotylation of iso-butyraldeyde in the presence of iso-propyl 
alcohol (200 mol%) as reductant resulted in higher anti-diastereoselectivity (8:1) than iso-
butyralalcohol (6:1).These finding are in accordance with previous findings form our 
laboratory.
10e
  Nevertheless, to get right anti-diastereomer, the alcohol has to be inverted. Before 
long, we found out that any variation of Mitsunobu inversion was not fruitful, possibly due to the 
steric hindrance of the two contiguous isopropyl group on each side of reacting alcohol. On the 
other hand, it was possible to perform substitution on the corresponding mesylate. The crotyl 
alcohol 5.14 was converted to mesylate 5.15 in 91% yield using standard mesylation condition 
(Scheme 5.3). Treatment of this mesylate with cesium benzoate resulted in substitution product 
5.16 in slightly inferior yield, and more importantly with minimal enantiomeric erosion (Table 
5.1) 
Scheme 5.3 Synthesis of fragment B. 
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 It was unsuccessful to optimization the substitution of 5.15 using cesium benzoate, by 
changing reaction conditions. The solvent screening however, displayed the reaction is slightly 
faster in DMF (Table 5.1). Increase in reaction temperature result in elimination pathway. 
Table 5.1 Solvent effect on substitution on mesylate 5.15. 
 
Additionally, the nucleophilic partner cesium benzoate salts were screened. The 
introduction of electron donating substitution at benzoate resulted in improvement in the product 
yield. The 3- N,N-dimethylbenzoate 5.24 and 4-N,N-dimethylbenzoate 5.25 both resulted in 39% 
product yield (Table 5.2, entries 4 and 5). However, the same effect was not true for methoxy 
substituent. Cesium 4-methoxybenzoate gave poor yield 5.26 while 3,4-dimethoxybenzoate gave 
slightly higher yield 5.27 (Table 5.2, entries 6 and 7). As the electron donating substituent at 3-
position resulted in slight improvement the 3,5-dimethoxybenzoate 5.29 resulted in higher yield 
(42%) among the nucleophile screened (Table 5.2, entry 9). The 2,6-dimethoxybenzoate 5.28 on 
the other hand, gave slightly lowered yield possibly due to steric hindrance. The benylic and 







Table 5.2 Effect of different cesium benzoate on substitution.  
 
We were able to utilized the benzoate as protecting group, however, later in the synthesis, 
we found out that it was not effective and we needed to use PMB ether as protecting alcohol in 
fragment B. We were able to perform protecting group exchange by DIBAL reduction of 3,5-
dimethoxybenzoate in quantitative yield. Treatment of the corresponding crotyl alcohol with 
PMBCl and NaH provided the desire fragment B, 5.18, in 86% yield (Scheme 5.3).  
As we witnessed this approach requires inversion of the crotyl alcochol to acquire the 
correct syn-diastereoselectivity and protection-deprotection sequence increases the number of 
steps, this no longer remains a desirable route. The same fragment B has been synthesized before 
using Brown crotylation method.
101
 We were able to reproduce the same conditions in our 
laboratory. PMB protection resulted in the fragment B in two steps. Recently, our research group 
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has devoted studies towards development of syn-crotylation protocols
102
 which would enable us 
to provide a second generation synthesis of fragment B. 
 
Scheme 5.4 Brown crotylation in synthesis of syn-crotyl fragment B. 
5.3.3 Synthesis of Fragment C: Polyol Fragment 
Two directional bis C-allylation was conducted with 1,3-propanediol with the ortho-
cyclometalated iridium C,O-benzoate (R)-I generated in situ from [Ir(cod)Cl]2, (R)-Cl,MeO-
BIPHEP, 4-chloro-3- nitrobenzoic acid, and allyl acetate, double allylation product 5.32 was 
isolated in 70% yield and >99% ee. Conversion of 5.32 to acetonide 5.33 followed by ozonolysis 
of the olefinic termini provides the homologous diol 5.34, constituting “one iteration” of two-
directional carbonyl allylation from the alcohol oxidation level. In subsequent iterations of two-
directional carbonyl allylation, ozonolysis reactions were quenched with NaBH4 to furnish the 
homologous diols. In large scale ozonolysis reactions, NaBH4 reduction of the ozonide is 
preferred as this protocol circumvents generation of stoichiometric organic byproducts; hence, 
facilitates product purification. 
Subsequent iteration of two-directional carbonyl allylation of 5.34 was conducted. 
Double allylation product 5.35 was produced in 71% yield and >20:1 dr. Protection with TBS 
group (5.36) followed by ozonolysis generated diol 5.37, which was ready for the third carbonyl 
bisallylation reaction. The final bis-allylation produced bis-homoallylic alcohol 5.38 in 78% and 
>20:1 dr. Protecting group exchange (5.39) followed by ozonolysis furnished three acetonide 
protected diol 5.3. With all three iterations of two-directional allylation, complete levels of 
catalyst-directed diastereoselectivity were observed, providing rapid access to the acetonide-
protected C2-symmetric 1,3-polyol 5.3 as a single diastereomer. Thus, trisacetonide 5.3, which 





Scheme 5.5 Synthesis of trisacetonide fragment using three iteration of iridium catalyzed 
bisallylation reaction. 
Differentiation of diol temini of tris-acetonide 5.3 was required. Grieco’s two-step 
method
103
 for primary alcohol dehydration was conducted. Because the diol termini of 5.3 are 
homotopic, the selenylation product appeared as a component of a statistical mixture with 1.1 eq 
of O-(NO2)PhSeCN. Mono-selenide 24 was obtained in 50% yield along with the formation of 
diselenide in 18% yield. Recovered starting material 5.3 (21%) was re-submitted to the second 
round of the reaction. The combined yield of the two reactions was 60%. The second elimination 
step was very sensitive to base and the amount of H2O2, NaHCO3 appeared to be the best base 




Scheme 5.6 Synthesis of fragment C in total synthesis of (+)-roxaticin.   
5.3.4 End Game: Combing Fragments 
Once we have all fragments in hand, cross metathesis was attempted with the previously 
prepared homoallylic ether fragments C and B with various catalytic systems. Hoveyda-Grubbs 
II catalyst With 10 mol% of loading, 53% of cross coupling product 5.41 was obtained in DCM 
at 40 
o
C. Direct carbonyl crotylation from the alcohol oxidation level at C14 using the preformed 
iridium C,O-benzoate complex (S)-II delivered the desired adduct 27 in 85% yield with 14:1 
anti-diastereoselectivity, (Scheme 5.7). 
 
Scheme 5.7 Combination of fragment B and C by cross methathesis and crotylation of the 5.41. 
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With homoallylic alcohol 5.42 in hand, installation of the polyene substructure was 
undertaken. The unprotected homoallylic alcohol 5.42 was subjected to cross metathesis with 
acrolein to deliver the corresponding enal 5.43 in 74% yield (BRSM) with complete (E)-




 TES protection and DDQ deprotection of PMB ether 
resulted in hydroxyl enal 5.44. Exposure of the enal 5.44 to the previously reported Horner-
Wadsworth-Emmons intermediate fragments A, delivered polyunsaturated ester 5.45 in 61% 
yield. Ester hydrolysis followed by Yamaguchi lactonization and global deprotection, as 
practiced in prior syntheses by Mori and Evans, were attempted to deliver (+)-roxaticin. This 
three-step sequence delivered (+)-roxaticin in 31% yield, (Scheme 5.8). 
 
Scheme 5.8 End game of synthesis of (+)-roxaticin. 
5.4 Summary 
In summary the total synthesis of (+)-roxaticin was possible using the iterative 
bisallylation to construct the C2-symmetric 1,3-polyol substructure C14−C28 unit of roxaticin. 
This fragment was elaborated to roxaticin employing transformation that resulted in functional 
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groups that were directly compatible with the next transformation, e.g. alcohols were directly 
reacted under iridium catalyzed crotylation reaction and alkenes were subjected to cross 
metathesis.  (+)-Roxaticin is prepared from 1,3-propane diol in 20 longest linear steps and a total 
number of 29 manipulations. In this approach, nine of ten C-C bonds formed in the longest linear 
sequence was made via metal catalysis, including 7 C-C bonds formed via iridium catalyzed 
alcohol C-C coupling. This approach bypasses the redox manipulations and use of any chiral 
auxiliary. Notably, this total synthesis represents the most concise preparation of any oxo-
polyene macrolide reported to date, and is achieved in the absence of chiral reagents, chiral 




5.5 Experimental Section 
5.5.1 Fragment A: Experimental Details and Spectral Data  
(2E,4E)-hexa-2,4-diene-1,6-diol (5.6) 
 
Literature procedure was followed. To a stirred solution of 1,6-hexadiyne 5.5 (1 g, 9.08 mmol, 
100 mol%) in THF (100 mL, 0.09 M) at 0 
o
C was added LiAlH4 (1.72 g, 45.41 mmol, 500 
mol%) in four portions. The reaction mixture was stirred at 0 
o
C for 30 min and heated to reflux 
for 24 h. The reaction mixture was diluted with ether (100 mL) and carefully quench with H2O (2 
mL), 15% aqueous NaOH (2 mL) and H2O (5 mL). The suspension is filtered through celite and 
the residue was rinsed with ethyl acetate. The filterate is dried over MgSO4, concentrated in 
vacuo to give the desire diol 5.6 (0.88g, 7.74 mmol) as white solid in 85 % yield. 
1
H NMR [(400 MHz, ( CD)3CO)]: δ 6.27-6.19 (m, 2H), 5.81-5.71 (m, 2H), 4.09 (brs, 4H), 3.78 
(s, 2H). 
13
C NMR [100 MHz,( CD)3CO)]: δ 133.9, 130.2, 62.8. FTIR (neat): υ 3484, 1726, 
1712, 1242, 1030, 991, 889, 671 cm
-1






To a stirred solution of imidazole (1.23 g, 18.07 mmol, 150 mol%) in DMF (24 mL, 0.75 M) was 
dropwise added solution of diol 5.6 (2.05 g, 12.05 mmol, 100 mol%) in DMF (5 mL, 2.4 M) at 
ambient temperature. The reaction mixture was stirred for 45 min. TBSCl (1.99 g, 13.25 mmol, 
110 mol%) was added to reaction mixture in one portion. The reaction mixture was stirred for 20 
h at ambient temperature. H2O (25 mL) was added to reaction mixture and the resulting solution 
was extracted with ether (50 mL x 3). The combined organic extracts were washed with brine 
(20 mL), dried over Na2SO4, filtered and concentrated in vacuo. The residue was purified by 
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column chromatography (SiO2: ethyl acetate:hexanes, 1:10 to 1:4) to give the mono protected 
diol 5.7 (1.85 g, 8.10 mmol) as a colorless liquid in 67% yield. 
TLC (SiO2): Rf = 0.45 (ethyl acetate:hexanes, 1:1). 
1
H NMR (400 MHz, CDCl3): δ 6.26-6.16 
(m, 2H), 5.80-5.70 (m, 2H), 4.19 (d, J = 4.8 Hz, 2H), 4.13 (d, J = 7.0 Hz, 2H), 1.84 (br s, 1H), 
0.88 (s, 9H), 0.04 (s, 6H). 
13
C NMR (100 MHz, CDCl3): δ 132.9, 131.5, 130.7, 128.9, 63.3, 63.1, 
25.9, 18.3, -5.3. FTIR (neat): υ 3355, 2958, 2954, 2929, 2883, 2856, 1471, 1463, 1370, 1361, 
1254, 1109, 1081, 987, 774, 672 cm
-1






To a stirred solution of oxalyl chloride (1.2 mL, 13.79 mmol, 150 mol%) in DCM (35 mL, 0.4 
M) at -78 
o
C was added DMSO (1 mL, 13.79 mmol, 150 mol%). The reaction mixture was 
allowed to stir for 20 min at -78 
o
C. The alcohol 5.7 (2.1 g, 9.19 mmol, 100 mol%) in DCM (12 
mL, 0.75 M) was added to reaction mixture and the resulting solution was allowed to stir for 30 
min at -78 
o
C. Triethylamine (6.4 mL, 45.97 mmol, 500 mol%) was added to the reaction 
mixture. The resulting solution was allowed to stir for 30 min at -78 
o
C, warmed to ambient 
temperature and stirred for 5 hr. The reaction was quenched with H2O (40 mL) and extracted 
with DCM (80 mL x 3). The combined organic phase was washed with H2O (40 mL), brine (40 
mL), dried with MgSO4 and concentrated in vacuo. The residue was purified by column 
chromatography (SiO2: ethyl acetate:hexanes, 1:10 with 0.1% TEA) to give the aldehyde 5.8 
(1.33 g, 5.87 mmol) as a slightly yellow oil in 64% yield. 
TLC (SiO2): Rf = 0.40 (ethyl acetate:hexanes, 1:10). 
1
H NMR (400 MHz, CDCl3): δ 9.53 (d, J = 
8.0 Hz, 1H), 7.10 (dd, J = 14.8, 11.2 Hz, 1H), 6.56-6.49 (m, 1H), 6.29 (dt, J = 14.8, 4 Hz, 1H), 
6.11 (dd, J = 15.6, 7.6 Hz, 1H), 4.31 (dd, J = 4.0, 2.0 Hz, 2H), 0.89 (s, 9H), 0.06 (s, 6H). 
13
C 
NMR (100 MHz, CDCl3): δ 193.7, 151.6, 144.3, 131.1, 126.6, 62.7, 25.8, 25.6, -5.5. FTIR 
(neat): υ 2954, 2929, 2883, 2856, 2722, 1682, 1644, 1602, 1471, 1445, 1377, 1352, 1252, 1161, 
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1131, 1010, 986, 960, 809, 775, 675. HRMS (CI) Calcd. for C12H23O2Si [M+H]
+
: 227.1467, 
Found: 227.1467.  
(2E,4E,6E)-ethyl 8-(tert-butyldimethylsilyloxy)octa-2,4,6-trienoate (5.9) 
 
To a stirred solution of the triethyl phosphonoacetate (2.9 mL, 14.48 mmol, 110 mol%) in THF 
(66 mL, 0.22 M) was added LiHMDS (1M solution in THF, 13.8 mL, 13.82 mmol, 105 mol%) at 
0 
o
C and the reaction mixture was stirred for 20 min. The aldehyde 5.8 (3 g, 13.16 mmol, 100 
mol%) in THF (10 mL, 1.3 M) was added dropwise to reaction mixture at 0 
o
C. The reaction 
mixture was warmed to ambient temperature in 3 hr, quenched with saturated aq. NH4Cl (50 mL) 
and extracted with ether (100 mL x 3). The combined organic phase was washed with H2O (50 
mL), brine (50 mL), dried over Na2SO4 and concentrated in vacuo. The residue was purified by 
column chromatography (SiO2: diethyl ether:hexanes, 1:20 to 1:10 with 0.1% TEA) to give the 
ester 5.9 (2.85 g, 9.61 mmol) as a colorless oil in 73% yield. 
TLC (SiO2): Rf = 0.35 (diethyl ether:hexanes, 1:10). 
1
H NMR (400 MHz, CDCl3): δ 7.30 (dd, J 
= 15.2, 11.2 Hz, 1H), 6.56 (dd, J = 15.2, 10.8 Hz, 1H), 6.39-6.31 (m, 1H), 6.28 (dd, J = 14.0, 
10.4 Hz, 1H), 5.97 (dt, J = 15.2, 4.8, Hz, 1H), 5.86 (d, J = 15.2 Hz, 1H), 4.27 (d, J = 4.4 Hz, 2H), 
4.20 (q, J = 7.2 Hz, 2H), 1.29 (t, J = 7.2 Hz, 3H), 0.92 (s, 9H), 0.08 (s, 6H). 
13
C NMR (100 
MHz, CDCl3): δ 167.1, 144.5, 140.1, 137.7, 129.3, 128.5, 120.7, 63.1, 60.2, 25.9, 18.4, 14.3, -
5.3. FTIR (neat): υ 2954, 2929, 2885, 2856, 1704, 1637, 1618, 1471, 1377, 1338, 1294, 1272, 
1247, 1098, 1014, 977, 941, 892, 776, 744, 716, 666. HRMS (CI) Calcd. for C16H29O3Si 
[M+H]
+
: 297.1886, Found: 297.1890. 
(2E,4E,6E)-ethyl 8-hydroxyocta-2,4,6-trienoate (5.10) 
 
To a stirred solution of ester 5.9 (2.52 g, 8.49 mmol, 100 mol%) in THF (42 mL, 0.2 M) was 
added TBAF (1M solution in THF, 10.2 mL, 10.2 mmol, 120 mo%) at 0 
o
C. The reaction 
mixture was stirred at 0 
o
C for 1 hr and Ethyl acetate (200 mL) was added. The the organic layer 
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was washed with H2O (50 mL x 2), brine (50 mL) and dried with Na2SO4. The organic phase 
was concentrated in vacuo and the residue was was purified by column chromatography (SiO2: 
ethyl acetate:hexanes, 1:1 with 0.1% TEA) to give the alcohol 5.10 (1.50 g, 8.32 mmol) as a 
white solid in 98% yield. 
TLC (SiO2): Rf = 0.40 (ethyl acetate:hexanes, 1:1). 
1
H NMR (400 MHz, CDCl3): δ 7.26 (dd, J = 
15.2, 11.6 Hz, 1H), 6.54 (dd, J = 14.8, 10.8 Hz, 1H), 6.36-6.24 (m, 2H), 6.00 (dt, J = 14.8, 5.6 
Hz, 1H), 5.84 (d, J = 15.6 Hz, 1H), 4.27 (d, J = 4.8 Hz, 2H), 4.16 (q, J = 7.2 Hz, 2H), 2.35 (br s, 
1H), 1.26 (t, J = 7.2 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ 167.1, 144.3, 139.8, 137.1, 129.8, 
129.6, 121.0, 62.7, 60.3, 14.2. FTIR (neat): υ 3303, 3199, 3017, 2993, 2901, 2951, 1705, 1615, 
1588, 1479, 1444, 1336, 1260, 1214, 1179, 1132, 1086, 967, 915, 876, 843, 814, 778, 747, 715, 
692. HRMS (CI) Calcd. for C10H15O3 [M+H]
+
: 183.1021, Found: 183.1025. 
(2E,4E,6E)-ethyl 8-(diethoxyphosphoryl)octa-2,4,6-trienoate (A) 
 
To a stirred solution of the alcohol 5.10 (570 mg, 3.13 mmol, 100 mol%) in DCM (11 mL, 0.3 
M) was added pyridine (30 μL, 0.38 mmol, 12 mol%) followed by PBr3 (1M solution in DCM, 
4.7 mL, 4.70 mmol, 150 mol%) at 0 
o
C for 10 min. The reaction was quenched with water (20 
mL) and extracted with ether (20 mL x 3). The combined organic phase was washed with water 
(20 mL), saturated aq. NaHCO3 (30 mL), brine (30 mL), dried with Na2SO4, filtered and 
concentrated in vacuo to give allylic bromide as white semi solid which was used without any 
further purification. 
The allylic bromide was dissolved in toluene (21 mL, 0.15 M) and triethylphosphite (1.35 mL, 
7.82 mmol, 250 mol%) was added. The reaction mixture was heated at reflux for 12 hr. Ethyl 
acetate (21 mL) was added and the reaction mixture was washed with water (20 mL x 3) and 
brine (20 mL). The organic phase was dried with Na2SO4, filtered and concentrated in vacuo. 
The residue was purified by column chromatography (SiO2: ethyl acetate:hexanes, 3:1 to 5:1) to 
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give the desire phosphonate ester A (662 mg,  2.189 mmol) as a light yellow semi solid in 70% 
yield over two steps. 
TLC (SiO2): Rf = 0.30 (ethyl acetate). 
1
H NMR (400 MHz, CDCl3): δ 7.27 (dd, J = 15.2, 10.8 
Hz, 1H), 6.48 (dd, J = 15.2, 10.4 Hz, 1H), 6.31-6.23 (m, 2H), 5.83 (d, J = 15.6 Hz, 1H), 5.87-
5.81 (m, 1H), 4.20 (q, J = 7.2 Hz, 2H), 4.15-4.07 (m, 4H), 2.65 (dd, J = 23.2, 7.6 Hz, 2H), 1.30 
(t, J = 7.2 Hz, 6H), 1.28 (t, J = 7.2 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ 167.0, 144.1 (d, J = 
12 Hz), 139.6 (d, J = 20.8 Hz), 134.3 (d, J = 59.6 Hz), 129.7 (d, J = 20.8 Hz), 127.2 (d, J = 53.6 
Hz), 121.3, 62.1 (d, J = 26.8 Hz), 60.3, 31.9, 30.5, 16.5, 16.4, 14.3. FTIR (neat): υ 3443, 2982, 
2828, 2901, 1704, 1632, 1618, 1584, 1445, 1368, 1393, 1231, 1188, 1148, 1133, 1018, 961, 894, 
844, 786, 714. HRMS (CI) Calcd. for C14H24O5P [M+H]
+
: 303.1361, Found: 303.1363. 
5.5.2 Fragment B: Experimental Details and Spectral Data  
(3R,4S)-2,4-Dimethylhex-5-en-3-ol (5.14) 
 
To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with [Ir(cod)Cl]2 
(33.6 mg, 0.05 mmol, 2.5 mol%), (S)-SEGPHOS (61.1 mg, 0.1 mmol, 5 mol%), Cs2CO3 (0.13 g, 
0.4 mmol, 20 mol%) and 4-cyano-3-nitrobenzoic acid (38.4 mg, 0.2 mmol, 10 mol%) was added 
THF (1.0 mL) followed by acetic acid 3-buten-2-yl ester (0.46 g, 4.0 mmol, 200 mol%). The 
reaction mixture was allowed to stir at 90 
o
C for 0.5 hr and cooled to ambient temperature. 
Isobutyraldehyde 5.12 (0.183 mL, 2.0 mmol, 100 mol%) in THF (1.0 mL) and isopropanol (0.3 
mL, 4.0 mmol, 200 mol%) were added to the reaction mixture and the reaction mixture was 
allowed to stir at 90 
o
C for 48 hr. The reaction mixture, without the removal of solvent, was 
passed through silica gel (elution with diethyl ether:pentane, 1:10) and carefully concentrated. 
The residue was purified by distillation (bp = 155-170 
o
C) to give 5.14 (0.141 g, 1.100 mmol, 
anti:syn = 8:1) as a colorless oil in 55% yield. 
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TLC (SiO2): Rf = 0.35 (diethyl ether:pentane, 1:10). [α]
26
D  = +76.7 (c = 0.3, CHCl3). 
1
H NMR 
(400 MHz, CDCl3): δ 5.82-5.72 (m, 1H), 5.13-5.07 (m, 2H), 3.07 (dd, J = 10.4, 4.8 Hz, 1H), 
2.35-2.29 (m, 1H), 1.76-1.71 (m, 1H), 1.50 (d, J = 4.4 Hz, 1H), 1.01 (d, J = 6.8 Hz, 3H), 0.95 (d, 
J = 6.8 Hz, 3H), 0.90 (d, J = 6.8 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ 140.7, 116.4, 79.6, 
41.6, 30.5, 20.1, 17.2, 16.6. FTIR (neat): υ 3419, 3075, 2960, 2931, 2872, 1460, 1413, 1382, 
1240, 1171, 1131, 1086, 963, 950, 910, 850, 811 cm
-1
. Chrial GC: Enantiomeric excess was 
determined by chiral GC using Cyclosil-B (30 m, Inter diameter  0.320 mm and film 0.25 μm) 
column using method 50 
o
C for 3 min and 50 – 200 
o
C increasing 10 
o
C/min for 15 min. tmajor = 
8.43 min, tminor = 8.51 min; ee = 96%. 
(3R,4S)-2,4-Dimethylhex-5-en-3-yl methanesulfonate (5.15) 
 
To a stirred solution of the alcohol 5.14 (50 mg, 0.390 mmol) in DCM (2.0 mL) were added 
methanesulfonyl chloride (45 μL, 0.585 mmol), Et3N (0.11 mL, 0.780 mmol) and DMAP (9.5 
mg, 0.078 mmol) at 0 
o
C. The reaction mixture was stirred for 4 hr at ambient temperature, and 
then quenched with H2O (1 mL). The resulting solution was extracted with DCM (10 mL × 2). 
The combined organic extracts were washed with brine (10 mL), dried over MgSO4, filtered and 
concentrated in vacuo. The residue was purified by column chromatography (SiO2: ethyl 
acetate:hexanes, 1:20 to 1:10 with 0.1% TEA) to give 5.15 (73.4 mg, 0.356 mmol) as a colorless 
oil in 91% yield. 
TLC (SiO2): Rf = 0.30 (ethyl acetate:hexanes, 1:10). [α]
26
D  = +53.3 (c = 0.6, CHCl3). 
1
H NMR 
(400 MHz, CDCl3): δ 5.84-5.74 (m, 1H), 5.15-5.07 (m, 2H), 4.45 (t, J = 6.0 Hz, 1H), 3.03 (s, 
3H), 2.61-2.55 (m, 1H), 2.04-1.94 (m, 1H), 1.09 (d, J = 7.2 Hz, 3H), 1.01 (d, J = 6.8 Hz, 3H), 
0.98 (d, J = 6.8 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ 139.7, 116.4, 92.5, 40.9, 39.2, 30.2, 
20.0, 18.1, 17.7. FTIR (neat): υ 2970, 2936, 2879, 1743, 1465, 1417, 1332, 1170, 999, 971, 840, 
805 cm
-1
. HRMS (CI) Calcd. for C9H19O3S [M+H]
+




(3S,4S)-2,4-Dimethylhex-5-en-3-yl 3,5-dimethoxybenzoate (5.16) 
 
To a stirred solution of the mesylate 5.15 (0.5 g, 2.424 mmol) in DMF (12.1 mL) was added 
cesium 3,5-dimethoxybenzoate (3.8 g, 12.12 mmol) at ambient temperature. The reaction 
mixture was stirred for 20 hr at 70 
o
C, and then quenched with H2O (5 mL). The resulting 
solution was extracted with EtOAc (20 mL × 2). The combined organic extracts were washed 
with brine (10 mL × 2), dried over MgSO4, filtered and concentrated in vacuo. The residue was 
purified by column chromatography (SiO2: ethyl acetate:hexanes, 1:50 to 1:20 with 0.1% TEA) 
to give 5.16 (0.30 g, 1.026 mmol) as a colorless oil in 42% yield. 
TLC (SiO2): Rf = 0.48 (ethyl acetate:hexanes, 1:10). [α]
26
D  = +44.0 (c = 0.5, CHCl3). 
1
H NMR 
(400 MHz, CDCl3): δ 7.21-7.19 (m, 2H), 6.66-6.63 (m, 1H), 5.79-5.69 (m, 1H), 5.09 (dd, J = 
17.2, 1.2 Hz, 1H), 4.01 (dd, J = 10.4, 1.2 Hz, 1H), 3.82 (s, 6H), 2.63-2.56 (m, 1H), 2.06-2.00 (m, 
1H), 1.03 (d, J = 6.8 Hz, 3H), 0.95 (d, J = 6.8 Hz, 3H), 0.92 (d, J = 6.8 Hz, 3H). 
13
C NMR (100 
MHz, CDCl3): δ 166.5, 160.9, 140.6, 132.7, 115.3, 107.5, 105.4, 81.6, 55.8, 40.2, 30.0, 20.0, 
16.8, 15.8. FTIR (neat): υ 2965, 2932, 2869, 2839, 1716, 1644, 1595, 1457, 1427, 1387, 1352, 
1323, 1299, 1230, 1204, 1101, 1048, 998, 979, 952, 914, 844 cm
-1
. HRMS (CI) Calcd. for 
C17H25O4 [M+H]
+
: 293.1753, Found: 293.1751. 
(3S,4S)-2,4-dimethylhex-5-en-3-ol (5.17) 
 
To a stirred solution of the ester 5.16 (1.93 g, 6.60 mmol, 100 mol%) in DCM (33 mL, 0.2 M) 
was dropwise added neat DIBAL (2.82 g, 19.80 mmol, 300 mol%) at -78 
o
C. The reaction 
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mixture was stirred for 1 hr at 70 
o
C and allowed to warm to ambient temperature for 12 h. The 
reaction mixture was cooled to 0 
o
C and carefully quenched with MeOH (3 mL) and stirred at 
amient temperature for 15 min. The reaction mixture was filtered through celite and carefully 
concentrated. The residue was purified by column chromatography (SiO2: ether:pentane, 1:20 to 
1:15) to give 5.17 (0.83 g, 6.47 mmol) as a colorless oil in 98% yield. 
TLC (SiO2): Rf = 0.40 (ether:pentane, 1:15). [α]
26
D  = -35.0 (c = 1.0, CHCl3). 
1
H NMR (400 MHz, 
CDCl3): δ 5.83-5.75 (m, 1H), 5.10-5.04 (m, 2H), 3.16 (dd, J = 5.8 Hz, 1H), 2.36 (m, 1H), 1.75 
(m, 1H), 1.38 (m, 1H), 1.02 (d, J = 6.4 Hz, 3H), 0.93 (d, J = 6.8, 3H), 0.92 (d, J = 6.8, 3H). 
13
C 
NMR (100 MHz, CDCl3): δ141.8, 114.6, 79.4, 40.5, 30.4, 19.5, 17.1, 13.4. FTIR (neat): υ 3388, 
3077, 2962, 2932, 2905, 2874, 1641, 1460, 1419, 1383, 1368, 1286, 1236, 1087, 981, 960, 846, 
758 cm
-1
. HRMS (CI) Calcd. for C8H17O [M+H]
+
: 129.1279, Found: 129.1277. Chrial GC: 
Enantiomeric excess was determined by chiral GC using Cyclosil-B (30 m, Inter diameter  0.320 
mm and film 0.25 μm) column using method 50 
o
C for 3 min and 50 – 200 
o
C increasing 10 
o
C/min for 15 min. tmajor = 8.84 min, tminor = 8.95 min; ee = 92%. 
1-(((3S,4S)-2,4-dimethylhex-5-en-3-yloxy)methyl)-4-methoxybenzene (5.18, B) 
 
Literature procedure was followed
3
. To sodium hydride (0.41 g of 60% suspension in mineral 
oil, 10.16 mmol, 220 mol%) suspension in DMSO (10 mL, 1M) was added the alcohol 5.17 
(0.59 g, 4.62 mmol, 100 mol%) in THF (4 mL, 1.1 M) at ambient temperature which resulted in 
brown color solution. The reaction mixture was stirred for 30 min. PMBCl (0.87 g, 5.54 mmol, 
120 mol%) was added and allowed to stirred for 12 hr. The reaction was quenched with brine (30 
mL) and extracted with ether (50 mL x 2). The combined organic layer was washed with brine, 
dried with Na2SO4, filtered and concentrated in vacuo. The residue was purified by column 
chromatography (SiO2: ether:hexanes, 1:100 to 1:50) to give the product 5.18, B (0.98 g, 3.97 
mmol) as a colorless oil in 86% yield. 
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TLC (SiO2): Rf = 0.35 (ether:hexanes, 1:20). [α]
26
D  = +15.0 (c = 1.0, CHCl3). 
1
H NMR (400 
MHz, CDCl3): δ 7.29 (d, J = 8.4 Hz, 2H), 6.88 (d, J = 8.4 Hz, 2H), 5.88-5.5.80 (m, 1H), 5.05 
(ddd, J = 17.2, 1.6, 1.6 Hz, 1H), 4.99-4.96 (m, 1H), 4.54 (d, J = 10.2 Hz, 1H), 4.49 (d, J =10.2 
Hz, 1H), 3.81 (s, 3H), 3.01 (t, J = 5.4 Hz, 1H), 2.47-2.43 (m, 1H), 1.88-1.83 (m, 1H), 1.08 (d, J = 
6.6 Hz, 3H), 0.96 (d, J = 6.8 Hz, 3H), 0.94 (d, J = 6.8 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ 
159.2, 142.7, 131.5, 129.2, 113.7, 113.6, 88.4, 74.9, 55.3, 41.1, 31.0, 20.4, 17.5, 15.4. FTIR 
(neat): υ 3070, 2959, 2928, 2905, 2870, 2835, 1633, 1613, 1513, 1463, 1420, 1350, 1301, 1171, 
1109, 1086, 1062, 1037, 998, 957, 911, 821, 755, 681. HRMS (CI) Calcd. for C16H25O2 [M+H]
+
: 
249.1854, Found: 249.1855. 
 
5.5.3 Fragment C: Experimental Details and Spectral Data  
(4R,6R)-Nona-1,8-diene-4,6-diol (5.32) 
 
To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with [Ir(cod)Cl]2 
(1.35 g, 2.012 mmol, 5 mol%), (R)-Cl,MeO-BIPHEP (2.61 g, 4.008 mmol, 10 mol%), Cs2CO3 
(5.22 g, 16.03 mmol, 40 mol%) and 4-chloro-3-nitrobenzoic acid (1.62 g, 8.016 mmol, 20 mol%) 
was added 1,4-dioxane (100 mL) followed by allyl acetate (43 mL, 0.401 mol, 1000 mol%). The 
reaction mixture was allowed to stir at 90 
o
C for 0.5 hr and cooled to ambient temperature. 1,3-
Propanediol (3.05 g, 40.08 mmol, 100 mol%) in 1,4-dioxane (100 mL, 0.4 M) was added to the 
reaction mixture and the reaction mixture was allowed to stir at 90 
o
C for 72 hr. The reaction 
mixture was filtered through the pad of celite and evaporated in vacuo. Purification of the 
product by column chromatography (SiO2: ethyl acetate:hexanes 1:3 to 1:1 with 0.1% TEA) 
provided 5.32 (4.36 g, 27.93 mmol, dr > 30:1) as pale yellow oil in 70% yield. 
TLC (SiO2): Rf = 0.25 (ethyl acetate:hexanes, 1:2). [α]
24
D  = –23.5 (c = 1.0, CHCl3). 
1
H NMR 
(400 MHz, CDCl3): δ 5.86-5.75 (m, 2H), 5.15-5.09 (m, 4H), 4.01-3.94 (m, 2H), 2.69 (br s, 2H), 
2.28-2.23 (m, 4H), 1.62 (t, J = 6.0 Hz, 2H). 
13
C NMR (100 MHz, CDCl3): δ 134.9, 118.3, 68.3, 
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42.2, 41.7. FTIR (neat): υ 3346, 3076, 3005, 2978, 2936, 1827, 1641, 1433, 1335, 1230, 1131, 
1071, 1046, 994, 871, 830 cm
-1
. HRMS (CI) Calcd. for C9H17O2 (M+H)
+
: 157.1229, Found: 
157.1225. HPLC: Enantiomeric excess was determined by HPLC analysis of bis-4-nitro-
benzoate derivative of the product. (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 1.0 
mL/min, 254 nm), tminor = 17.2 min, tmajor = 40.8 min; ee > 99%. 
(4R,6R)-4,6-Diallyl-2,2-dimethyl-1,3-dioxane (5.33) 
 
To a stirred solution of the diol 5.4 (3.5 g, 22.42 mmol, 100 mol%) in DCM (224 mL, 0.1 M) 
were added 2,2-dimethoxypropane (41 mL, 0.336 mol, 1500 mol%) and pyridinium p-
toluenesulfonate (0.56 g, 2.242 mmol, 10 mol%) at ambient temperature. The reaction mixture 
was stirred for 1 hr and quenched with saturated aq. NaHCO3 (100 mL). The aqueous layer was 
extracted with DCM (100 mL × 2). The combined organic extracts were washed with brine (20 
mL), dried over MgSO4, filtered and concentrated in vacuo. The residue was purified by column 
chromatography (SiO2: ethyl acetate:hexanes, 1:50 to 1:15 with 0.1% TEA) to give the acetonide 
5.33 (3.99 g, 20.33 mmol) as a colorless oil in 91% yield. 
TLC (SiO2): Rf = 0.40 (ethyl acetate:hexanes, 1:20). [α]
24
D  = –56.0 (c = 1.0, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ 5.84-5.73 (m, 2H), 5.10-5.01 (m, 4H), 3.88-3.80 (m, 2H), 2.33-2.25 (m, 
2H), 2.21-2.13 (m, 2H), 1.59 (t, J = 7.6 Hz, 2H), 1.34 (s, 6H). 
13
C NMR (100 MHz, CDCl3): δ 
134.7, 117.1, 100.5, 66.4, 40.4, 37.7, 25.1. FTIR (neat): υ 3077, 2986, 2937, 1831, 1642, 1431, 
1377, 1361, 1172, 1121, 1015, 993, 911, 833, 814 cm
-1
. HRMS (CI) Calcd. for C12H21O2 
[M+H]
+





To a stirred solution of the acetonide 5.33 (3.8 g, 19.36 mmol, 100 mol%) in DCM/MeOH (1:1, 
130 mL, 0.15 M) was bubbled ozone at −78 
o
C until a blue color persisted. The excess ozone 
was then purged with argon for 5 min. Sodium borohydride (7.3 g, 0.194 mol, 1000 mol%) was 
added in one portion at – 78 
o
C and the resulting solution was slowly warmed to ambient 
temperature. The mixture was stirred for 24 hr at ambient temperature, and then quenched with 
H2O (40 mL). The resulting mixture was concentrated and extracted with DCM (200 mL × 2). 
The combined organic extracts were dried over MgSO4, filtered and concentrated in vacuo. The 
residue was purified by column chromatography (SiO2: ethyl acetate:hexanes, 1:1 to ethyl 
acetate:methanol, 20:1 with 0.1% TEA) to give the diol 5.34 (3.42 g, 16.74 mmol) as a colorless 
oil in 86% yield. 
TLC (SiO2): Rf = 0.28 (ethyl acetate). [α]
25
D  = –29.0 (c = 1.0, CH2Cl2). 
1
H NMR (400 MHz, 
CDCl3): δ 4.08-4.00 (m, 2H), 3.71 (m, 4H), 2.62 (s, 2H), 1.75-1.69 (m, 4H), 1.66 (t, J = 7.6 Hz, 
2H), 1.34 (s, 6H). 
13
C NMR (100 MHz, CDCl3): δ 100.8, 66.8, 61.1, 38.3, 37.9, 25.1. FTIR 
(neat): υ 3357, 2986, 2939, 2879, 2359, 1654, 1441, 1416, 1381, 1223, 1164, 1123, 1014, 974, 
937, 902, 877 cm
-1
. HRMS (CI) Calcd. for C10H21O4 [M+H]
+
: 205.1440, Found: 205.1438. 
(2S,2'S)-1,1'-((4R,6R)-2,2-Dimethyl-1,3-dioxane-4,6-diyl)dipent-4-en-2-ol (5.35) 
 
To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with [Ir(cod)Cl]2 
(0.58 g, 0.857 mmol, 5 mol%), (S)-Cl,MeO-BIPHEP (1.12 g, 1.714 mmol, 10 mol%), Cs2CO3 
(2.23 g, 6.856 mmol, 40 mol%) and 4-chloro-3-nitrobenzoic acid (0.69 g, 3.428 mmol, 20 mol%) 
was added THF (43 mL) followed by allyl acetate (1.85 mL, 0.171 mol, 1000 mol%). The 
reaction mixture was allowed to stir at 90 
o
C for 0.5 hr and cooled to ambient temperature. The 
diol 5.34 (3.5 g, 17.14 mmol, 100 mol%) in THF (43 mL) was added to the reaction mixture and 
the reaction mixture was allowed to stir at 110 
o
C for 48 hr. The reaction mixture was filtered 
through the pad of celite and evaporated in vacuo. Purification of the product by column 
chromatography (SiO2: ethyl acetate:hexanes 1:3 to 1:1 with 0.1% TEA) provided 5.35 (3.46 g, 
12.17 mmol, dr > 20:1) as pale yellow oil in 71% yield. 
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TLC (SiO2): Rf = 0.30 (ethyl acetate:hexanes, 1:3). [α]
24
D  = –18.0 (c = 1.0, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ 5.85-5.74 (m, 2H), 5.11-5.06 (m, 4H), 4.17-4.09 (m, 2H), 3.86 (br m, 2H), 
2.61 (br s, 2H), 2.25-2.15 (m, 4H), 1.66-1.55 (m, 6H), 1.33 (s, 6H). 
13
C NMR (100 MHz, 
CDCl3): δ 135.1, 118.0, 100.9, 67.9, 64.6, 42.3, 41.5, 38.0, 25.0. FTIR (neat): υ 3415, 3075, 
2985, 2938, 2917, 2850, 1837, 1717, 1640, 1433, 1380, 1222, 1163, 1129, 1081, 1035, 994, 869, 
810 cm
-1
. HRMS (CI) Calcd. for C16H29O4 (M+H)
+




To a stirred solution of the diol 5.35 (0.49 g, 1.723 mmol, 100 mol%) in DMF (3.4 mL, 0.5 M) 
were added imidazole (0.47 g, 6.892 mmol, 400 mol%) and TBSCl (0.78 g, 5.169 mmol, 300 
mol%) at ambient temperature. The reaction mixture was allowed to stir for 48 hr at 45 
o
C, and 
then quenched with H2O (5 mL). The reaction mixture was extracted with EtOAc (15 mL × 2). 
The combined organic extracts were washed with H2O (3 mL × 2), dried over MgSO4, filtered 
and concentrated in vacuo. The residue was purified by column chromatography (SiO2: ethyl 
acetate:hexanes, 1:50 to 1:30 with 0.1% TEA) to give 5.36 (0.75 g, 1.464 mmol) as a colorless 
oil in 85% yield. 
TLC (SiO2): Rf = 0.33 (ethyl acetate:hexanes, 1:30). [α]
26
D  = +24.0 (c = 0.5, CHCl3). 
1
H NMR 
(400 MHz, CDCl3): δ 5.88-5.77 (m, 2H), 5.11-5.01 (m, 4H), 3.95-3.82 (m, 4H), 2.30-2.16 (m, 
4H), 1.67-1.41 (m, 6H), 1.33 (s, 6H), 0.89 (s, 18H), 0.68 (s, 12H). 
13
C NMR (100 MHz, CDCl3): 
δ 135.0, 127.2, 99.9, 68.8, 63.8, 44.1, 42.8, 39.3, 26.2, 25.9, 18.3, -3.7, -4.2. FTIR (neat): υ 
3078, 2989, 2945, 2929, 2882, 2856, 1641, 1472, 1462, 1434, 1377, 1253, 1223, 1168, 1112, 
1061, 1003, 948, 912, 833 cm
-1
. HRMS (CI) Calcd. for C28H57O4Si2 [M+H]
+








To a stirred solution of 5.36 (0.58 g, 1.132 mmol, 100 mol%) in DCM/MeOH (1:1, 57 mL, 0.02 
M) was bubbled ozone at −78 
o
C until a blue color persisted. The excess ozone was then purged 
with argon for 5 min. Sodium borohydride (0.43 g, 11.32 mmol, 1000 mol%) was added in one 
portion at –78 
o
C and the resulting solution was slowly warmed to ambient temperature. The 
mixture was stirred for 12 hr at ambient temperature, and then quenched with H2O (5 mL). The 
resulting solution was then concentrated and extracted with DCM (20 mL × 2). The combined 
organic extracts was dried over MgSO4, filtered and concentrated in vacuo. The residue was 
purified by column chromatography (SiO2: ethyl acetate:hexanes, 1:3 to 1:1 with 0.1% TEA) to 
give the diol 5.37 (0.50 g, 0.962 mmol) as a colorless oil in 85% yield. 
TLC (SiO2): Rf = 0.24 (ethyl acetate:hexanes, 1:2). [α]
26
D  = +28.0 (c = 1.0, CHCl3). 
1
H NMR 
(400 MHz, CDCl3): δ 4.01-3.93 (m, 2H), 3.90-3.71 (m, 4H), 3.70-3.65 (m, 2H), 2.40 (br s, 2H), 
1.86-1.53 (m, 10H), 1.31 (s, 6H), 0.85 (s, 18H), 0.67 (s, 6H), 0.53 (s, 6H). 
13
C NMR (100 MHz, 
CDCl3): δ 100.3, 69.1, 64.1, 59.7, 43.7, 39.4, 39.2, 26.1, 26.0, 25.7, 18.2, -4.1, -4.3. FTIR (neat): 
υ 3398, 2986, 2951, 2992, 2882, 2856, 2242, 1472, 1462, 1429, 1379, 1252, 1223, 1165, 1055, 
1005, 938, 909 cm
-1
. HRMS (CI) Calcd. for C26H57O6Si2 [M+H]
+




To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with [Ir(cod)Cl]2 
(32.2 mg, 0.048 mmol, 5 mol%), (S)-Cl,MeO-BIPHEP (62.5 mg, 0.096 mmol, 10 mol%), 
Cs2CO3 (0.125 g, 0.384 mmol, 40 mol%) and 4-chloro-3-nitrobenzoic acid (39 mg, 0.192 mmol, 
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20 mol%) was added THF (2.4 mL) followed by allyl acetate (1.04 mL, 9.599 mol, 1000 mol%). 
The reaction mixture was allowed to stir at 90 
o
C for 0.5 hr and cooled to ambient temperature. 
The diol 5.37 (0.5 g, 0.960 mmol, 100 mol%) in THF (2.4 mL) was added to the reaction mixture 
and the reaction mixture was allowed to stir at 110 
o
C for 48 hr, at which point the reaction 
mixture was evaporated onto silica gel. Purification of the product by column chromatography 
(SiO2: ethyl acetate:hexanes 1:5 to 1:3 with 0.1% TEA) provided 5.38 (0.45 g, 0.749 mmol, dr > 
20:1) as pale yellow oil in 78% yield. 
TLC (SiO2): Rf = 0.28 (ethyl acetate:hexanes, 1:3). [α]
26
D  = +15.0 (c = 0.3, CHCl3). 
1
H NMR 
(400 MHz, CDCl3): δ 5.87-5.76 (m, 2H), 5.12-5.07 (m, 4H), 3.94-3.81 (m, 6H), 2.99 (s, 2H), 
2.21 (t, J = 6.4 Hz, 4H), 1.85-1.76 (m, 2H), 1.74-1.68 (m, 2H), 1.62-1.53 (m, 6H), 1.32 (s, 6H), 
0.88 (s, 18H), 0.79 (s, 12H). 
13
C NMR (100 MHz, CDCl3): δ 135.2, 117.7, 100.5, 70.3, 69.0, 
64.4, 44.4, 43.9, 42.6, 39.8, 26.1, 25.3, 18.1, -4.0, -4.1. FTIR (neat): υ 3432, 3075, 2948, 2928, 
2856, 2030, 1720, 1641, 1472, 1462, 1429, 1379, 1359, 1251, 1223, 1165, 1115, 1063, 1003, 
938, 912 cm
-1
. HRMS (CI) Calcd. for C32H65O6Si2 (M+H)
+




To a stirred solution of 5.38 (0.4 g, 0.666 mmol, 100 mol%) in methanol (6.7 mL, 0.1 M) was 
added p-toluenesulfonic acid monohydrate (12.7 mg, 0.067 mmol, 10 mol%). The reaction 
mixture was stirred for 1 hr at ambient temperature. TLC analysis showed complete consumption 
of the starting material. The reaction mixture was diluted with 2,2-dimethoxypropane (8.2 mL, 
66.55 mmol, 10000 mol%) and stirred for 1 hr at ambient temperature. After concentrated in 
vacuo, the residue was diluted with 2,2-dimethoxypropane (4.1 mL, 33.28 mmol, 5000 mol%) 
and stirred for 1 hr at ambient temperature. The reaction mixture was again concentrated in 
vacuo. 2,2-Dimethoxypropane (4.1 mL, 33.28 mmol, 5000 mol%) was added and the reaction 
mixture was stirred for 1 hr at ambient temperature. The reaction mixture was diluted with 
EtOAc (30 mL) and washed with saturated aq. NaHCO3 (15 mL) and brine (15 mL). The organic 
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layer was dried over MgSO4, filtered and concentrated in vacuo. The residue was purified by 
column chromatography (SiO2: ethyl acetate:hexanes, 1:20 to 1:15 with 0.1% TEA) to give 5.39 
(0.28 g, 0.619 mmol) as a colorless oil in 93% yield. 
TLC (SiO2): Rf = 0.38 (ethyl acetate:hexanes, 1:10). [α]
26
D  = +18.5 (c = 0.6, CHCl3). 
1
H NMR 
(400 MHz, CDCl3): δ 5.82-5.72 (m, 2H), 5.08-5.01 (m, 4H), 4.06-3.98 (m, 4H), 3.89-3.83 (m, 
2H), 2.31-2.25 (m, 2H), 2.16-2.09 (m, 2H), 1.55-1.46 (m, 8H), 1.40 (s, 6H), 1.36 (s, 6H), 1.30 (s, 
6H), 1.16-1.07 (m, 2H). 
13
C NMR (100 MHz, CDCl3): δ 134.1, 117.0, 100.4, 98.5, 68.7, 64.9, 
62.4, 42.2, 40.8, 39.0, 36.8, 30.2, 24.4, 19.8. FTIR (neat): υ 2989, 2941, 2907, 2860, 2239, 2106, 
1736, 1642, 1460, 1431, 1373, 1350, 1223, 1199, 1143, 1111, 1024, 981, 939, 911, 881, 812 cm
-
1
. HRMS (CI) Calcd. for C26H45O6 [M+H]
+




To a stirred solution of 5.39 (0.15 g, 0.331 mmol, 100 mol%) in in DCM/MeOH (1:1, 17 mL, 
0.02 M) was bubbled ozone at −78 
o
C until a blue color persisted. The excess ozone was then 
purged with argon for 5 min. Sodium borohydride (0.0.125 g, 3.31 mmol, 1000 mol%) was 
added in one portion at –78 
o
C and the resulting solution was warmed to ambient temperature 
slowly. The mixture was stirred for 12 hr at ambient temperature, and then quenched with H2O 
(5 mL). The resulting mixture was concentrated and extracted with DCM (20 mL × 2). The 
combined organic extracts was dried over MgSO4, filtered and concentrated in vacuo. The 
residue was purified by column chromatography (SiO2: ethyl acetate:hexanes, 1:1 to ethyl 
acetate:methanol 1:20 with 0.1% TEA) to give the diol 5.3 (0.119 g, 0.258 mmol) as a colorless 
syrup in 78% yield. 
TLC (SiO2): Rf = 0.20 (ethyl acetate:hexanes, 1:1). [α]
26
D  = +72.5 (c = 0.8, CHCl3). 
1
H NMR 
(400 MHz, CDCl3): δ 4.13-4.02 (m, 6H), 3.81-3.74 (m, 4H), 2.55-2.52 (m, 2H), 1.74-1.70 (m, 





C NMR (100 MHz, CDCl3): δ 100.7, 98.9, 77.5, 69.6, 65.2, 62.6, 60.9, 42.3, 39.1, 38.3, 
37.3, 30.5, 24.6, 20.1. FTIR (neat): υ 3400, 2990, 2942, 2917, 2882, 1467, 1422, 1380, 1346, 
1242, 1222, 1198, 1167, 1137, 1095, 1049, 1010, 936, 910, 875, 824 cm
-1
. HRMS (CI) Calcd. 
for C24H45O8 [M+H]
+
: 461.3114, Found: 461.3111.  
2-((4S,6S)-6-(((4S,6S)-6-(((4R,6R)-2,2-dimethyl-6-(2-(2-nitrophenylselanyl)ethyl)-1,3-
dioxan-4-yl)methyl)-2,2-dimethyl-1,3-dioxan-4-yl)methyl)-2,2-dimethyl-1,3-dioxan-4-
yl)ethanol (5.40)  
 
To a stirred solution of the alcohol 5.3 (288 mg, 0.626 mmol, 100 mol%) in THF (3.1 mL, 0.2 
M) were added 2-nitrophenyl selenocyanate (156 mg, 0.689 mmol, 110 mol%) and freshly 
distilled n-tributylphosphine (0.17 mL, 0.689 mmol, 110 mol%). The reaction mixture was 
stirred for 4 hr at ambient temperature and concentrated in vacuo. The residue was purified by 
column chromatography (SiO2: ethyl acetate:hexanes, 1:15 to 1:10 with 0.1% TEA) to give the 
selenide 5.40 (202 mg, 0.313 mmol) as a brownish oil in 50% yield and the starting diol 5.3 (61 
mg, 0.131 mmol, 21% recovered yield). The recovered diol 3 was subjected to second round of 
mono-selenylation to give 5.40 (29 mg, 0.066 mmol, 10% yield). 
TLC (SiO2): Rf = 0.20 (ethyl acetate:hexanes, 1:1). [α]
26
D  = +2.47 (c = 1.0, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ 8.28 (d, J = 8.0 Hz, 1H), 7.58 (d, J = 8.0 Hz, 1H), 7.51 (t, J = 7.6 Hz, 1H), 
7.30 (t, J = 7.6 Hz, 1H), 4.16-3.88 (m, 6H), 3.82-3.68 (m, 2H), 3.10-3.03 (m, 1H), 2.97-2.90 (m, 
1H), 2.56 (br s, 1H), 1.95-1.84 (m, 2H), 1.74-1.69 (m, 2H), 1.56-1.46 (m, 6H), 1.43 (s, 3H), 1.42 
(s, 3H), 1.40 (s, 3H), 1.37 (s, 3H), 1.31 (s, 6H), 1.29-1.15 (m, 4H). 
13
C NMR (100 MHz, 
CDCl3): δ 146.8, 133.6, 133.5, 129.0, 126.5, 125.3, 100.5, 98.7, 98.6, 77.2, 69.7, 68.4, 64.9, 62.4, 
62.3, 61.0, 42.2, 42.1, 38.9, 38.0, 37.0, 35.1, 30.3, 30.2, 24.4, 21.5, 19.9, 19.8. FTIR (neat): υ 
2945, 1591, 1514, 1381, 1333, 1304, 1248, 1224, 1201, 1166, 1038 cm
-1
. HRMS (CI) Calcd. for 
C30H48NO9Se [M+H]
+






To a stirred solution of the selenide 5.40 (420 mg, 0.651 mmol, 100 mol%) in THF (13 mL, 0.05 
M) were added NaHCO3 (164 mg, 1.953 mmol, 300 mol%) and H2O2 (0.71 mL, 500 mol%, 30% 
w/w in H2O). The reaction mixture was stirred for 24 hr at ambient temperature and extracted 
with EtOAc. The combined organic extracts was washed with brine, dried over MgSO4, filtered 
and concentrated in vacuo. The residue was purified by column chromatography (SiO2: ethyl 
acetate:hexanes, 1:3 with 0.1% TEA) to give the allylic ether C (251 mg, 0.566 mmol) as a 
colorless oil in 87% yield.  
TLC (SiO2): Rf = 0.45 (ethyl acetate:hexanes, 1:1). [α]
26
D  = +11.3 (c = 0.8, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ 5.85-5.77 (m, 1H), 5.24 (d, J = 17.6 Hz, 1H), 5.11 (d, J = 10.4 Hz, 1H), 
4.37-4.33 (m, 1H), 4.14-4.01 (m, 5H), 3.78-3.75 (m, 2H), 2.55 (br s, 1H), 1.74-1.70 (m, 2H), 
1.61-1.46 (m, 8H), 1.45 (s, 3H), 1.44 (s, 3H), 1.41 (s, 3H), 1.37 (s, 3H), 1.32 (s, 6H), 1.30-1.23 
(m, 2H). 
13
C NMR (100 MHz, CDCl3): δ 138.7, 115.3, 100.4, 98.6, 70.3, 69.5, 64.9, 64.7, 62.3, 
60.8, 42.1, 42.1, 38.9, 38.0, 37.1, 37.0, 30.3, 30.2, 24.4, 19.8, 19.7. FTIR (neat): υ 3491, 2989, 
2942, 2915, 1380, 1250, 1224, 1200, 1169, 1142, 1040, 1013, 992, 938, 916, 874, 827, 792 cm
-1
. 
HRMS (CI) Calcd. for C24H43O7 [M+H]
+













To a stirred solution of C (245 mg, 0.554 mmol, 100 mol%) and A (413 mg, 1.662 mmol, 300 
mol%) in DCM (5.5 mL, 0.1 M) was added Hoveyda-Grubbs catalyst 2
nd
 generation (35 mg, 
0.055 mmol, 10 mol%). The reaction mixture was stirred for 24 hr at 40 
o
C and concentrated in 
vacuo. Purification of the product by column chromatography (SiO2: ethyl acetate:hexanes 1:3 
with 0.1% TEA) provided 5.41 (195 mg, 0.29 mmol) as pale yellow oil in 53% yield. 
TLC (SiO2): Rf = 0.50 (ethyl acetate:hexanes, 1:1). [α]
26
D  = +11.0 (c = 1.0, CHCl3). 
1
H NMR 
(400 MHz, CDCl3): δ 7.27 (m, 2H), 6.86 (dd, J = 6.8, 2.0 Hz, 2H), 5.65 (dd, J = 15.6, 7.6 Hz, 
1H), 5.46 (dd, J = 15.6, 6.4 Hz, 1H), 4.47 (s, 2H), 4.36-4.27 (m, 1H), 4.14-4.02 (m, 5H), 3.80 (s, 
3H), 3.80-3.74 (m, 2H), 2.96 (m, 1H), 2.54 (br s, 1H), 2.48-2.38 (m, 1H), 1.83-1.78 (m, 1H), 
1.74-1.70 (m, 2H), 1.60-1.52 (m, 6H), 1.44 (s, 6H), 1.40 (s, 3H), 1.37 (s, 3H), 1.32 (s, 6H), 1.30-
1.21 (m, 4H), 1.06 (d, J = 6.4 Hz, 3H), 0.93 (d, J = 6.4 Hz, 6H). 
13
C NMR (100 MHz, CDCl3): δ 
158.9, 135.7, 131.1, 129.8, 129.2, 113.6, 100.4, 98.5, 98.4, 88.4, 74.7, 70.3, 69.3, 64.9, 64.7, 
62.3, 60.6, 55.1, 42.1, 39.4, 38.9, 38.2, 38.0, 37.5, 37.0, 30.9, 30.2, 24.3, 20.2, 19.7, 17.7, 15.2. 
FTIR (neat): υ 2997, 1979, 1674, 1514, 1382, 1215, 1037, 935, 746, 696, 667 cm
-1
. HRMS (CI) 
Calcd. for C38H61O9  [M-H]
+








An oven-dried sealed tube under one atmosphere of nitrogen gas was charged with alcohol 5.41 
(133 mg, 0.2 mmol, 100 mol%), (S)-II (20.7 mg, 0.02 mmol, 10 mol%), K3PO4 (43 mg, 0.20 
mmol, 100 mol%). THF (0.2 mL, 1.0 M), H2O (18 1.0 mmol, 500 mol%) and crotyl acetate 
(68 mg, 0.60 mmol, 300 mol%) were added and the mixture was stirred at ambient temperature 
for 0.5 hr. The reaction mixture was allowed to stir at 70 
o
C for 48 hr, at which point the reaction 
mixture was concentrated in vacuo. Purification of the residue by column chromatography (SiO2; 
ethyl acetate: hexanes, 1:7 with 0.1% TEA) provided 5.42 (121.9 mg, 0.17 mmol) as a yellow oil 
in 85% yield (14:1 dr). 
TLC (SiO2): Rf = 0.65 (ethyl acetate:hexanes, 1:3). [α]
26
D  = +98.0 (c = 1.0, CH2Cl2). 
1
H NMR 
(300 MHz, CDCl3): δ 7.27 (d, J = 8.4 Hz, 2H), 6.86 (d, J = 8.4 Hz, 2H), 5.86-5.77 (m, 1H), 5.65 
(dd, J = 15.2, 7.6 Hz, 1H), 5.46 (dd, J = 15.2, 6.4 Hz, 1H), 5.07 (s, 1H), 5.03 (d, J = 6.0 Hz, 1H), 
4.47 (s, 2H), 4.34-4.26 (m, 1H), 4.14-3.98 (m, 5H), 3.79 (s, 3H), 3.72-3.66 (m, 1H), 3.45 (s, 1H), 
2.97-2.94 (m, 1H), 2.44-2.39 (m, 1H), 2.24-2.20 (m, 1H), 1.83-1.78 (m, 1H), 1.56-1.46 (m, 8H), 
1.45 (s, 3H), 1.44 (s, 3H), 1.40 (s, 3H), 1.36 (s, 3H), 1.32 (s, 6H), 1.30-1.20 (m, 4H), 1.05 (d, J = 
7.2 Hz, 3H), 1.04 (d, J = 7.2 Hz, 3H), 0.93 (d, J = 6.8 Hz, 6H). 
13
C NMR (75 MHz, CDCl3): δ 
158.9, 140.4, 135.7, 131.1, 129.8, 129.2, 115.0, 113.6, 100.3, 98.6, 98.5, 88.4, 74.7, 74.6, 70.4, 
70.2, 64.9, 64.7, 62.3, 62.2, 55.1, 43.8, 42.1, 42.0, 39.7, 39.4, 38.9, 37.5, 37.4, 30.9, 30.2, 30.1, 
24.3, 20.2, 19.8, 19.8, 17.7, 15.4, 15.2. FTIR (neat): υ 3502, 2987, 2943, 1940, 1737, 1613, 
1514, 1461, 1431, 1380, 1301, 1247, 1224, 1200, 1168, 1127, 1087, 1037, 980, 936, 913, 874, 
823, 702 cm
-1
. HRMS (CI) Calcd. for C42H67O9  [M-H]
+







To a stirred solution of 5.42 (122 mg, 0.170 mmol, 100 mol%) and acrolein (48 mg, 0.85 mmol, 
500 mol%) in DCE (1.7 mL, 0.1 M) was added Hoveyda-Grubbs catalyst 2
nd
 generation (8.0 mg, 
0.013 mmol, 7.5 mol%). The reaction mixture was stirred for 24 hr at 60 
o
C. Acrolein (48 mg, 
0.85 mmol, 500 mol%) and Hoveyda-Grubbs catalyst 2
nd
 generation (8.0 mg, 0.013 mmol, 7.5 
mol%) were added and the reaction mixture was stirred for 24 hr at 60 
o
C. The reaction mixture 
was concentrated in vacuo. Purification of the product by column chromatography (SiO2: ethyl 
acetate:hexanes 1:3 with 0.1% TEA) provided the starting material 5.42 (37 mg, 0.051mmol, 
30% recovered yield) and the product 5.43 (66 mg, 0.09 mmol, 52% yield, 74% BRSM) as a pale 
yellow oil. 
TLC (SiO2): Rf = 0.25 (ethyl acetate:hexanes, 1:3). [α]
26
D  = +70.0 (c = 1.0, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ 9.53 (d, J = 8.0 Hz, 1H), 7.27 (d, J = 8.4 Hz, 2H), 6.94 (dd, J = 15.6, 8.0 
Hz, 1H), 6.85 (d, J = 8.4 Hz, 2H), 6.12 (dd, J = 15.6, 8.0 Hz, 1H), 5.65 (dd, J = 15.2, 7.6 Hz, 
1H), 5.45 (dd, J = 15.2, 6.0 Hz, 1H), 4.47 (s, 2H), 4.32-4.27 (m, 1H), 4.12-3.98 (m, 5H), 3.86-
3.80 (m, 2H), 3.79 (s, 3H), 2.97-2.93 (m, 1H), 2.49-2.40 (m, 2H), 1.83-1.77 (m, 1H), 1.56-1.46 
(m, 8H), 1.46 (s, 3H), 1.44 (s, 3H), 1.40 (s, 3H), 1.37 (s, 3H), 1.31 (s, 3H), 1.30 (s, 3H), 1.28-
1.19 (m, 4H), 1.15 (d, J = 6.8 Hz, 3H), 1.05 (d, J = 6.8 Hz, 3H), 0.93 (d, J = 6.4 Hz, 6H). 
13
C 
NMR (100 MHz, CDCl3): δ 194.0, 160.0, 158.9, 135.7, 132.9, 131.1, 129.8, 129.2, 113.6, 100.4, 
98.8, 98.5, 88.4, 74.8, 74.7, 70.8, 70.3, 64.8, 64.7, 62.3, 62.2, 55.2, 43.2, 42.1, 41.9, 40.4, 39.4, 
38.8, 37.5, 37.4, 30.9, 30.2, 30.1, 24.3, 20.2, 19.8, 19.7, 17.7, 15.6, 15.2. FTIR (neat): υ 3508, 
185 
 
2987, 2940, 1690,1613, 1514, 1459, 1380, 1301, 1247, 1224, 1200, 1168, 1127, 1085, 1036, 977, 
936, 874, 821, 732 cm
-1
. HRMS (CI) Calcd. for C43H67O10  [M-H]
+





To a stirred solution of 5.43 (37 mg, 0.05 mmol, 100 mol%) in DCM (0.5 mL, 0.1 M) were 
added 2,6-lutidine (23 µL, 0.2 mmol, 400 mol%) and TESOTf (23 µL, 0.1 mmol, 200 mol%)  at 
-78 
o
C. The reaction mixture was stirred for 2 hr at -78 
o
C, and then quenched with saturated aq. 
NaHCO3 (2 mL). The reaction mixture was extracted with DCM. The combined organic extracts 
wase washed with brine, dried over MgSO4, filtered and concentrated in vacuo. The residue was 
purified by column chromatography (SiO2: ethyl acetate:hexanes, 1:20 to 1:10 with 0.1% TEA) 
to give 5.43a (38 mg, 0.044 mmol) as a yellow oil in 87% yield. 
TLC (SiO2): Rf = 0.60 (ethyl acetate:hexanes, 1:3). [α]
26
D  = +29.0 (c = 1.0, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ 9.51 (d, J = 8.0 Hz, 1H), 7.27 (d, J = 8.0 Hz, 2H), 6.90-6.85 (m, 1H), 6.86 
(d, J = 8.0 Hz, 2H), 6.09 (dd, J = 15.6, 8.0 Hz, 1H), 5.65 (dd, J = 15.6, 8.0 Hz, 1H), 5.45 (dd, J = 
15.2, 5.6 Hz, 1H), 4.47 (s, 2H), 4.34-4.26 (m, 1H), 4.10-3.96 (m, 4H), 3.95-3.88 (m, 1H), 3.88-
3.82 (m, 1H), 3.79 (s, 3H), 2.97-2.94 (m, 1H), 2.66-2.58 (m, 1H), 2.46-2.38 (m, 1H), 1.84-1.76 
(m, 1H), 1.56-1.46 (m, 8H), 1.44 (s, 3H), 1.39 (s, 6H), 1.34 (s, 3H), 1.32 (s, 6H), 1.28-1.21 (m, 
4H), 1.12 (d, J = 6.4 Hz, 3H), 1.05 (d, J = 6.0 Hz, 3H), 0.98-0.92 (m, 15H), 0.63 (q, J = 7.6 Hz, 
6H). 
13
C NMR (75 MHz, CDCl3): δ 193.9, 160.4, 158.9, 135.6, 132.9, 131.1, 129.8, 129.1, 
113.5, 100.3, 98.4, 98.2, 88.4, 74.7, 71.5, 70.2, 65.6, 64.9, 64.7, 62.3, 55.1, 42.1, 42.0, 41.9, 41.8, 
39.4, 38.9, 37.6, 37.5,30.8, 30.2, 30.1, 24.3, 20.2, 19.7, 19.6, 17.7, 15.9, 15.1, 6.8, 5.0. FTIR 
(neat): υ 2987, 2950, 2912, 2876, 1693, 1613, 1514, 1460, 1379, 1301, 1246, 1224, 1199, 1169, 
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1128, 1083, 1034, 981, 938, 873, 854, 821, 781, 740, 726 cm
-1
. HRMS (CI) Calcd. for 
C49H81O10Si1 [M-H]
+





To a stirred solution of 5.43a (38 mg, 0.044 mmol, 100 mol%) in DCM/H2O (1.4 mL/0.07 mL, 
0.03M) was added DDQ (13 mg, 0.057 mmol, 130 mol%) at 0 
o
C. The reaction mixture was 
stirred for 2 hr at 0 
o
C, and then quenched with saturated aq. NaHCO3 (0.5 mL). The reaction 
mixture was extracted with DCM. The combined organic extracts were washed with H2O, dried 
over MgSO4, filtered and concentrated in vacuo. The residue was purified by column 
chromatography (SiO2: ethyl acetate:hexanes, 1:7 to 1:5 with 0.1% TEA) to give 5.44 (28 mg, 
0.037 mmol) as a colorless oil in 85% yield. 
TLC (SiO2): Rf = 0.40 (ethyl acetate:hexanes, 1:3). [α]
26
D  = +78.0 (c = 1.0, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ 9.50 (d, J = 7.6 Hz, 1H), 6.87 (dd, J = 15.6, 8.0 Hz, 1H), 6.09 (dd, J = 
15.6, 8.0 Hz, 1H), 5.62 (dd, J = 15.6, 6.8 Hz, 1H), 5.48 (dd, J = 15.6, 6.0 Hz, 1H), 4.34-4.31 (m, 
1H), 4.10-3.96 (m, 4H), 3.95-3.87 (m, 1H), 3.87-3.81 (m, 1H), 3.16-3.13 (m, 1H), 2.66-2.57 (m, 
1H), 2.36-2.31 (m, 1H), 1.74-1.67 (m, 1H), 1.59-1.45 (m, 8H), 1.44 (s, 3H), 1.39 (s, 6H), 1.34 (s, 
3H), 1.32 (s, 6H), 1.28-1.21 (m, 4H), 1.12 (d, J = 6.8 Hz, 3H), 1.01 (d, J = 6.8 Hz, 3H), 0.98-
0.89 (m, 15H), 0.60 (q, J = 8.0 Hz, 6H). 
13
C NMR (75 MHz, CDCl3): δ 194.0, 160.6, 134.8, 
132.9, 130.9, 100.4, 98.5, 98.3, 79.5, 71.6, 70.2, 65.7, 64.9, 64.7, 62.3, 42.2, 42.1, 41.8, 39.2, 
38.9, 37.6, 30.4, 30.2, 30.1, 24.3, 19.7, 19.6, 17.0, 15.9, 13.8, 6.8, 5.0. FTIR (neat): υ 3515, 
2987, 2950, 2876, 1692, 1634, 1459, 1379, 1224, 1199, 1168, 1142, 1084, 1021, 1006, 981, 938, 
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913, 874, 855, 816, 781, 731 cm
-1









This entire experimental procedure was performed in the dark. 
To a stirred solution of EtO2C(CH=CH)3CH2PO(OEt)2 A (34 mg, 0.111 mmol, 300 mol%) in 
THF (1.11 mL. 0.1 M) was added LHMDS (0.11 mL, 1.0 M in THF, 0.111 mmol, 300 mol%) at 
-78 
o
C. The reaction mixture was stirred for 30 min at -78 
o
C, and a solution of 5.44 (28 mg, 
0.037 mmol, 100 mol%) in THF (0.37 mL. 0.1 M) was added slowly -78 
o
C. The resulting 
solution was stirred for 30 min at -78 
o
C and gradually warmed to ambient temperature. The 
reaction mixture was stirred for an additional 8 hr, and then quenched with saturated aq. NH4Cl. 
The resulting solution was extracted with Et2O. The combined organic extracts were washed 
with brine, dried over MgSO4, filtered and concentrated in vacuo. The residue was purified by 
column chromatography (SiO2: ethyl acetate:hexanes, 1:7 to 1:5 with 0.1% TEA) to give 5.45 
(59 mg, 0.067 mmol) as a yellow oil in 61% yield. 
TLC (SiO2): Rf = 0.55 (ethyl acetate:hexanes, 1:3). [α]
26
D  = -11.0 (c = 1.0, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ 7.31 (dd, J = 14.8, 11.2 Hz, 1H), 6.59 (dd, J = 14.4, 11.2 Hz, 1H), 6.42 
(dd, J = 14.0, 10.4 Hz, 1H), 6.34-6.25 (m, 3H), 6.20 (dd, J = 14.8, 10.4 Hz, 1H), 6.07 (dd, J = 
15.2, 10.0 Hz, 1H), 5.85 (d, J = 14.8 Hz, 1H), 5.74 (dd, J = 15.2, 8.0 Hz, 1H), 5.62 (dd, J = 15.6, 
6.8 Hz, 1H), 5.49 (dd, J = 14.8, 5.2 Hz, 1H), 4.28-4.36 (m, 1H), 4.20 (q, J =7.2 Hz, 2H), 4.10-
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3.96 (m, 4H), 3.96-3.86 (m, 1H), 3.76-3.68 (m, 1H), 3.20-3.12 (m, 1H), 2.37-2.33 (m, 2H), 1.74-
1.67 (m, 1H), 1.56-1.44 (m, 8H), 1.43 (s, 3H), 1.38 (s, 6H), 1.33 (s, 3H), 1.31 (s, 6H), 1.28-1.21 
(m, 4H), 1.03-0.87 (m, 24H), 0.59 (q, J = 8.0 Hz, 6H). 
13
C NMR (75 MHz, CDCl3): δ 167.1, 
144.4, 140.8, 139.0, 137.4, 135.9, 134.8, 131.2, 131.0, 130.6, 130.5, 129.5, 120.3, 100.4, 98.6, 
98.3, 79.6, 71.9, 70.2, 66.2, 64.9, 64.7, 62.4, 62.3, 60.2, 42.6, 42.3, 42.1, 41.1, 39.2, 38.9, 37.6, 
30.5, 30.2, 30.1, 24.4, 19.8, 19.7,19.6, 17.1, 15.7, 14.3, 13.7, 6.9, 5.1. FTIR (neat): υ 3510, 2952, 
2875, 1708, 1622, 1578, 1459, 1379, 1300, 1248, 1224, 1199, 1168, 1128, 1007, 937, 912, 874, 
817, 737 cm
-1
. HRMS (ESI) Calcd. for C51H86O10Si [M+Na]
+





This entire experimental procedure was performed in the dark. 
To a stirred solution of 5.45 (59 mg, 0.067 mmol, 100 mol%) in 4:1:1 THF/MeOH/H2O (3.35 
mL, 0.02 M) was added LiOH (0.34 mL, 1.0 M in H2O, 0.335 mmol, 500 mol%) at ambient 
temperature. The reaction mixture was stirred for 6 hr at ambient temperature, and diluted with 
saturated aq. NH4Cl. The resulting solution was extracted with EtOAc. The combined organic 
extracts were dried over MgSO4, filtered and concentrated in vacuo. The resulting seco-acid was 
employed directly in the next reaction. 
To a stirred solution of the seco-acid in THF (3.35 mL, 0.02 M) were added Et3N (19 µL, 0.134 
mmol, 200 mol%) and 2,4,6-trichlrobenzoyl chloride (16 µL, 0.101 mmol, 150 mol%). The 
reaction mixture was stirred for 3 hr at ambient temperature, filtered through the pad of celite 
and diluted with toluene (10 mL). This solution was added over a period of 8 hr using a syringe 
pump to a solution of 4-dimethylaminopyridine (327 mg, 2.68 mmol, 4000 mol%) in toluene 
189 
 
(133 mL, 0.02 M) at 50 
o
C. The reaction mixture was stirred for an additional 4 hr, and toluene 
was removed under reduced pressure. The cloudy oil was diluted in 1:1 hexanes/ethyl acetate, 
filtered through a silica plug over a pad of celite and washed with 1:1 hexanes/ethyl acetate, then 
concentrated under reduced pressure to afford a bright yellow oil. The resulting oil was used 
directly in the next reaction. 
A solution of protected crude roxaticin in MeOH (5 mL) was treated with Dowex 50Wx8 acidic 
resin (100 mg). After being stirred for 4 hr, the mixture was filtered and concentrated in vacuo. 
Purification by preparative reverse-phase thin-layer chromatography (RP-18, 100x100x0.25 mm, 




D  = +11.3 (c = 0.17, dioxane). 
1
H NMR (400 MHz, DMSO- d6): δ 7.11 (dd, J = 15.6, 11.6 
Hz, 1H), 6.69 (dd, J = 15.2, 10.8 Hz, 1H), 6.47 (dd, J = 14.4, 11.2 Hz, 1H), 6.42-6.26 (m, 4H), 
6.10 (dd, J = 15.2, 10.0 Hz, 1H), 5.88 (dd, J = 15.6, 7.2 Hz, 1H), 5.82 (d, J = 15.2 Hz, 1H), 5.54 
(dd, J = 15.6, 5.1 Hz, 1H), 5.34 (dd, J = 16.0, 3.6 Hz, 1H), 5.01 (s, 1H), 4.65 (dd, J = 7.2, 2.5 Hz, 
1H), 4.59 (d, J = 3.6 Hz, 1H), 4.36 (d, J = 4.0 Hz, 1H), 4.20 (d, J = 5.4 Hz, 1H), 4.15 (m, 1H), 
4.12 (d, J = 5.0 Hz, 1H), 3.93 (d, J = 5.8 Hz, 1H), 3.84 (m, 1H), 3.98-3.72 (m, 5H), 3.42 (m, 1H), 
2.55 (m, 2H), 1.86 (m 1H), 1.48 (m, 2H), 1.40-0.99 (m, 10H), 1.00 (d, J = 6.9 Hz, 3H), 0.98 (d, J 
= 6.6 Hz, 3H), 0.92 (d, J = 6.6 Hz, 3H), 0.84 (d, J = 6.6 Hz, 3H). 
13
C NMR (75 MHz, CDCl3): δ 
166.1, 144.6, 141.1,139.2, 137.6, 135.7, 133.1, 131.0, 130.4, 129.4, 129.1, 128.7, 120.2, 79.3, 
71.0, 69.8, 67.7, 64.9, 64.3, 62.9, 62.4, 47.3, 46.7, 46.6, 44.4, 44.3, 42.6, 40.9, 35.7, 28.8, 19.7, 
18.7, 13.7, 10.8. FTIR (neat): υ 3410, 1708, 1612, 1588, 1379, 1304, 1268, 1138, 1007, 933, 
910, 872, 737 cm
-1
. HRMS (ESI) Calcd. for C41H73O9Si1 [M+Na]
+







Appendix I: NMR Spectra of New Compounds 
Chapter 2 








































































































































































































































































































































































































































































































































































































































































I Part One: Elongation of 1,3-Polyol 


























































































































































































































































III Part Two: Spectra data of Vinylogous Aldol Products  




































































IV Experiment Details Catalyst-Directed Diastereoafacial Selection 











































































































































































































6 Krische Rychnovsky Mori Evans
Me 2CH 0.84 (d, 6.5) 0.84 (d, 6.6) 0.83 (d, 6.1) 0.84 (d, 6.6) 0.84 (d, 6.6)
Me 2CH 0.93 (d, 6.5) 0.92 (d, 6.6) 0.92 (d, 7.3) 0.93 (d, 6.6) 0.92 (d, 7.0)
C13-Me 0.99 (d, 6.5) 0.98 (d, 6.6) 0.97 (d, 7.3) 0.99 (d, 6.7) 0.97 (d, 6.6)
C29-Me 1.01 (d, 7.5) 1.00 (d, 6.9) 1.00 (d, 6.1) 1.01 (d, 6.8) 1.00 (d, 7.0)
H15,17,19,21,23,25 0.95-1.34, 1.16-1.34, 1.49 (m) 0.99-1.40, 1.48 (m) 1.00-1.30 (m), 1.49 (m) 1.00-1.40, 1.49 (m) 0.99-1.32, 1.48 (m)
Me2CH 1.87 (m) 1.86 (m) 1.86 (m) 1.87 (m) 1.86 (m)
H13,29 2.55 (m) 2.55 (m) 2.55 (m) 2.55 (m) 2.55 (m)
H14,16,18,20,22,24 3.42, 3.71-3.89 (m) 3.42, 3.72-3.98 (m) 3.42, 3.73 (s) 3.42, 3.71-3.98 (m) 3.42, 3.83 (m)
CHOH 3.88 (d, 6.0) 3.84 (m) 3.83 (m) 3.87 (d, 4.6) 3.83 (m)
CHOH 3.94 (d, 6.0) 3.93 (d, 5.8) 3.93 ( d, 6.1) 3.93 (d, 5.6) 3.93 (d, 5.9)
CHOH 4.13 (d, 6.0) 4.12 (d, 5.0) 4.11 (d, 4.9) 4.12 (d, 5.1) 4.11 (d, 4.4)
H26 4.16 (m) 4.15 (m) 4.15 (m) 4.15 (m) 4.15 (m)
CHOH 4.22 (d, 5.0) 4.20 (d, 5.4) 4.20 (d, 4.9) 4.21 (d, 5.4) 4.20 (d, 5.9)
CHOH 4.38 (d, 4.5) 4.36 (d, 4.0) 4.35 (d, 3.7) 4.36 (d, 3.9) 4.36 (d, 4.4)
CHOH 4.60 (d, 4.0) 4.59 (d, 3.6) 4.58 (d, 3.7) 4.59 (d, 2.9) 4.59 (d, 3.7)
H30 4.66 (dd, 7.0, 2.5) 4.65 (dd, 7.2, 2.5) 4.64 (d, 7.3) 4.66 (dd, 9.5, 2.5) 4.64 (dd, 7.0, 2.6)
CHOH 5.00 (d, 2.5) 5.01 (s) 4.98 (s) 4.99 (s) 4.99 (s)
H28 5.35 (dd,  15.5, 3.0) 5.34 (dd, 16.0, 3.6) 5.34 (d, 15.9) 5.35 (dd, 16.4, 3.6) 5.33 (dd, 15.8, 3.3)
H27 5.55 (dd, 15.5, 4.4) 5.54 (dd,  15.6, 5.1) 5.50 (dd, 15.9, 3.7) 5.55 (dd, 15.4, 5.1) 5.53 (dd, 15.5, 5.0)
H3 5.83 (d, 15.5) 5.82 (d, 15.2) 5.81 (d, 14.6) 5.83 (d, 15.1) 5.82 (d, 15.0)
H12 5.89 (dd, 15.5, 7.0) 5.88 (dd, 15.6, 7.2) 5.87 (dd, 14.6, 6.1) 5.89 (dd, 15.1, 7.3) 5.89 (dd, 15.1, 7.0)
H11 6.12 (dd, 15.5, 10.0) 6.10 (dd, 15.2, 10.0) 6.10 (dd, 14.6, 11.0) 6.12 (dd, 15.4, 10.7) 6.10 (dd, 14.4, 11.2)
H9 6.28 (dd, 15.5, 10.0) 6.26-6.42 (m) 6.25-6.41 (m) 6.25-6.43 (m) 6.26-6.41 (m)
H7 6.33 (dd, 14.5, 10.0) 6.26-6.42 (m) 6.25-6.41 (m) 6.25-6.43 (m) 6.26-6.41 (m)
H10 6.36 (dd, 15.0, 10.0) 6.26-6.42 (m) 6.25-6.41 (m) 6.25-6.43 (m) 6.26-6.41 (m)
H5 6.40 (dd, 15.0, 11.0) 6.26-6.42 (m) 6.25-6.41 (m) 6.25-6.43 (m) 6.26-6.41 (m)
H8 6.48 (dd, 14.5, 10.0) 6.47 (dd, 14.4, 11.2) 6.47 (dd, 14.6, 11.0) 6.48 (dd, 15.1, 10.7) 6.47 (dd, 14.4, 11.2)
H6 6.70 (dd, 15.0, 10.0) 6.69 (dd, 15.2, 10.8) 6.69 (dd, 14.6, 11.0) 6.70 (dd, 14.4, 11.2) 6.70 (dd, 14.4, 11.2)
H4 7.13 (dd, 15.5, 11.0) 7.11 (dd,  15.6, 11.6) 7.11 (dd, 15.9, 12.2) 7.12 (dd, 15.4, 11.7) 7.11 (dd, 15.5, 11.7)
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